User login
Role of Shock Index in ICU Transfers
The decision to transfer a patient to the intensive care unit (ICU) from a general care setting is complex and based not only on clinical findings and patient wishes but also on the understanding that ICU resources are limited and costly.1 Adding to the decision‐making complexity is the knowledge that patients who transfer to an ICU from a general medical unit comprise the highest mortality group of ICU patients, with the mortality rate directly proportional to both the time spent on the general medical unit1, 2 and the number of physiologic abnormalities before ICU admission.3, 4
Prior studies have shown that cardiac arrest and unplanned (unexpected) transfers to the ICU are preceded by a period of physiologic instability reflected in the vital signs.510 However, vital signs alone may not accurately indicate clinical condition. For example, a person may be able to maintain normal blood pressure and heart rate despite severe illness or may have abnormal vital signs at baseline, which may be the case for an otherwise healthy young woman who has baseline low systolic blood pressure. Also, noncritical conditions commonly seen in hospitalized medical or surgical patients, such as anxiety or pain, may increase the respiratory rate or heart rate. Conversely, certain common medications, such as ‐blockers, may mask or blunt the normal physiologic response to illness. Overall, the prevalence of abnormal physiologic variables is high among hospitalized adult patients irrespective of the presence of serious adverse events.11 This prevalence may be a reason why 2 recent studies of inpatient medical emergency teams (METs) or rapid response teams (RRTs), which generally rely on vital signs for activation, failed to show a decrease in adult mortality rates.12, 13
Given the complexity of interpreting single vital sign readings, we evaluated a simple and clinically intuitive variable, the shock index (SI) (heart rate/systolic blood pressure, a noninvasive indication of left ventricular function),14 as a potential marker of the need for intensive care. Allgwer and Burri14 first developed the SI in studies of patients with acute blood loss, intraabdominal bleeding, fat emboli, and severe infections. They observed that a healthy adult had a mean SI of 0.54 (standard deviation [SD], 0.021), while an index of 1.0 indicated threatened shock and indices greater than 1.5 were seen in volume‐deficient shock.
We hypothesized that an elevated SI is a differentiating factor between a patient who had an unplanned ICU transfer and a general medical patient who did not require this higher level of care. To our knowledge, the SI has not been studied for this application previously.
Patients and Methods
Study Design
We conducted a retrospective case‐control study of 50 consecutive general medical patients who had unplanned transfers to the ICU and 50 matched control patients, with the approval of the Mayo Clinic Institutional Review Board. All patients were admitted to a general medical unit, and only patients who previously provided permission for their records to be used in research were included in the study.
Patients
This study enrolled patients who were at least 18 years old and who were admitted to a single general medical unit for 24 hours or longer. Patients were excluded if they required a surgical intervention, were transferred from another hospital, received care on a different general medical unit at any time during the hospitalization, or were pregnant. Our data collection began at the patients' (cases and controls) arrival on the general medical unit; we did not include data from any evaluation (outpatient or emergency department) before hospital admission.
Case Definition
An unplanned transfer was defined as an episode of unexpected clinical deterioration in a general medical patient that necessitated transfer to the ICU, as opposed to a preemptive or elective transfer following a procedure. Patients with unplanned transfers from December 9, 2003, to December 29, 2004, were eligible for the study. Only the first transfer to the ICU was considered for patients who had multiple ICU transfers during a single hospitalization. Because these data were collected before METs or RRTs were introduced at our institution, the recommendation for ICU transfer was a joint decision by the primary care team and the ICU team.
Control Definition
The matched controls were identified from among patients admitted to the general medical unit from January 16, 2002, to December 13, 2004. To reduce the effect of the heterogeneity inherent in general medical patients, we matched controls for age (within 5 years of age of the corresponding case), admission diagnosis code, and patient care unit of admission and required that they were admitted for at least 24 hours before dismissal. Patients who had an ICU stay during the same admission were excluded. The median difference in admission dates between the cases and the controls was 327 days, and 26 of the 50 matched pairs had admission dates within 1 year of each other. This lengthy interval between cases and controls was a consequence of the low incidence of patients who met the matching criteria.
Setting
This study involved the general medical units and ICUs of the 1157‐bed Saint Mary's Hospital, an academic tertiary care facility at Mayo Clinic in Rochester, Minnesota.
Vital Sign Determination
Vital signs abstracted for this study included blood pressure, heart rate, respiratory rate, oxygen saturation, and temperature. The SI was calculated for each set of abstracted vital signs. Staff nurses were responsible for the routine measurement and recording of vital signs at least once every 8 hours, although in several instances not all parameters were checked. In accordance with nursing policy, values outside the defined parameters were rechecked by the nursing supervisor of each care unit and, if found to be abnormal, were conveyed to the patient's physician. This system meant that abnormal results were checked by numerous observers, with differences in the frequency of recordings for individual patients.
Data Collection
Demographic data and information on the vital signs were abstracted through a comprehensive chart review. Demographic data included age, sex, ethnicity, comorbid conditions, hospital care unit, date and time of admission, admission diagnosis, date and time of transfer to the ICU, length of stay, dismissal date, and disposition at discharge. Comorbid conditions were scored using the Charlson Comorbidity Index.15
Statistical Analysis
A sample size of 50 matched pairs provided 81% power to detect an odds ratio of 3.0 or greater between cases and controls, with a 0.05, 2‐tailed level of significance with McNemar test. Patient demographic characteristics were summarized by the frequencies for categorical data and by mean and SD for continuous data. Consistent with the study design, the McNemar test and conditional logistic model analyses were used to determine the association between the SI and the risk of unplanned ICU transfer. Shock indices for the cases and controls were compared with use of t test. A P value <0.05 was considered statistically significant. For the SI, we calculated the odds ratio and its 95% confidence interval (CI) and P value using different cut points. We did not perform a receiver operating characteristics analysis because matching of cases and controls greatly complicates estimation of the sensitivity and specificity of the SI;16 a cohort study is suggested to investigate this analysis further. All statistical analyses were performed by SAS version 9.1.3 software (SAS Institute Inc, Cary, NC).
Results
A total of 50 pairs of matching cases and controls was included in this study. Table 1 lists the source of admission, demographic characteristics, and numbers of deaths for cases and controls. There were no statistically significant differences in admission source, age, sex, ethnicity, admission care unit, or Charlson Comorbidity Index. Mean length of stay was 14.8 days (SD, 9.7 days) for the cases and 5.7 days (SD, 6.3 days; P < 0.001) for the controls. Admission diagnoses were classified on the basis of the organ system of involvement (Table 2). In 30 of 50 cases, the admission diagnosis and the reason for ICU transfer were related.
| Value | Cases (n = 50) | Controls (n = 50) | P Value* |
|---|---|---|---|
| |||
| Emergency department admission, No. (%) | 33 (66) | 28 (56) | 0.41 |
| Direct admission, No. (%) | 14 (28) | 15 (30) | 1.00 |
| Other admission, No. (%) | 3 (6) | 7 (14) | 0.32 |
| Age, mean (SD), years | 69.8 (15.7) | 70.3 (15.8) | 0.38 |
| Male sex, No. (%) | 26 (52) | 18 (36) | 0.12 |
| Ethnicity, No. (%) | 1.00 | ||
| White | 46 (92) | 46 (92) | |
| Other | 4 (8) | 4 (8) | |
| Charlson Comorbidity index, mean (SD) | 3.06 (2.31) | 2.66 (2.02) | 0.22 |
| Hospital stay, mean (SD), day | 14.8 (9.7) | 5.7 (6.3) | 0.0007 |
| Hospital deaths, No. | 9 | 1 | 0.008 |
| Deaths within 30 days, No. | 5 | 2 | 0.24 |
| Deaths within 6 months, No. | 9 | 6 | 0.40 |
| System | Primary Admission Diagnosis | No. of Cases |
|---|---|---|
| Constitutional | Fever, malaise, general symptoms | 7 |
| Cardiovascular | Hypertension, congestive heart failure, chest pain, peripheral vascular disease, edema | 5 |
| Dermatologic | Cellulitis, foot ulcer, skin rash | 3 |
| Gastrointestinal | Pancreatitis, gastrointestinal hemorrhage, nausea and vomiting, diarrhea, abdominal pain | 6 |
| Hematologic | Thrombocytopenia, abnormal coagulation | 2 |
| Musculoskeletal | Lymphedema, shoulder pain, lumbago, back ache, closed dorsal vertebral fracture | 7 |
| Neurologic | Delirium tremens, psychosis, convulsions | 3 |
| Pulmonary | Pneumonia, food or vomit aspiration pneumonitis, shortness of breath, respiratory abnormality | 13 |
| Renal | Hyperkalemia, acute renal failure, renal artery atherosclerosis | 4 |
We reviewed the vital signs and shock indices for the 24 hours before ICU transfer for each case and over the entire hospitalization for each control, to determine the worst set (the lowest systolic blood pressure and the highest heart rate, respiratory rate, and SI). The cases had 1 to 22 complete sets of vitals for the 24 hours before ICU transfer; the median number of sets was 3 and the mean was 4. The controls had 1 to 12 complete sets for the 24 hours before the worst SI: the median was 3 sets and the mean was 3. In 26 of 50 controls, the worst SI occurred within the first 24 hours after admission. There was a significant difference between the median values of the worst shock indices of the cases and the controls (0.87 vs. 0.72; P < 0.005).
Table 3 shows the different values of the SI and the corresponding odds ratio of unplanned ICU transfer for cases compared with controls. The difference was significant at an SI of 0.85 and greater, indicating a strong association with unplanned ICU transfer.
| Shock Index | P Value | Odds Ratio | 95% CI |
|---|---|---|---|
| |||
| 0.8 | 0.05 | 2.43 | 1.015.86 |
| 0.85 | 0.02 | 3.00 | 1.917.56 |
| 0.9 | 0.007 | 7.50 | 1.7232.78 |
| 0.95 | <0.03 | 5.50 | 1.2224.81 |
We also found that the patients who transferred to the ICU had a greater number of inpatient deaths (9 cases vs. 1 control; P = 0.008), which would be expected, but there was no difference in 30‐day or 6‐month mortality rate (Table 1). One patient died after 30 days and while still hospitalized.
Comparison between the temporal trend of vital signs and the SI of the cases for the 24 hours before ICU transfer is shown in Figure 1. This graph shows the median of all the worst values (minimum systolic blood pressure and maximum SI, heart rate, and respiratory rate) over the four 6‐hour time periods (24 hours) preceding ICU transfer. Of note, the change in vital signs is subtle even while the SI increased to more than 0.8 as the patients clinically worsened before transfer.
Discussion
In our comparison of the SI of 50 patients who required unplanned (unexpected) transfer to the ICU with the SI of 50 matched controls who did not require this higher level of care, we found that a SI of 0.85 or greater was significantly associated with unplanned transfer to the ICU. The cases had a significantly higher worst SI than the controls, and they also had a significantly longer hospital stay and higher inpatient mortality rate, as would be expected for a sicker patient population. These findings are important given that the SI may be useful for assessing illness severity, for helping determine the need for transfer to the ICU, or for activating METs or RRTs.
A major problem with providing optimal care for hospitalized general medical patients is the inherent difficulty in determining illness severity and clinical decline, especially when the decline occurs gradually. Existing consensus recommendations for ICU admission include both specific diagnoses and arbitrary objective criteria based on abnormal vital signs and laboratory values.27 Also, individual institutions may have their own ICU admission requirements, which may differ from these or RRT criteria. Although vital signs are important as a snapshot of basic physiologic function, a number of noncritical conditions may lead to abnormal vital signs, and not all abnormal vital signs are associated with an adverse clinical event. By relying solely on vital signs, clinicians may not recognize critical illness and therefore not transfer a patient to the ICU or may inappropriately transfer a patient who does not need ICU‐level care.
Markers of illness severity other than vital signs, such as the Acute Physiology and Chronic Health Evaluation (APACHE) score, have been shown to predict the death of ICU patients17, 18 but have been rarely studied outside the ICU setting.19 Also, calculating the APACHE score is cumbersome, and there is no cutoff score that defines when a patient should be transferred to the ICU. Subbe et al.,20 in their study to identify critically ill patients, found that introduction of a physiological scoring system (including MET or RRT activation scores) would have identified only a small number of additional patients as critically ill. Another common marker of illness severity, the 4 criteria of the systemic inflammatory response syndrome (temperature <36C or >38C; heart rate >90 beats per minute; respiratory rate >20 breaths per minute or PCO2 <32 mm Hg; and white blood cell count >12,000/L or <4000/L or with more than 10% band cells)21 may be too sensitive to use as a decision aid, since even a healthy person running after a bus could have 2 of the 4 criteria.22 Likewise, surgical patients may have transient leukocytosis due to a stress response independent of an infection.23
The SI may be more accurate than vital signs alone to determine illness severity and who is at risk for an unplanned transfer to the ICU. Birkhahn et al.24 concluded that the SI may be more useful in early hemorrhage than either heart rate or systolic blood pressure alone. Rady et al.25 showed that the SI used in the emergency department can identify critical illness with apparently stable vital signs, where an elevation of the SI above 0.9 was associated with an illness that was treated immediately with admission to the hospital and intensive therapy on admission. However, it is unclear whether the SI can be used to monitor ongoing treatment, because a previous study showed that the SI may be of limited value in the assessment of systemic oxygen transport and response to therapy in clinical septic shock.26 Of note, the SI is mostly independent of the effects of pain or anxiety, which cause a concurrent rise in heart rate and systolic blood pressure. Because the heart's left ventricular work is unchanged or may increase from the underlying catecholamine surge, the SI will be unchanged or may actually decrease.
Our study adds to the medical literature the findings that: (1) the SI may be useful as an indicator of illness severity and a triage tool in patients with no trauma but with various medical conditions, and (2) the SI showed a strong association with unplanned ICU transfer.
The main strength of our study is its case‐control design with matched controls. Also, by comparing groups from the same patient care unit, we sought to minimize the selection bias that can be inherent in case‐control studies. Limitations include the retrospective, nonrandomized study design and the fact that there may have been variations in vital sign measurements by the multiple caregivers. However, the vital signs were taken according to standard hospital practice and reflect real‐world conditions. Although generalizability may be somewhat limited because of our homogeneous patient population, our patients had a wide range of various medical illnesses, so our study should be applicable to other hospital settings, both academic and community‐based.
One of the main weaknesses of our study is that the results were not adjusted for the burden of comorbid conditions, although there were no statistically significant differences in the number of comorbid conditions among the cases and the controls (P = 0.96). Also, we did not directly compare the SI with vital signs alone to determine superiority.
The SI may be an important objective measure to help clinicians decide when patients need treatment that is more aggressive, assistance from a MET or an RRT, or a preemptive, rather than unplanned, transfer to an ICU. Although it is unlikely that a single measure will allow accurate triage of all medical or surgical patients, the SI may be a useful adjunct to clinical judgment and other objective measures in determining illness severity and clinical decline. Further prospective studies are needed to compare the role of the SI specifically with MET or RRT activation criteria, to clarify the role of comorbid conditions in unplanned transfers to the ICU, to validate the cut point for the SI in various disease states, and to assess its utility in patients with septic shock. Depending on these results, it may be beneficial to incorporate the SI into the electronic medical record as an automatic alert to identify patients at risk for ICU transfer.
Conclusions
The SI is an easily calculated composite index of heart rate and systolic blood pressure. An elevated SI of 0.85 can identify patients who are at risk for unplanned transfer to the ICU from general patient care units. Future studies will determine whether the SI is more accurate than simple vital signs as an indicator of clinical decline. If so, it may be useful as a trigger to activate METs or RRTs for treatment.
- ,.Outcome of intensive care patients in a group of British intensive care units.Crit Care Med.1998;26(8):1337–1345.
- ,,,.The longer patients are in hospital before Intensive Care admission the higher their mortality.Intensive Care Med.2004;30(10):1908–1913.
- ,.Physiological abnormalities in early warning scores are related to mortality in adult inpatients.Br J Anaesth.2004;92(6):882–884.
- ,,,,.Association between clinically abnormal observations and subsequent in‐hospital mortality: a prospective study.Resuscitation.2004;62(2):137–141.
- ,,,,,.Recognising clinical instability in hospital patients before cardiac arrest or unplanned admission to intensive care: a pilot study in a tertiary‐care hospital.Med J Aust.1999;171(1):22–25.
- ,,.Physiological values and procedures in the 24 h before ICU admission from the ward.Anaesthesia.1999;54(6):529–534.
- ,,, et al.Antecedents to hospital deaths.Intern Med J.2001;31(6):343–348.
- ,,, et al.A comparison of antecedents to cardiac arrests, deaths and emergency intensive care admissions in Australia and New Zealand, and the United Kingdom: the ACADEMIA study.Resuscitation.2004;62(3):275–282.
- ,,,,.Anticipating events of in‐hospital cardiac arrest.Eur J Emerg Med.2004;11(1):24–28.
- ,,, et al.Duration of life‐threatening antecedents prior to intensive care admission.Intensive Care Med.2002;28(11):1629–1634.
- ,,,.The prevalence of recordings of the signs of critical conditions and emergency responses in hospital wards: the SOCCER study.Resuscitation.2005;65(2):149–157.
- ,,,,,.Hospital‐wide code rates and mortality before and after implementation of a rapid response team.JAMA.2008;300(21):2506–2513.
- ,,,,.Rapid response teams: a systematic review and meta‐analysis.Arch Intern Med.2010;170(1):18–26.
- ,. [Shock index.]Dtsch Med Wochenschr.1967;92(43):1947–50. [German]
- ,,,.A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.J Chronic Dis.1987;40(5):373–83.
- ,.Matching in studies of classification accuracy: implications for analysis, efficiency, and assessment of incremental value.Biometrics.2008;64(1):1–9.
- ,,,.APACHE II: a severity of disease classification system.Crit Care Med.1985;13(10):818–829.
- ,.Outcome prediction in critical care: the Acute Physiology and Chronic Health Evaluation models.Curr Opin Crit Care.2008;14(5):491–497.
- ,,.APACHE II predicts long‐term survival in COPD patients admitted to a general medical ward.J Gen Intern Med.2003;18(10):824–830.
- ,,,.Validation of physiological scoring systems in the accident and emergency department.Emerg Med J.2006;23(11):841–845.
- ,,, et al;2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.Crit Care Med.2003;31(4):1250–1256.
- .Dear SIRS, I'm sorry to say that I don't like you...Crit Care Med.1997;25(2):372–374.
- ,.The inflammatory response to surgery and trauma.Curr Opin Crit Care.2006;12(4):325–332.
- ,,,,.Shock index in diagnosing early acute hypovolemia.Am J Emerg Med.2005;23(3):323–326.
- ,,,,.A comparison of the shock index and conventional vital signs to identify acute, critical illness in the emergency department.Ann Emerg Med.1994;24(4):685–690. Erratum in:Ann Emerg Med.year="1994"1994;24(6):1208.
- ,,,.Shock index: a re‐evaluation in acute circulatory failure.Resuscitation.1992;23(3):227–234.
- ,,,,, et al.Guidelines for intensive care unit admission, discharge, and triage. Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine.Crit Care Med.1999;27(3):633–638.
The decision to transfer a patient to the intensive care unit (ICU) from a general care setting is complex and based not only on clinical findings and patient wishes but also on the understanding that ICU resources are limited and costly.1 Adding to the decision‐making complexity is the knowledge that patients who transfer to an ICU from a general medical unit comprise the highest mortality group of ICU patients, with the mortality rate directly proportional to both the time spent on the general medical unit1, 2 and the number of physiologic abnormalities before ICU admission.3, 4
Prior studies have shown that cardiac arrest and unplanned (unexpected) transfers to the ICU are preceded by a period of physiologic instability reflected in the vital signs.510 However, vital signs alone may not accurately indicate clinical condition. For example, a person may be able to maintain normal blood pressure and heart rate despite severe illness or may have abnormal vital signs at baseline, which may be the case for an otherwise healthy young woman who has baseline low systolic blood pressure. Also, noncritical conditions commonly seen in hospitalized medical or surgical patients, such as anxiety or pain, may increase the respiratory rate or heart rate. Conversely, certain common medications, such as ‐blockers, may mask or blunt the normal physiologic response to illness. Overall, the prevalence of abnormal physiologic variables is high among hospitalized adult patients irrespective of the presence of serious adverse events.11 This prevalence may be a reason why 2 recent studies of inpatient medical emergency teams (METs) or rapid response teams (RRTs), which generally rely on vital signs for activation, failed to show a decrease in adult mortality rates.12, 13
Given the complexity of interpreting single vital sign readings, we evaluated a simple and clinically intuitive variable, the shock index (SI) (heart rate/systolic blood pressure, a noninvasive indication of left ventricular function),14 as a potential marker of the need for intensive care. Allgwer and Burri14 first developed the SI in studies of patients with acute blood loss, intraabdominal bleeding, fat emboli, and severe infections. They observed that a healthy adult had a mean SI of 0.54 (standard deviation [SD], 0.021), while an index of 1.0 indicated threatened shock and indices greater than 1.5 were seen in volume‐deficient shock.
We hypothesized that an elevated SI is a differentiating factor between a patient who had an unplanned ICU transfer and a general medical patient who did not require this higher level of care. To our knowledge, the SI has not been studied for this application previously.
Patients and Methods
Study Design
We conducted a retrospective case‐control study of 50 consecutive general medical patients who had unplanned transfers to the ICU and 50 matched control patients, with the approval of the Mayo Clinic Institutional Review Board. All patients were admitted to a general medical unit, and only patients who previously provided permission for their records to be used in research were included in the study.
Patients
This study enrolled patients who were at least 18 years old and who were admitted to a single general medical unit for 24 hours or longer. Patients were excluded if they required a surgical intervention, were transferred from another hospital, received care on a different general medical unit at any time during the hospitalization, or were pregnant. Our data collection began at the patients' (cases and controls) arrival on the general medical unit; we did not include data from any evaluation (outpatient or emergency department) before hospital admission.
Case Definition
An unplanned transfer was defined as an episode of unexpected clinical deterioration in a general medical patient that necessitated transfer to the ICU, as opposed to a preemptive or elective transfer following a procedure. Patients with unplanned transfers from December 9, 2003, to December 29, 2004, were eligible for the study. Only the first transfer to the ICU was considered for patients who had multiple ICU transfers during a single hospitalization. Because these data were collected before METs or RRTs were introduced at our institution, the recommendation for ICU transfer was a joint decision by the primary care team and the ICU team.
Control Definition
The matched controls were identified from among patients admitted to the general medical unit from January 16, 2002, to December 13, 2004. To reduce the effect of the heterogeneity inherent in general medical patients, we matched controls for age (within 5 years of age of the corresponding case), admission diagnosis code, and patient care unit of admission and required that they were admitted for at least 24 hours before dismissal. Patients who had an ICU stay during the same admission were excluded. The median difference in admission dates between the cases and the controls was 327 days, and 26 of the 50 matched pairs had admission dates within 1 year of each other. This lengthy interval between cases and controls was a consequence of the low incidence of patients who met the matching criteria.
Setting
This study involved the general medical units and ICUs of the 1157‐bed Saint Mary's Hospital, an academic tertiary care facility at Mayo Clinic in Rochester, Minnesota.
Vital Sign Determination
Vital signs abstracted for this study included blood pressure, heart rate, respiratory rate, oxygen saturation, and temperature. The SI was calculated for each set of abstracted vital signs. Staff nurses were responsible for the routine measurement and recording of vital signs at least once every 8 hours, although in several instances not all parameters were checked. In accordance with nursing policy, values outside the defined parameters were rechecked by the nursing supervisor of each care unit and, if found to be abnormal, were conveyed to the patient's physician. This system meant that abnormal results were checked by numerous observers, with differences in the frequency of recordings for individual patients.
Data Collection
Demographic data and information on the vital signs were abstracted through a comprehensive chart review. Demographic data included age, sex, ethnicity, comorbid conditions, hospital care unit, date and time of admission, admission diagnosis, date and time of transfer to the ICU, length of stay, dismissal date, and disposition at discharge. Comorbid conditions were scored using the Charlson Comorbidity Index.15
Statistical Analysis
A sample size of 50 matched pairs provided 81% power to detect an odds ratio of 3.0 or greater between cases and controls, with a 0.05, 2‐tailed level of significance with McNemar test. Patient demographic characteristics were summarized by the frequencies for categorical data and by mean and SD for continuous data. Consistent with the study design, the McNemar test and conditional logistic model analyses were used to determine the association between the SI and the risk of unplanned ICU transfer. Shock indices for the cases and controls were compared with use of t test. A P value <0.05 was considered statistically significant. For the SI, we calculated the odds ratio and its 95% confidence interval (CI) and P value using different cut points. We did not perform a receiver operating characteristics analysis because matching of cases and controls greatly complicates estimation of the sensitivity and specificity of the SI;16 a cohort study is suggested to investigate this analysis further. All statistical analyses were performed by SAS version 9.1.3 software (SAS Institute Inc, Cary, NC).
Results
A total of 50 pairs of matching cases and controls was included in this study. Table 1 lists the source of admission, demographic characteristics, and numbers of deaths for cases and controls. There were no statistically significant differences in admission source, age, sex, ethnicity, admission care unit, or Charlson Comorbidity Index. Mean length of stay was 14.8 days (SD, 9.7 days) for the cases and 5.7 days (SD, 6.3 days; P < 0.001) for the controls. Admission diagnoses were classified on the basis of the organ system of involvement (Table 2). In 30 of 50 cases, the admission diagnosis and the reason for ICU transfer were related.
| Value | Cases (n = 50) | Controls (n = 50) | P Value* |
|---|---|---|---|
| |||
| Emergency department admission, No. (%) | 33 (66) | 28 (56) | 0.41 |
| Direct admission, No. (%) | 14 (28) | 15 (30) | 1.00 |
| Other admission, No. (%) | 3 (6) | 7 (14) | 0.32 |
| Age, mean (SD), years | 69.8 (15.7) | 70.3 (15.8) | 0.38 |
| Male sex, No. (%) | 26 (52) | 18 (36) | 0.12 |
| Ethnicity, No. (%) | 1.00 | ||
| White | 46 (92) | 46 (92) | |
| Other | 4 (8) | 4 (8) | |
| Charlson Comorbidity index, mean (SD) | 3.06 (2.31) | 2.66 (2.02) | 0.22 |
| Hospital stay, mean (SD), day | 14.8 (9.7) | 5.7 (6.3) | 0.0007 |
| Hospital deaths, No. | 9 | 1 | 0.008 |
| Deaths within 30 days, No. | 5 | 2 | 0.24 |
| Deaths within 6 months, No. | 9 | 6 | 0.40 |
| System | Primary Admission Diagnosis | No. of Cases |
|---|---|---|
| Constitutional | Fever, malaise, general symptoms | 7 |
| Cardiovascular | Hypertension, congestive heart failure, chest pain, peripheral vascular disease, edema | 5 |
| Dermatologic | Cellulitis, foot ulcer, skin rash | 3 |
| Gastrointestinal | Pancreatitis, gastrointestinal hemorrhage, nausea and vomiting, diarrhea, abdominal pain | 6 |
| Hematologic | Thrombocytopenia, abnormal coagulation | 2 |
| Musculoskeletal | Lymphedema, shoulder pain, lumbago, back ache, closed dorsal vertebral fracture | 7 |
| Neurologic | Delirium tremens, psychosis, convulsions | 3 |
| Pulmonary | Pneumonia, food or vomit aspiration pneumonitis, shortness of breath, respiratory abnormality | 13 |
| Renal | Hyperkalemia, acute renal failure, renal artery atherosclerosis | 4 |
We reviewed the vital signs and shock indices for the 24 hours before ICU transfer for each case and over the entire hospitalization for each control, to determine the worst set (the lowest systolic blood pressure and the highest heart rate, respiratory rate, and SI). The cases had 1 to 22 complete sets of vitals for the 24 hours before ICU transfer; the median number of sets was 3 and the mean was 4. The controls had 1 to 12 complete sets for the 24 hours before the worst SI: the median was 3 sets and the mean was 3. In 26 of 50 controls, the worst SI occurred within the first 24 hours after admission. There was a significant difference between the median values of the worst shock indices of the cases and the controls (0.87 vs. 0.72; P < 0.005).
Table 3 shows the different values of the SI and the corresponding odds ratio of unplanned ICU transfer for cases compared with controls. The difference was significant at an SI of 0.85 and greater, indicating a strong association with unplanned ICU transfer.
| Shock Index | P Value | Odds Ratio | 95% CI |
|---|---|---|---|
| |||
| 0.8 | 0.05 | 2.43 | 1.015.86 |
| 0.85 | 0.02 | 3.00 | 1.917.56 |
| 0.9 | 0.007 | 7.50 | 1.7232.78 |
| 0.95 | <0.03 | 5.50 | 1.2224.81 |
We also found that the patients who transferred to the ICU had a greater number of inpatient deaths (9 cases vs. 1 control; P = 0.008), which would be expected, but there was no difference in 30‐day or 6‐month mortality rate (Table 1). One patient died after 30 days and while still hospitalized.
Comparison between the temporal trend of vital signs and the SI of the cases for the 24 hours before ICU transfer is shown in Figure 1. This graph shows the median of all the worst values (minimum systolic blood pressure and maximum SI, heart rate, and respiratory rate) over the four 6‐hour time periods (24 hours) preceding ICU transfer. Of note, the change in vital signs is subtle even while the SI increased to more than 0.8 as the patients clinically worsened before transfer.
Discussion
In our comparison of the SI of 50 patients who required unplanned (unexpected) transfer to the ICU with the SI of 50 matched controls who did not require this higher level of care, we found that a SI of 0.85 or greater was significantly associated with unplanned transfer to the ICU. The cases had a significantly higher worst SI than the controls, and they also had a significantly longer hospital stay and higher inpatient mortality rate, as would be expected for a sicker patient population. These findings are important given that the SI may be useful for assessing illness severity, for helping determine the need for transfer to the ICU, or for activating METs or RRTs.
A major problem with providing optimal care for hospitalized general medical patients is the inherent difficulty in determining illness severity and clinical decline, especially when the decline occurs gradually. Existing consensus recommendations for ICU admission include both specific diagnoses and arbitrary objective criteria based on abnormal vital signs and laboratory values.27 Also, individual institutions may have their own ICU admission requirements, which may differ from these or RRT criteria. Although vital signs are important as a snapshot of basic physiologic function, a number of noncritical conditions may lead to abnormal vital signs, and not all abnormal vital signs are associated with an adverse clinical event. By relying solely on vital signs, clinicians may not recognize critical illness and therefore not transfer a patient to the ICU or may inappropriately transfer a patient who does not need ICU‐level care.
Markers of illness severity other than vital signs, such as the Acute Physiology and Chronic Health Evaluation (APACHE) score, have been shown to predict the death of ICU patients17, 18 but have been rarely studied outside the ICU setting.19 Also, calculating the APACHE score is cumbersome, and there is no cutoff score that defines when a patient should be transferred to the ICU. Subbe et al.,20 in their study to identify critically ill patients, found that introduction of a physiological scoring system (including MET or RRT activation scores) would have identified only a small number of additional patients as critically ill. Another common marker of illness severity, the 4 criteria of the systemic inflammatory response syndrome (temperature <36C or >38C; heart rate >90 beats per minute; respiratory rate >20 breaths per minute or PCO2 <32 mm Hg; and white blood cell count >12,000/L or <4000/L or with more than 10% band cells)21 may be too sensitive to use as a decision aid, since even a healthy person running after a bus could have 2 of the 4 criteria.22 Likewise, surgical patients may have transient leukocytosis due to a stress response independent of an infection.23
The SI may be more accurate than vital signs alone to determine illness severity and who is at risk for an unplanned transfer to the ICU. Birkhahn et al.24 concluded that the SI may be more useful in early hemorrhage than either heart rate or systolic blood pressure alone. Rady et al.25 showed that the SI used in the emergency department can identify critical illness with apparently stable vital signs, where an elevation of the SI above 0.9 was associated with an illness that was treated immediately with admission to the hospital and intensive therapy on admission. However, it is unclear whether the SI can be used to monitor ongoing treatment, because a previous study showed that the SI may be of limited value in the assessment of systemic oxygen transport and response to therapy in clinical septic shock.26 Of note, the SI is mostly independent of the effects of pain or anxiety, which cause a concurrent rise in heart rate and systolic blood pressure. Because the heart's left ventricular work is unchanged or may increase from the underlying catecholamine surge, the SI will be unchanged or may actually decrease.
Our study adds to the medical literature the findings that: (1) the SI may be useful as an indicator of illness severity and a triage tool in patients with no trauma but with various medical conditions, and (2) the SI showed a strong association with unplanned ICU transfer.
The main strength of our study is its case‐control design with matched controls. Also, by comparing groups from the same patient care unit, we sought to minimize the selection bias that can be inherent in case‐control studies. Limitations include the retrospective, nonrandomized study design and the fact that there may have been variations in vital sign measurements by the multiple caregivers. However, the vital signs were taken according to standard hospital practice and reflect real‐world conditions. Although generalizability may be somewhat limited because of our homogeneous patient population, our patients had a wide range of various medical illnesses, so our study should be applicable to other hospital settings, both academic and community‐based.
One of the main weaknesses of our study is that the results were not adjusted for the burden of comorbid conditions, although there were no statistically significant differences in the number of comorbid conditions among the cases and the controls (P = 0.96). Also, we did not directly compare the SI with vital signs alone to determine superiority.
The SI may be an important objective measure to help clinicians decide when patients need treatment that is more aggressive, assistance from a MET or an RRT, or a preemptive, rather than unplanned, transfer to an ICU. Although it is unlikely that a single measure will allow accurate triage of all medical or surgical patients, the SI may be a useful adjunct to clinical judgment and other objective measures in determining illness severity and clinical decline. Further prospective studies are needed to compare the role of the SI specifically with MET or RRT activation criteria, to clarify the role of comorbid conditions in unplanned transfers to the ICU, to validate the cut point for the SI in various disease states, and to assess its utility in patients with septic shock. Depending on these results, it may be beneficial to incorporate the SI into the electronic medical record as an automatic alert to identify patients at risk for ICU transfer.
Conclusions
The SI is an easily calculated composite index of heart rate and systolic blood pressure. An elevated SI of 0.85 can identify patients who are at risk for unplanned transfer to the ICU from general patient care units. Future studies will determine whether the SI is more accurate than simple vital signs as an indicator of clinical decline. If so, it may be useful as a trigger to activate METs or RRTs for treatment.
The decision to transfer a patient to the intensive care unit (ICU) from a general care setting is complex and based not only on clinical findings and patient wishes but also on the understanding that ICU resources are limited and costly.1 Adding to the decision‐making complexity is the knowledge that patients who transfer to an ICU from a general medical unit comprise the highest mortality group of ICU patients, with the mortality rate directly proportional to both the time spent on the general medical unit1, 2 and the number of physiologic abnormalities before ICU admission.3, 4
Prior studies have shown that cardiac arrest and unplanned (unexpected) transfers to the ICU are preceded by a period of physiologic instability reflected in the vital signs.510 However, vital signs alone may not accurately indicate clinical condition. For example, a person may be able to maintain normal blood pressure and heart rate despite severe illness or may have abnormal vital signs at baseline, which may be the case for an otherwise healthy young woman who has baseline low systolic blood pressure. Also, noncritical conditions commonly seen in hospitalized medical or surgical patients, such as anxiety or pain, may increase the respiratory rate or heart rate. Conversely, certain common medications, such as ‐blockers, may mask or blunt the normal physiologic response to illness. Overall, the prevalence of abnormal physiologic variables is high among hospitalized adult patients irrespective of the presence of serious adverse events.11 This prevalence may be a reason why 2 recent studies of inpatient medical emergency teams (METs) or rapid response teams (RRTs), which generally rely on vital signs for activation, failed to show a decrease in adult mortality rates.12, 13
Given the complexity of interpreting single vital sign readings, we evaluated a simple and clinically intuitive variable, the shock index (SI) (heart rate/systolic blood pressure, a noninvasive indication of left ventricular function),14 as a potential marker of the need for intensive care. Allgwer and Burri14 first developed the SI in studies of patients with acute blood loss, intraabdominal bleeding, fat emboli, and severe infections. They observed that a healthy adult had a mean SI of 0.54 (standard deviation [SD], 0.021), while an index of 1.0 indicated threatened shock and indices greater than 1.5 were seen in volume‐deficient shock.
We hypothesized that an elevated SI is a differentiating factor between a patient who had an unplanned ICU transfer and a general medical patient who did not require this higher level of care. To our knowledge, the SI has not been studied for this application previously.
Patients and Methods
Study Design
We conducted a retrospective case‐control study of 50 consecutive general medical patients who had unplanned transfers to the ICU and 50 matched control patients, with the approval of the Mayo Clinic Institutional Review Board. All patients were admitted to a general medical unit, and only patients who previously provided permission for their records to be used in research were included in the study.
Patients
This study enrolled patients who were at least 18 years old and who were admitted to a single general medical unit for 24 hours or longer. Patients were excluded if they required a surgical intervention, were transferred from another hospital, received care on a different general medical unit at any time during the hospitalization, or were pregnant. Our data collection began at the patients' (cases and controls) arrival on the general medical unit; we did not include data from any evaluation (outpatient or emergency department) before hospital admission.
Case Definition
An unplanned transfer was defined as an episode of unexpected clinical deterioration in a general medical patient that necessitated transfer to the ICU, as opposed to a preemptive or elective transfer following a procedure. Patients with unplanned transfers from December 9, 2003, to December 29, 2004, were eligible for the study. Only the first transfer to the ICU was considered for patients who had multiple ICU transfers during a single hospitalization. Because these data were collected before METs or RRTs were introduced at our institution, the recommendation for ICU transfer was a joint decision by the primary care team and the ICU team.
Control Definition
The matched controls were identified from among patients admitted to the general medical unit from January 16, 2002, to December 13, 2004. To reduce the effect of the heterogeneity inherent in general medical patients, we matched controls for age (within 5 years of age of the corresponding case), admission diagnosis code, and patient care unit of admission and required that they were admitted for at least 24 hours before dismissal. Patients who had an ICU stay during the same admission were excluded. The median difference in admission dates between the cases and the controls was 327 days, and 26 of the 50 matched pairs had admission dates within 1 year of each other. This lengthy interval between cases and controls was a consequence of the low incidence of patients who met the matching criteria.
Setting
This study involved the general medical units and ICUs of the 1157‐bed Saint Mary's Hospital, an academic tertiary care facility at Mayo Clinic in Rochester, Minnesota.
Vital Sign Determination
Vital signs abstracted for this study included blood pressure, heart rate, respiratory rate, oxygen saturation, and temperature. The SI was calculated for each set of abstracted vital signs. Staff nurses were responsible for the routine measurement and recording of vital signs at least once every 8 hours, although in several instances not all parameters were checked. In accordance with nursing policy, values outside the defined parameters were rechecked by the nursing supervisor of each care unit and, if found to be abnormal, were conveyed to the patient's physician. This system meant that abnormal results were checked by numerous observers, with differences in the frequency of recordings for individual patients.
Data Collection
Demographic data and information on the vital signs were abstracted through a comprehensive chart review. Demographic data included age, sex, ethnicity, comorbid conditions, hospital care unit, date and time of admission, admission diagnosis, date and time of transfer to the ICU, length of stay, dismissal date, and disposition at discharge. Comorbid conditions were scored using the Charlson Comorbidity Index.15
Statistical Analysis
A sample size of 50 matched pairs provided 81% power to detect an odds ratio of 3.0 or greater between cases and controls, with a 0.05, 2‐tailed level of significance with McNemar test. Patient demographic characteristics were summarized by the frequencies for categorical data and by mean and SD for continuous data. Consistent with the study design, the McNemar test and conditional logistic model analyses were used to determine the association between the SI and the risk of unplanned ICU transfer. Shock indices for the cases and controls were compared with use of t test. A P value <0.05 was considered statistically significant. For the SI, we calculated the odds ratio and its 95% confidence interval (CI) and P value using different cut points. We did not perform a receiver operating characteristics analysis because matching of cases and controls greatly complicates estimation of the sensitivity and specificity of the SI;16 a cohort study is suggested to investigate this analysis further. All statistical analyses were performed by SAS version 9.1.3 software (SAS Institute Inc, Cary, NC).
Results
A total of 50 pairs of matching cases and controls was included in this study. Table 1 lists the source of admission, demographic characteristics, and numbers of deaths for cases and controls. There were no statistically significant differences in admission source, age, sex, ethnicity, admission care unit, or Charlson Comorbidity Index. Mean length of stay was 14.8 days (SD, 9.7 days) for the cases and 5.7 days (SD, 6.3 days; P < 0.001) for the controls. Admission diagnoses were classified on the basis of the organ system of involvement (Table 2). In 30 of 50 cases, the admission diagnosis and the reason for ICU transfer were related.
| Value | Cases (n = 50) | Controls (n = 50) | P Value* |
|---|---|---|---|
| |||
| Emergency department admission, No. (%) | 33 (66) | 28 (56) | 0.41 |
| Direct admission, No. (%) | 14 (28) | 15 (30) | 1.00 |
| Other admission, No. (%) | 3 (6) | 7 (14) | 0.32 |
| Age, mean (SD), years | 69.8 (15.7) | 70.3 (15.8) | 0.38 |
| Male sex, No. (%) | 26 (52) | 18 (36) | 0.12 |
| Ethnicity, No. (%) | 1.00 | ||
| White | 46 (92) | 46 (92) | |
| Other | 4 (8) | 4 (8) | |
| Charlson Comorbidity index, mean (SD) | 3.06 (2.31) | 2.66 (2.02) | 0.22 |
| Hospital stay, mean (SD), day | 14.8 (9.7) | 5.7 (6.3) | 0.0007 |
| Hospital deaths, No. | 9 | 1 | 0.008 |
| Deaths within 30 days, No. | 5 | 2 | 0.24 |
| Deaths within 6 months, No. | 9 | 6 | 0.40 |
| System | Primary Admission Diagnosis | No. of Cases |
|---|---|---|
| Constitutional | Fever, malaise, general symptoms | 7 |
| Cardiovascular | Hypertension, congestive heart failure, chest pain, peripheral vascular disease, edema | 5 |
| Dermatologic | Cellulitis, foot ulcer, skin rash | 3 |
| Gastrointestinal | Pancreatitis, gastrointestinal hemorrhage, nausea and vomiting, diarrhea, abdominal pain | 6 |
| Hematologic | Thrombocytopenia, abnormal coagulation | 2 |
| Musculoskeletal | Lymphedema, shoulder pain, lumbago, back ache, closed dorsal vertebral fracture | 7 |
| Neurologic | Delirium tremens, psychosis, convulsions | 3 |
| Pulmonary | Pneumonia, food or vomit aspiration pneumonitis, shortness of breath, respiratory abnormality | 13 |
| Renal | Hyperkalemia, acute renal failure, renal artery atherosclerosis | 4 |
We reviewed the vital signs and shock indices for the 24 hours before ICU transfer for each case and over the entire hospitalization for each control, to determine the worst set (the lowest systolic blood pressure and the highest heart rate, respiratory rate, and SI). The cases had 1 to 22 complete sets of vitals for the 24 hours before ICU transfer; the median number of sets was 3 and the mean was 4. The controls had 1 to 12 complete sets for the 24 hours before the worst SI: the median was 3 sets and the mean was 3. In 26 of 50 controls, the worst SI occurred within the first 24 hours after admission. There was a significant difference between the median values of the worst shock indices of the cases and the controls (0.87 vs. 0.72; P < 0.005).
Table 3 shows the different values of the SI and the corresponding odds ratio of unplanned ICU transfer for cases compared with controls. The difference was significant at an SI of 0.85 and greater, indicating a strong association with unplanned ICU transfer.
| Shock Index | P Value | Odds Ratio | 95% CI |
|---|---|---|---|
| |||
| 0.8 | 0.05 | 2.43 | 1.015.86 |
| 0.85 | 0.02 | 3.00 | 1.917.56 |
| 0.9 | 0.007 | 7.50 | 1.7232.78 |
| 0.95 | <0.03 | 5.50 | 1.2224.81 |
We also found that the patients who transferred to the ICU had a greater number of inpatient deaths (9 cases vs. 1 control; P = 0.008), which would be expected, but there was no difference in 30‐day or 6‐month mortality rate (Table 1). One patient died after 30 days and while still hospitalized.
Comparison between the temporal trend of vital signs and the SI of the cases for the 24 hours before ICU transfer is shown in Figure 1. This graph shows the median of all the worst values (minimum systolic blood pressure and maximum SI, heart rate, and respiratory rate) over the four 6‐hour time periods (24 hours) preceding ICU transfer. Of note, the change in vital signs is subtle even while the SI increased to more than 0.8 as the patients clinically worsened before transfer.
Discussion
In our comparison of the SI of 50 patients who required unplanned (unexpected) transfer to the ICU with the SI of 50 matched controls who did not require this higher level of care, we found that a SI of 0.85 or greater was significantly associated with unplanned transfer to the ICU. The cases had a significantly higher worst SI than the controls, and they also had a significantly longer hospital stay and higher inpatient mortality rate, as would be expected for a sicker patient population. These findings are important given that the SI may be useful for assessing illness severity, for helping determine the need for transfer to the ICU, or for activating METs or RRTs.
A major problem with providing optimal care for hospitalized general medical patients is the inherent difficulty in determining illness severity and clinical decline, especially when the decline occurs gradually. Existing consensus recommendations for ICU admission include both specific diagnoses and arbitrary objective criteria based on abnormal vital signs and laboratory values.27 Also, individual institutions may have their own ICU admission requirements, which may differ from these or RRT criteria. Although vital signs are important as a snapshot of basic physiologic function, a number of noncritical conditions may lead to abnormal vital signs, and not all abnormal vital signs are associated with an adverse clinical event. By relying solely on vital signs, clinicians may not recognize critical illness and therefore not transfer a patient to the ICU or may inappropriately transfer a patient who does not need ICU‐level care.
Markers of illness severity other than vital signs, such as the Acute Physiology and Chronic Health Evaluation (APACHE) score, have been shown to predict the death of ICU patients17, 18 but have been rarely studied outside the ICU setting.19 Also, calculating the APACHE score is cumbersome, and there is no cutoff score that defines when a patient should be transferred to the ICU. Subbe et al.,20 in their study to identify critically ill patients, found that introduction of a physiological scoring system (including MET or RRT activation scores) would have identified only a small number of additional patients as critically ill. Another common marker of illness severity, the 4 criteria of the systemic inflammatory response syndrome (temperature <36C or >38C; heart rate >90 beats per minute; respiratory rate >20 breaths per minute or PCO2 <32 mm Hg; and white blood cell count >12,000/L or <4000/L or with more than 10% band cells)21 may be too sensitive to use as a decision aid, since even a healthy person running after a bus could have 2 of the 4 criteria.22 Likewise, surgical patients may have transient leukocytosis due to a stress response independent of an infection.23
The SI may be more accurate than vital signs alone to determine illness severity and who is at risk for an unplanned transfer to the ICU. Birkhahn et al.24 concluded that the SI may be more useful in early hemorrhage than either heart rate or systolic blood pressure alone. Rady et al.25 showed that the SI used in the emergency department can identify critical illness with apparently stable vital signs, where an elevation of the SI above 0.9 was associated with an illness that was treated immediately with admission to the hospital and intensive therapy on admission. However, it is unclear whether the SI can be used to monitor ongoing treatment, because a previous study showed that the SI may be of limited value in the assessment of systemic oxygen transport and response to therapy in clinical septic shock.26 Of note, the SI is mostly independent of the effects of pain or anxiety, which cause a concurrent rise in heart rate and systolic blood pressure. Because the heart's left ventricular work is unchanged or may increase from the underlying catecholamine surge, the SI will be unchanged or may actually decrease.
Our study adds to the medical literature the findings that: (1) the SI may be useful as an indicator of illness severity and a triage tool in patients with no trauma but with various medical conditions, and (2) the SI showed a strong association with unplanned ICU transfer.
The main strength of our study is its case‐control design with matched controls. Also, by comparing groups from the same patient care unit, we sought to minimize the selection bias that can be inherent in case‐control studies. Limitations include the retrospective, nonrandomized study design and the fact that there may have been variations in vital sign measurements by the multiple caregivers. However, the vital signs were taken according to standard hospital practice and reflect real‐world conditions. Although generalizability may be somewhat limited because of our homogeneous patient population, our patients had a wide range of various medical illnesses, so our study should be applicable to other hospital settings, both academic and community‐based.
One of the main weaknesses of our study is that the results were not adjusted for the burden of comorbid conditions, although there were no statistically significant differences in the number of comorbid conditions among the cases and the controls (P = 0.96). Also, we did not directly compare the SI with vital signs alone to determine superiority.
The SI may be an important objective measure to help clinicians decide when patients need treatment that is more aggressive, assistance from a MET or an RRT, or a preemptive, rather than unplanned, transfer to an ICU. Although it is unlikely that a single measure will allow accurate triage of all medical or surgical patients, the SI may be a useful adjunct to clinical judgment and other objective measures in determining illness severity and clinical decline. Further prospective studies are needed to compare the role of the SI specifically with MET or RRT activation criteria, to clarify the role of comorbid conditions in unplanned transfers to the ICU, to validate the cut point for the SI in various disease states, and to assess its utility in patients with septic shock. Depending on these results, it may be beneficial to incorporate the SI into the electronic medical record as an automatic alert to identify patients at risk for ICU transfer.
Conclusions
The SI is an easily calculated composite index of heart rate and systolic blood pressure. An elevated SI of 0.85 can identify patients who are at risk for unplanned transfer to the ICU from general patient care units. Future studies will determine whether the SI is more accurate than simple vital signs as an indicator of clinical decline. If so, it may be useful as a trigger to activate METs or RRTs for treatment.
- ,.Outcome of intensive care patients in a group of British intensive care units.Crit Care Med.1998;26(8):1337–1345.
- ,,,.The longer patients are in hospital before Intensive Care admission the higher their mortality.Intensive Care Med.2004;30(10):1908–1913.
- ,.Physiological abnormalities in early warning scores are related to mortality in adult inpatients.Br J Anaesth.2004;92(6):882–884.
- ,,,,.Association between clinically abnormal observations and subsequent in‐hospital mortality: a prospective study.Resuscitation.2004;62(2):137–141.
- ,,,,,.Recognising clinical instability in hospital patients before cardiac arrest or unplanned admission to intensive care: a pilot study in a tertiary‐care hospital.Med J Aust.1999;171(1):22–25.
- ,,.Physiological values and procedures in the 24 h before ICU admission from the ward.Anaesthesia.1999;54(6):529–534.
- ,,, et al.Antecedents to hospital deaths.Intern Med J.2001;31(6):343–348.
- ,,, et al.A comparison of antecedents to cardiac arrests, deaths and emergency intensive care admissions in Australia and New Zealand, and the United Kingdom: the ACADEMIA study.Resuscitation.2004;62(3):275–282.
- ,,,,.Anticipating events of in‐hospital cardiac arrest.Eur J Emerg Med.2004;11(1):24–28.
- ,,, et al.Duration of life‐threatening antecedents prior to intensive care admission.Intensive Care Med.2002;28(11):1629–1634.
- ,,,.The prevalence of recordings of the signs of critical conditions and emergency responses in hospital wards: the SOCCER study.Resuscitation.2005;65(2):149–157.
- ,,,,,.Hospital‐wide code rates and mortality before and after implementation of a rapid response team.JAMA.2008;300(21):2506–2513.
- ,,,,.Rapid response teams: a systematic review and meta‐analysis.Arch Intern Med.2010;170(1):18–26.
- ,. [Shock index.]Dtsch Med Wochenschr.1967;92(43):1947–50. [German]
- ,,,.A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.J Chronic Dis.1987;40(5):373–83.
- ,.Matching in studies of classification accuracy: implications for analysis, efficiency, and assessment of incremental value.Biometrics.2008;64(1):1–9.
- ,,,.APACHE II: a severity of disease classification system.Crit Care Med.1985;13(10):818–829.
- ,.Outcome prediction in critical care: the Acute Physiology and Chronic Health Evaluation models.Curr Opin Crit Care.2008;14(5):491–497.
- ,,.APACHE II predicts long‐term survival in COPD patients admitted to a general medical ward.J Gen Intern Med.2003;18(10):824–830.
- ,,,.Validation of physiological scoring systems in the accident and emergency department.Emerg Med J.2006;23(11):841–845.
- ,,, et al;2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.Crit Care Med.2003;31(4):1250–1256.
- .Dear SIRS, I'm sorry to say that I don't like you...Crit Care Med.1997;25(2):372–374.
- ,.The inflammatory response to surgery and trauma.Curr Opin Crit Care.2006;12(4):325–332.
- ,,,,.Shock index in diagnosing early acute hypovolemia.Am J Emerg Med.2005;23(3):323–326.
- ,,,,.A comparison of the shock index and conventional vital signs to identify acute, critical illness in the emergency department.Ann Emerg Med.1994;24(4):685–690. Erratum in:Ann Emerg Med.year="1994"1994;24(6):1208.
- ,,,.Shock index: a re‐evaluation in acute circulatory failure.Resuscitation.1992;23(3):227–234.
- ,,,,, et al.Guidelines for intensive care unit admission, discharge, and triage. Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine.Crit Care Med.1999;27(3):633–638.
- ,.Outcome of intensive care patients in a group of British intensive care units.Crit Care Med.1998;26(8):1337–1345.
- ,,,.The longer patients are in hospital before Intensive Care admission the higher their mortality.Intensive Care Med.2004;30(10):1908–1913.
- ,.Physiological abnormalities in early warning scores are related to mortality in adult inpatients.Br J Anaesth.2004;92(6):882–884.
- ,,,,.Association between clinically abnormal observations and subsequent in‐hospital mortality: a prospective study.Resuscitation.2004;62(2):137–141.
- ,,,,,.Recognising clinical instability in hospital patients before cardiac arrest or unplanned admission to intensive care: a pilot study in a tertiary‐care hospital.Med J Aust.1999;171(1):22–25.
- ,,.Physiological values and procedures in the 24 h before ICU admission from the ward.Anaesthesia.1999;54(6):529–534.
- ,,, et al.Antecedents to hospital deaths.Intern Med J.2001;31(6):343–348.
- ,,, et al.A comparison of antecedents to cardiac arrests, deaths and emergency intensive care admissions in Australia and New Zealand, and the United Kingdom: the ACADEMIA study.Resuscitation.2004;62(3):275–282.
- ,,,,.Anticipating events of in‐hospital cardiac arrest.Eur J Emerg Med.2004;11(1):24–28.
- ,,, et al.Duration of life‐threatening antecedents prior to intensive care admission.Intensive Care Med.2002;28(11):1629–1634.
- ,,,.The prevalence of recordings of the signs of critical conditions and emergency responses in hospital wards: the SOCCER study.Resuscitation.2005;65(2):149–157.
- ,,,,,.Hospital‐wide code rates and mortality before and after implementation of a rapid response team.JAMA.2008;300(21):2506–2513.
- ,,,,.Rapid response teams: a systematic review and meta‐analysis.Arch Intern Med.2010;170(1):18–26.
- ,. [Shock index.]Dtsch Med Wochenschr.1967;92(43):1947–50. [German]
- ,,,.A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.J Chronic Dis.1987;40(5):373–83.
- ,.Matching in studies of classification accuracy: implications for analysis, efficiency, and assessment of incremental value.Biometrics.2008;64(1):1–9.
- ,,,.APACHE II: a severity of disease classification system.Crit Care Med.1985;13(10):818–829.
- ,.Outcome prediction in critical care: the Acute Physiology and Chronic Health Evaluation models.Curr Opin Crit Care.2008;14(5):491–497.
- ,,.APACHE II predicts long‐term survival in COPD patients admitted to a general medical ward.J Gen Intern Med.2003;18(10):824–830.
- ,,,.Validation of physiological scoring systems in the accident and emergency department.Emerg Med J.2006;23(11):841–845.
- ,,, et al;2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.Crit Care Med.2003;31(4):1250–1256.
- .Dear SIRS, I'm sorry to say that I don't like you...Crit Care Med.1997;25(2):372–374.
- ,.The inflammatory response to surgery and trauma.Curr Opin Crit Care.2006;12(4):325–332.
- ,,,,.Shock index in diagnosing early acute hypovolemia.Am J Emerg Med.2005;23(3):323–326.
- ,,,,.A comparison of the shock index and conventional vital signs to identify acute, critical illness in the emergency department.Ann Emerg Med.1994;24(4):685–690. Erratum in:Ann Emerg Med.year="1994"1994;24(6):1208.
- ,,,.Shock index: a re‐evaluation in acute circulatory failure.Resuscitation.1992;23(3):227–234.
- ,,,,, et al.Guidelines for intensive care unit admission, discharge, and triage. Task Force of the American College of Critical Care Medicine, Society of Critical Care Medicine.Crit Care Med.1999;27(3):633–638.
Copyright © 2010 Society of Hospital Medicine
Postcards from Our Students
During their junior medicine rotation, our students are asked to post to Blackboard (an online student forum) an anonymous essay about an issue of professionalism or ethics, either inspiring or troubling. In many ways, these vignettes are like postcards, written by visitors describing foreign cultures and norms. They represent a way for the students to debrief, but also provide an opportunity for us, as faculty, to reflect upon the way we practice and teach medicine. Many postingslike postcards from exotic or historic placesare inspiring stories of residents and faculty extending themselves for their patients. Unfortunately, unlike typical postcards, there are also essays that are troubling or provoking and challenge us to consider how we could improve the professional and ethical environment on our teams.
In order to begin a learning process with our faculty and housestaff, we have presented a number of these anonymous essays at both faculty and housestaff Department of Medicine conferences as well as our monthly hospital Ethics conference. The goal of these conferences was to gather as a moral community to reflect on our students' experience and consider ways in which our day to day practice as attendings could be informed by what they tell us. In addition, the junior medicine site directors have a session each quarter with their junior students to review some of the most significant issues brought up by their essays.
Practically, these vignettes and conferences serve three main purposes:
-
Raising Awareness: Many professional issues noted by our students occur under the radar. Attendings are often unaware of the issues of professionalism and/or ethics confronting our students and housestaff.
-
Exploring Attitudes: Some attending may underemphasize the importance of specific issues of professionalism and/or ethics. Open discussions at faculty or resident conferences create opportunities for individuals to reflect upon their own reactions and for the group to create a norm.
-
Sharing Skills: It is difficult to learn the practice of professionalism and ethics from a book. Skill in this area is gained primarily by experience. Conferences provide an excellent forum for seasoned physicians to share wisdom with less experienced physicians. In addition, important teaching points can be made: Students should not deliver bad news alone. Errors should be disclosed.
Following are 3 of the essays we presented, along with brief commentaries. At the end, we provide practical suggestions for individual attendings to improve the professional climate on their teams.
The Hospital Didn't Wait
Code. On 12, the surgical wards floor. Elise sprinted to the stairwell, dashed up to 12, and ran to the corner room as fast as she could. She could see the room before she got there. Instinctively, she started reviewing the steps she had memorized so many months ago. But when she finally arrived at the patient's bathroom, her thought process came to a jolting halt as she came upon the gruesome scene.
The 76‐year‐old patient had hanged himself with the cinching rope from his garment bag, and now dangled suspended from a high towel rack against the wall. Nurses from the floor started to file in, and without losing a beat Elise barked commands. Together they brought the man's body down to the floor, laid him on his back, and stripped off his hospital gown. Elise was in charge; deliberately but forcefully, she ordered a nurse to retrieve a defibrillator, and had another resident check for a pulse. There was none. Anesthesiology was here. Quickly and expertly, they shoved a plastic tube down his throat and began ventilation. The nurse placed on the electrodes between chest compressions then called to clear the body. Airway stepped back. The chest pumper stepped back. The body lurched forward as the defibrillator issued a long beep and discharged. Still no pulse. The cycle repeated.
Finally, Elise called a stop. Time of death, 19:37. By now there were about 20 people crammed in the patient room, all of whom had a separate role during the code. Some stayed behind, while the rest left to return to their interrupted work. The medical student didn't know what to think as he returned to the team room. His jaw was sorehad he been clenching it the whole time?and as he brought his hand up to rub his face, he saw that his knuckles were bloody. Somehow he had scraped them during the code. As he logged back into the computer to finish off his evening notes, he knew that he wouldn't have time to reflect until hours later when he returned home. Codes happened all the time. There was still work to be done in the hospital, and the hospital didn't wait.
The room had already been assigned to a patient waiting in the Emergency Department downstairs. That patient would be here in a few minutes. The hospital didn't wait.
When we presented this case in our conferences, there was universal agreement that such a traumatic event merits, even demands, team debriefing and processing. But in the real life aftermath of this traumatic event, the take‐home message for the medical student was that the hospital didn't wait for such discussions. We know this is not unique to our institution. In a study of 32 medical students who were asked to reflect on their most memorable patient death,1 debriefing sessions were rare and many students felt inadequately supported. While experienced clinicians may be accustomed to seeing patients die, students are new to the culture of the hospital, and have not had the chance to develop the defense mechanisms necessary to cope with this sort of experience. Angoff2 writes, As medical educators, we ought to ask our students how they are coping with long hours, fatigue, illness, suffering, and death. We ought to model and commend compassion and react to the deep feelings of our students in the same way we would teach them to react to the deep feelings of their patients.
I Told a Man Today That He Had Brain Cancer
The resident, intern, and I were huddled together in our team room when the report came back on the computer. New 3.5 2.3 1.7 cm contrast‐enhancing lesion seen anterior to genu of corpus callosum. Concerning for metastatic focus vs. lymphoma. Advise follow‐up. It wasn't unexpected but we had nevertheless been hoping for better.
The three of us went into his room and I was waiting to see how my resident would deliver the bad news, but she didn't. She simply said that we were continuing to do imaging studies and that a neurology team would be in touch. There were probably several reasons why she didn't tell him: not enough time, not her responsibility, or maybe she was just uncomfortable with it. Whatever the case, we left the room with my patient still oblivious to the awful mass now tangled in his head.
If my resident was taking a pass on this conversation, I knew it fell to me he needed to hear it from his primary team. I came back after rounds alone, sat down next to his bed, and told him that his MRI results had come back, and that I had unfortunate news.
I told him that the images showed that his lung cancer had spread to his brain.
I paused to give him a chance to let it sink in. He turned away and looked up at the ceiling.
Where is it? How big is it?
What now?
Reflecting on this case, our audiences were disturbed that a student would attempt this difficult conversation alone, while recognizing that the student clearly felt a sense of responsibility and desire to help his patient by sharing important information. We talked about how students may erroneously pick up a message that the team member who has spent the most time with a patient is the most obvious choice to have difficult conversations. We also noted that, unfortunately, sometimes students are directly asked by their team to shoulder this responsibility on their own. In this painful account, there is no mention of preparation, supervision, or support for the student before or after the encounter. The student perceived (rightly or wrongly) that the team leaders lacked comfort or skill to deliver the bad news, and stepped in. It is possible that the attending lacked the skill and ability to model an interaction, but more likely the deficit was in awareness and attitude. It is unlikely the attending knew that the student had this conversation alone. One of the major reasons we present these vignettes is to make attendings and housestaff more aware of issues that occur under their radar so that they can take preventative action. However, once the resident or attending found out that the student had this conversation alone, the student should be pulled aside for a 1:1 discussion. At the end of the day, the student should know that it was inappropriate to attempt this conversation alone
Rosenbaum3 reviewed a number of strategies to teach the skill of delivering bad news, from lecture and small group discussions to role play and standardized patients. When asked, students cited role‐modeling as the best way to learn how to deliver bad news.4 Observation of a veteran clinician provides a firm foundation for learning; but that is not enough. Unfortunately, we know from the literature (and our student vignettes suggest) that students and residents are unprepared to carry out these conversations properly, either because of misguided attitudes, lack of experience, or inadequate training.57 We conceptualize engaging in difficult conversations as a procedure, demanding a skill set. Mere observation of an expert executing this procedure is only a beginning. With any other skill, from successful completion of a lumbar puncture to initiating cardiopulmonary resuscitation (CPR), a student would never conclude that knowing the patient the best sufficiently credentials the student to undertake these procedures. We maintain that a difficult conversationbe it breaking bad news, discussing end‐of‐life care preferences, code status discussions, or prognosisis a clinical intervention, like any other procedure in medicine. If performed with skill and caution, it can bring about a stronger therapeutic relationship and increased support for the patient; if performed clumsily, it can lead to unintended adverse outcomes, including misunderstanding, mistrust, anxiety, and anger.
A Decimal Point Got Misplaced
On palliative care, I had a 90 year‐old man with end stage lung CA that presented to the ED with increasing SOB. The resident decided that giving him some morphine would be a good solution but was worried that too much would push him over the edge. He was thin; his O2 sats weren't that good After some discussion it was decided that 2.5 mg should be the starting amount. Unfortunately, when the note was written a decimal point got misplaced and he got 25 mg as a first dose. He ended up very sedated for most of the day but his breathing was ok.
The mistake was not discussed with the patient or the patient's family. While it did not cause any lasting harm, I wondered if telling the patient/patient's family that an error had been made would have been more ethically sound.
When we presented this case in our conferences, there was little controversy about whether the error should have been disclosed. The discussion did provide reinforcement for doing a simple but difficult task. Our analysis is that the nondiscussion of this error reflects a deficit in attitude and possibly skill. The team was aware of the error, but the resident and attending did not take the opportunity to disclose an error. They should have. We do not know whether the attending or resident felt unprepared to discuss this or were simply unimpressed with the adverse event. We do get the sense that the student did not feel comfortable raising the issue with the team. As such, it was a missed opportunity to seek help from any number of hospital resources and find encouragement to take on difficult encounters.
Much has been written about apologies.810 Disclosing errors and apologizing is the ethical standard, and many of our institutions have made it policy. Yet in the moment, it is embarrassing, anxiety provoking, and our concern about litigation looms large. Learning to do the right thing begins, perhaps with lectures and standardized patients, but only when students see it modeled by our housestaff and faculty, does it take root for good.
Our housestaff are quite good at managing medical issues, but they may still need help in creating the appropriate environment for professional learning and growth. This is 1 of the most important contributions an attending can make. We have emphasized that faculty have an important role to play in the area of professional development, reinforcing the rudimentary information preclinical students are presented with in the classroom and processing experiences residents are exposed to on a regular basis. If the hospital doesn't wait, then it is the attending physician's job to create the space and time for trainees to think about what is happening and ask if it could have been done better.
A number of seasoned clinical teachers have written about ways to improve teaching on the wards.11 Below, we will add to that discussion by considering practical ways to enhance learning about professionalism and ethics (see Table 1). Note should be made that while we focus on specific behaviors and activities, underlying all is the importance of availability, presence, and intention. Like all good teaching, these activities require planning and effort.
| Attending Activity | Examples |
|---|---|
| Creating an Open Climate | |
| Breaking Communication Barriers | Setting aside time for introductions and team building exercises at the beginning of a rotation, with attending participating equally with residents and students |
| Emphasizing attending availability to discuss or review problems of any kind | |
| Setting Clear Expectations | Emphasizing the importance of patient‐clinician or family‐clinician communication from the outset |
| Devoting some attending rounds to Difficult Conversations (e.g., breaking bad news or code status discussions) | |
| Explicitly stating that no ethical question is a stupid question and providing positive feedback for raising such questions for the team | |
| Regular Check‐ins | Establishing team communication rounds: 10 minutes every day to review a good, bad, or awkward interaction from the past day (e.g., family meeting, DNR discussion) |
| Setting aside time on rounds or during attending teaching sessions to explore the team's or an individual's emotional responses to a patient's death or deterioration | |
| Writing exercises that focus on our reactions to challenging situations that are shared with the group | |
| Supervision and Modeling | |
| Planning | Clarifying an agenda and practicing key phrases for a family meeting with the resident prior to meeting the family |
| Anticipating which patients may require a code status discussion and discussing a game plan on rounds | |
| Modeling | Students observe the attending facilitate a family meeting |
| Residents observe the attending apologizing for an error, no matter how small | |
| Attending thinks about an interpersonal conflict out loud and models asking patient‐relations for help | |
| Debriefing | Reviewing a family meeting with and giving feedback to the resident who facilitated |
| Reviewing a challenging code status discussion as a team |
Creating an Open Climate
The medical team, of which the attending, residents, and students are all a part, should not only be a unit that provides excellent medical care to its patients, but should also create a culture of continuous learning and improvement. As such, it is important to create a safe atmosphere where teachers are invested in the growth of their learners and learners feel free to question the prevailing logic and practice, including issues of professionalism and ethics. As Malcolm Gladwell12 describes in Outliers, Korean Air jets were crashing because subordinates were afraid to question their superiors. Once that culture changed, Korean Air safety improved dramatically. Similarly, breaking down some of the hierarchical barriers should improve the culture of a medical team. We typically make an effort to get to know our students and residents on a more personal basis: where they are from, who is in their family, what was their major, what are their interests outside of medicine, and what has been surprising to them in their training so far. Whether we set aside time when we first meet or e‐mail our questions before the first day, we aim for this to be 1 of the first team activities. We also share our own stories, making clear that the attending is part of the team, and not just an evaluating supervisor.
Vignette 1 describes the student's trauma of witnessing a code and the inability to process the event with anyone afterward. Failed resuscitation attempts are the most dramatic examples, but even expected deaths, nonfatal adverse events, and conflict between patients and providers may be traumatic for new trainees inexperienced with the reality of medicine. Attendings should be aware of these potentially traumatic events and make time to check in with the team members about how they are dealing with their emotions. Taking time on attending rounds, for example, allows the attending to not only model reflective practice and self‐care, but also elevates team support to a place traditionally reserved for discussions about diagnosis and treatment.
Supervision and Modeling
Vignettes 2 and 3 center around challenging communication tasks that require special training, including instruction, modeling, feedback, and practice. Unfortunately, as some of our student accounts document, many teaching opportunities are missed. As attendings, our duties include being aware of these opportunities, and being prepared to model competent patientor familydoctor interactions. Emphasizing the importance of the doctor‐patient relationship is in fact one of the key skills of an effective attending role model.13
When opportunities arise for any potentially difficult conversation, we make every effort to identify the issue, prebrief with the team about how to conduct the discussion, and either offer to model the conversation or be present to observe and provide feedback and debriefing afterwards. For example, by asking about all DNR discussions had with our patients, we gain insight into the skill level of our housestaff. As important, the housestaff understand that we believe that these conversations are vital to review during formal rounds, with the same attention we give to chest pain and electrocardiograms (ECGs).
Two key skills that develop with experience are the ability to know the limits of one's knowledge and to know when to ask for help. We try to be open about naming those limits and thinking about the other members of the larger healthcare team that may provide insight, skill, and expertise. We are used to doing this with medical questions (eg, asking the gastroenterology consult team to locate a source of bleeding). Asking our risk management, patient‐relations, or ethics services to assist with a difficult communication task or conflict with a family is no different, and often something the housestaff may not readily do.
We are grateful to our students and their postcards for the snapshots of our local medical culture. While we are gratified to read of excellent role modeling, we are also disappointed to read of situations which have left our students confused, demoralized and cynical. But if these exercises are to reach their full potential, they should tell us about where we would like to go, in addition to where we have been. We believe that our conferences have stimulated our faculty and housestaff to reflect on the professionalism lessons they are teaching. Reading the student postings has definitely affected our approach to teaching professionalism. They reinforce what every parent and educator knows: when it comes to teaching professionalism, communication and ethics, what matters most is the behavior of the teacher. Our words mean little if our actions do not live out what we espouse.
Acknowledgements
We are grateful for Michael Chan and his classmates from the NUFSM class of 2010 for their thoughtful essays. David Neely, Director of Undergraduate Education, Department of Medicine, Eytan Szmuilowicz, Palliative Medicine. Kathy Neely, Chairman of NMH Ethics Committee. Co‐director of Patient, Physician and Society. This article was previously published in this journal in Vol 5, Issue 5:E10E13 (2010) as online‐only.
- .This is just too awful; I just can't believe I experienced that.Acad Med.2005;80(7):634–640.
- .A piece of my mind.JAMA.2001;286(9):1017–1018.
- .Teaching medical students and residents skills for delivering bad news: a review of strategies.Acad Med.2004;79(2):107–117.
- .Third‐year medical students' experiences with dying patients during the internal medicine clerkship: a qualitative study of the informal curriculum.Acad Med.2005;80(7):641–647.
- ,,.How do medical residents discuss resuscitation with patients? Official journal of the Society for Research and Education in Primary Care Internal Medicine.J Gen Intern Med.1995;10(8):436–442.
- ,,.See one, do one, teach one? House staff experience discussing do‐not‐resuscitate orders.Arch Intern Med.1996;156(12):1285–1289.
- ,,,.Residents' end‐of‐life decision making with adult hospitalized patients: a review of the literature.Acad Med.2005:80(7)622–633.
- .Physician error and disclosure.Clin Obstet Gynecol.2008;51(4):700–708.
- .Revealing medical errors to your patients.Chest.2009;133:1064–1065.
- .Apology in medical practice.JAMA.2006;296:1401–1404.
- .What if Osler were one of us? Inpatient teaching today.J Gen Intern Med.1997;12(Suppl 2):S41–S48.
- Malcolm Gladwell.Outliers.New York:Little, Brown, Co.,2008: p.177–223.
- ,,,,.Attributes of excellent attending‐physician role models.N Engl J Med.1998;339(27):1986–1993.
During their junior medicine rotation, our students are asked to post to Blackboard (an online student forum) an anonymous essay about an issue of professionalism or ethics, either inspiring or troubling. In many ways, these vignettes are like postcards, written by visitors describing foreign cultures and norms. They represent a way for the students to debrief, but also provide an opportunity for us, as faculty, to reflect upon the way we practice and teach medicine. Many postingslike postcards from exotic or historic placesare inspiring stories of residents and faculty extending themselves for their patients. Unfortunately, unlike typical postcards, there are also essays that are troubling or provoking and challenge us to consider how we could improve the professional and ethical environment on our teams.
In order to begin a learning process with our faculty and housestaff, we have presented a number of these anonymous essays at both faculty and housestaff Department of Medicine conferences as well as our monthly hospital Ethics conference. The goal of these conferences was to gather as a moral community to reflect on our students' experience and consider ways in which our day to day practice as attendings could be informed by what they tell us. In addition, the junior medicine site directors have a session each quarter with their junior students to review some of the most significant issues brought up by their essays.
Practically, these vignettes and conferences serve three main purposes:
-
Raising Awareness: Many professional issues noted by our students occur under the radar. Attendings are often unaware of the issues of professionalism and/or ethics confronting our students and housestaff.
-
Exploring Attitudes: Some attending may underemphasize the importance of specific issues of professionalism and/or ethics. Open discussions at faculty or resident conferences create opportunities for individuals to reflect upon their own reactions and for the group to create a norm.
-
Sharing Skills: It is difficult to learn the practice of professionalism and ethics from a book. Skill in this area is gained primarily by experience. Conferences provide an excellent forum for seasoned physicians to share wisdom with less experienced physicians. In addition, important teaching points can be made: Students should not deliver bad news alone. Errors should be disclosed.
Following are 3 of the essays we presented, along with brief commentaries. At the end, we provide practical suggestions for individual attendings to improve the professional climate on their teams.
The Hospital Didn't Wait
Code. On 12, the surgical wards floor. Elise sprinted to the stairwell, dashed up to 12, and ran to the corner room as fast as she could. She could see the room before she got there. Instinctively, she started reviewing the steps she had memorized so many months ago. But when she finally arrived at the patient's bathroom, her thought process came to a jolting halt as she came upon the gruesome scene.
The 76‐year‐old patient had hanged himself with the cinching rope from his garment bag, and now dangled suspended from a high towel rack against the wall. Nurses from the floor started to file in, and without losing a beat Elise barked commands. Together they brought the man's body down to the floor, laid him on his back, and stripped off his hospital gown. Elise was in charge; deliberately but forcefully, she ordered a nurse to retrieve a defibrillator, and had another resident check for a pulse. There was none. Anesthesiology was here. Quickly and expertly, they shoved a plastic tube down his throat and began ventilation. The nurse placed on the electrodes between chest compressions then called to clear the body. Airway stepped back. The chest pumper stepped back. The body lurched forward as the defibrillator issued a long beep and discharged. Still no pulse. The cycle repeated.
Finally, Elise called a stop. Time of death, 19:37. By now there were about 20 people crammed in the patient room, all of whom had a separate role during the code. Some stayed behind, while the rest left to return to their interrupted work. The medical student didn't know what to think as he returned to the team room. His jaw was sorehad he been clenching it the whole time?and as he brought his hand up to rub his face, he saw that his knuckles were bloody. Somehow he had scraped them during the code. As he logged back into the computer to finish off his evening notes, he knew that he wouldn't have time to reflect until hours later when he returned home. Codes happened all the time. There was still work to be done in the hospital, and the hospital didn't wait.
The room had already been assigned to a patient waiting in the Emergency Department downstairs. That patient would be here in a few minutes. The hospital didn't wait.
When we presented this case in our conferences, there was universal agreement that such a traumatic event merits, even demands, team debriefing and processing. But in the real life aftermath of this traumatic event, the take‐home message for the medical student was that the hospital didn't wait for such discussions. We know this is not unique to our institution. In a study of 32 medical students who were asked to reflect on their most memorable patient death,1 debriefing sessions were rare and many students felt inadequately supported. While experienced clinicians may be accustomed to seeing patients die, students are new to the culture of the hospital, and have not had the chance to develop the defense mechanisms necessary to cope with this sort of experience. Angoff2 writes, As medical educators, we ought to ask our students how they are coping with long hours, fatigue, illness, suffering, and death. We ought to model and commend compassion and react to the deep feelings of our students in the same way we would teach them to react to the deep feelings of their patients.
I Told a Man Today That He Had Brain Cancer
The resident, intern, and I were huddled together in our team room when the report came back on the computer. New 3.5 2.3 1.7 cm contrast‐enhancing lesion seen anterior to genu of corpus callosum. Concerning for metastatic focus vs. lymphoma. Advise follow‐up. It wasn't unexpected but we had nevertheless been hoping for better.
The three of us went into his room and I was waiting to see how my resident would deliver the bad news, but she didn't. She simply said that we were continuing to do imaging studies and that a neurology team would be in touch. There were probably several reasons why she didn't tell him: not enough time, not her responsibility, or maybe she was just uncomfortable with it. Whatever the case, we left the room with my patient still oblivious to the awful mass now tangled in his head.
If my resident was taking a pass on this conversation, I knew it fell to me he needed to hear it from his primary team. I came back after rounds alone, sat down next to his bed, and told him that his MRI results had come back, and that I had unfortunate news.
I told him that the images showed that his lung cancer had spread to his brain.
I paused to give him a chance to let it sink in. He turned away and looked up at the ceiling.
Where is it? How big is it?
What now?
Reflecting on this case, our audiences were disturbed that a student would attempt this difficult conversation alone, while recognizing that the student clearly felt a sense of responsibility and desire to help his patient by sharing important information. We talked about how students may erroneously pick up a message that the team member who has spent the most time with a patient is the most obvious choice to have difficult conversations. We also noted that, unfortunately, sometimes students are directly asked by their team to shoulder this responsibility on their own. In this painful account, there is no mention of preparation, supervision, or support for the student before or after the encounter. The student perceived (rightly or wrongly) that the team leaders lacked comfort or skill to deliver the bad news, and stepped in. It is possible that the attending lacked the skill and ability to model an interaction, but more likely the deficit was in awareness and attitude. It is unlikely the attending knew that the student had this conversation alone. One of the major reasons we present these vignettes is to make attendings and housestaff more aware of issues that occur under their radar so that they can take preventative action. However, once the resident or attending found out that the student had this conversation alone, the student should be pulled aside for a 1:1 discussion. At the end of the day, the student should know that it was inappropriate to attempt this conversation alone
Rosenbaum3 reviewed a number of strategies to teach the skill of delivering bad news, from lecture and small group discussions to role play and standardized patients. When asked, students cited role‐modeling as the best way to learn how to deliver bad news.4 Observation of a veteran clinician provides a firm foundation for learning; but that is not enough. Unfortunately, we know from the literature (and our student vignettes suggest) that students and residents are unprepared to carry out these conversations properly, either because of misguided attitudes, lack of experience, or inadequate training.57 We conceptualize engaging in difficult conversations as a procedure, demanding a skill set. Mere observation of an expert executing this procedure is only a beginning. With any other skill, from successful completion of a lumbar puncture to initiating cardiopulmonary resuscitation (CPR), a student would never conclude that knowing the patient the best sufficiently credentials the student to undertake these procedures. We maintain that a difficult conversationbe it breaking bad news, discussing end‐of‐life care preferences, code status discussions, or prognosisis a clinical intervention, like any other procedure in medicine. If performed with skill and caution, it can bring about a stronger therapeutic relationship and increased support for the patient; if performed clumsily, it can lead to unintended adverse outcomes, including misunderstanding, mistrust, anxiety, and anger.
A Decimal Point Got Misplaced
On palliative care, I had a 90 year‐old man with end stage lung CA that presented to the ED with increasing SOB. The resident decided that giving him some morphine would be a good solution but was worried that too much would push him over the edge. He was thin; his O2 sats weren't that good After some discussion it was decided that 2.5 mg should be the starting amount. Unfortunately, when the note was written a decimal point got misplaced and he got 25 mg as a first dose. He ended up very sedated for most of the day but his breathing was ok.
The mistake was not discussed with the patient or the patient's family. While it did not cause any lasting harm, I wondered if telling the patient/patient's family that an error had been made would have been more ethically sound.
When we presented this case in our conferences, there was little controversy about whether the error should have been disclosed. The discussion did provide reinforcement for doing a simple but difficult task. Our analysis is that the nondiscussion of this error reflects a deficit in attitude and possibly skill. The team was aware of the error, but the resident and attending did not take the opportunity to disclose an error. They should have. We do not know whether the attending or resident felt unprepared to discuss this or were simply unimpressed with the adverse event. We do get the sense that the student did not feel comfortable raising the issue with the team. As such, it was a missed opportunity to seek help from any number of hospital resources and find encouragement to take on difficult encounters.
Much has been written about apologies.810 Disclosing errors and apologizing is the ethical standard, and many of our institutions have made it policy. Yet in the moment, it is embarrassing, anxiety provoking, and our concern about litigation looms large. Learning to do the right thing begins, perhaps with lectures and standardized patients, but only when students see it modeled by our housestaff and faculty, does it take root for good.
Our housestaff are quite good at managing medical issues, but they may still need help in creating the appropriate environment for professional learning and growth. This is 1 of the most important contributions an attending can make. We have emphasized that faculty have an important role to play in the area of professional development, reinforcing the rudimentary information preclinical students are presented with in the classroom and processing experiences residents are exposed to on a regular basis. If the hospital doesn't wait, then it is the attending physician's job to create the space and time for trainees to think about what is happening and ask if it could have been done better.
A number of seasoned clinical teachers have written about ways to improve teaching on the wards.11 Below, we will add to that discussion by considering practical ways to enhance learning about professionalism and ethics (see Table 1). Note should be made that while we focus on specific behaviors and activities, underlying all is the importance of availability, presence, and intention. Like all good teaching, these activities require planning and effort.
| Attending Activity | Examples |
|---|---|
| Creating an Open Climate | |
| Breaking Communication Barriers | Setting aside time for introductions and team building exercises at the beginning of a rotation, with attending participating equally with residents and students |
| Emphasizing attending availability to discuss or review problems of any kind | |
| Setting Clear Expectations | Emphasizing the importance of patient‐clinician or family‐clinician communication from the outset |
| Devoting some attending rounds to Difficult Conversations (e.g., breaking bad news or code status discussions) | |
| Explicitly stating that no ethical question is a stupid question and providing positive feedback for raising such questions for the team | |
| Regular Check‐ins | Establishing team communication rounds: 10 minutes every day to review a good, bad, or awkward interaction from the past day (e.g., family meeting, DNR discussion) |
| Setting aside time on rounds or during attending teaching sessions to explore the team's or an individual's emotional responses to a patient's death or deterioration | |
| Writing exercises that focus on our reactions to challenging situations that are shared with the group | |
| Supervision and Modeling | |
| Planning | Clarifying an agenda and practicing key phrases for a family meeting with the resident prior to meeting the family |
| Anticipating which patients may require a code status discussion and discussing a game plan on rounds | |
| Modeling | Students observe the attending facilitate a family meeting |
| Residents observe the attending apologizing for an error, no matter how small | |
| Attending thinks about an interpersonal conflict out loud and models asking patient‐relations for help | |
| Debriefing | Reviewing a family meeting with and giving feedback to the resident who facilitated |
| Reviewing a challenging code status discussion as a team |
Creating an Open Climate
The medical team, of which the attending, residents, and students are all a part, should not only be a unit that provides excellent medical care to its patients, but should also create a culture of continuous learning and improvement. As such, it is important to create a safe atmosphere where teachers are invested in the growth of their learners and learners feel free to question the prevailing logic and practice, including issues of professionalism and ethics. As Malcolm Gladwell12 describes in Outliers, Korean Air jets were crashing because subordinates were afraid to question their superiors. Once that culture changed, Korean Air safety improved dramatically. Similarly, breaking down some of the hierarchical barriers should improve the culture of a medical team. We typically make an effort to get to know our students and residents on a more personal basis: where they are from, who is in their family, what was their major, what are their interests outside of medicine, and what has been surprising to them in their training so far. Whether we set aside time when we first meet or e‐mail our questions before the first day, we aim for this to be 1 of the first team activities. We also share our own stories, making clear that the attending is part of the team, and not just an evaluating supervisor.
Vignette 1 describes the student's trauma of witnessing a code and the inability to process the event with anyone afterward. Failed resuscitation attempts are the most dramatic examples, but even expected deaths, nonfatal adverse events, and conflict between patients and providers may be traumatic for new trainees inexperienced with the reality of medicine. Attendings should be aware of these potentially traumatic events and make time to check in with the team members about how they are dealing with their emotions. Taking time on attending rounds, for example, allows the attending to not only model reflective practice and self‐care, but also elevates team support to a place traditionally reserved for discussions about diagnosis and treatment.
Supervision and Modeling
Vignettes 2 and 3 center around challenging communication tasks that require special training, including instruction, modeling, feedback, and practice. Unfortunately, as some of our student accounts document, many teaching opportunities are missed. As attendings, our duties include being aware of these opportunities, and being prepared to model competent patientor familydoctor interactions. Emphasizing the importance of the doctor‐patient relationship is in fact one of the key skills of an effective attending role model.13
When opportunities arise for any potentially difficult conversation, we make every effort to identify the issue, prebrief with the team about how to conduct the discussion, and either offer to model the conversation or be present to observe and provide feedback and debriefing afterwards. For example, by asking about all DNR discussions had with our patients, we gain insight into the skill level of our housestaff. As important, the housestaff understand that we believe that these conversations are vital to review during formal rounds, with the same attention we give to chest pain and electrocardiograms (ECGs).
Two key skills that develop with experience are the ability to know the limits of one's knowledge and to know when to ask for help. We try to be open about naming those limits and thinking about the other members of the larger healthcare team that may provide insight, skill, and expertise. We are used to doing this with medical questions (eg, asking the gastroenterology consult team to locate a source of bleeding). Asking our risk management, patient‐relations, or ethics services to assist with a difficult communication task or conflict with a family is no different, and often something the housestaff may not readily do.
We are grateful to our students and their postcards for the snapshots of our local medical culture. While we are gratified to read of excellent role modeling, we are also disappointed to read of situations which have left our students confused, demoralized and cynical. But if these exercises are to reach their full potential, they should tell us about where we would like to go, in addition to where we have been. We believe that our conferences have stimulated our faculty and housestaff to reflect on the professionalism lessons they are teaching. Reading the student postings has definitely affected our approach to teaching professionalism. They reinforce what every parent and educator knows: when it comes to teaching professionalism, communication and ethics, what matters most is the behavior of the teacher. Our words mean little if our actions do not live out what we espouse.
Acknowledgements
We are grateful for Michael Chan and his classmates from the NUFSM class of 2010 for their thoughtful essays. David Neely, Director of Undergraduate Education, Department of Medicine, Eytan Szmuilowicz, Palliative Medicine. Kathy Neely, Chairman of NMH Ethics Committee. Co‐director of Patient, Physician and Society. This article was previously published in this journal in Vol 5, Issue 5:E10E13 (2010) as online‐only.
During their junior medicine rotation, our students are asked to post to Blackboard (an online student forum) an anonymous essay about an issue of professionalism or ethics, either inspiring or troubling. In many ways, these vignettes are like postcards, written by visitors describing foreign cultures and norms. They represent a way for the students to debrief, but also provide an opportunity for us, as faculty, to reflect upon the way we practice and teach medicine. Many postingslike postcards from exotic or historic placesare inspiring stories of residents and faculty extending themselves for their patients. Unfortunately, unlike typical postcards, there are also essays that are troubling or provoking and challenge us to consider how we could improve the professional and ethical environment on our teams.
In order to begin a learning process with our faculty and housestaff, we have presented a number of these anonymous essays at both faculty and housestaff Department of Medicine conferences as well as our monthly hospital Ethics conference. The goal of these conferences was to gather as a moral community to reflect on our students' experience and consider ways in which our day to day practice as attendings could be informed by what they tell us. In addition, the junior medicine site directors have a session each quarter with their junior students to review some of the most significant issues brought up by their essays.
Practically, these vignettes and conferences serve three main purposes:
-
Raising Awareness: Many professional issues noted by our students occur under the radar. Attendings are often unaware of the issues of professionalism and/or ethics confronting our students and housestaff.
-
Exploring Attitudes: Some attending may underemphasize the importance of specific issues of professionalism and/or ethics. Open discussions at faculty or resident conferences create opportunities for individuals to reflect upon their own reactions and for the group to create a norm.
-
Sharing Skills: It is difficult to learn the practice of professionalism and ethics from a book. Skill in this area is gained primarily by experience. Conferences provide an excellent forum for seasoned physicians to share wisdom with less experienced physicians. In addition, important teaching points can be made: Students should not deliver bad news alone. Errors should be disclosed.
Following are 3 of the essays we presented, along with brief commentaries. At the end, we provide practical suggestions for individual attendings to improve the professional climate on their teams.
The Hospital Didn't Wait
Code. On 12, the surgical wards floor. Elise sprinted to the stairwell, dashed up to 12, and ran to the corner room as fast as she could. She could see the room before she got there. Instinctively, she started reviewing the steps she had memorized so many months ago. But when she finally arrived at the patient's bathroom, her thought process came to a jolting halt as she came upon the gruesome scene.
The 76‐year‐old patient had hanged himself with the cinching rope from his garment bag, and now dangled suspended from a high towel rack against the wall. Nurses from the floor started to file in, and without losing a beat Elise barked commands. Together they brought the man's body down to the floor, laid him on his back, and stripped off his hospital gown. Elise was in charge; deliberately but forcefully, she ordered a nurse to retrieve a defibrillator, and had another resident check for a pulse. There was none. Anesthesiology was here. Quickly and expertly, they shoved a plastic tube down his throat and began ventilation. The nurse placed on the electrodes between chest compressions then called to clear the body. Airway stepped back. The chest pumper stepped back. The body lurched forward as the defibrillator issued a long beep and discharged. Still no pulse. The cycle repeated.
Finally, Elise called a stop. Time of death, 19:37. By now there were about 20 people crammed in the patient room, all of whom had a separate role during the code. Some stayed behind, while the rest left to return to their interrupted work. The medical student didn't know what to think as he returned to the team room. His jaw was sorehad he been clenching it the whole time?and as he brought his hand up to rub his face, he saw that his knuckles were bloody. Somehow he had scraped them during the code. As he logged back into the computer to finish off his evening notes, he knew that he wouldn't have time to reflect until hours later when he returned home. Codes happened all the time. There was still work to be done in the hospital, and the hospital didn't wait.
The room had already been assigned to a patient waiting in the Emergency Department downstairs. That patient would be here in a few minutes. The hospital didn't wait.
When we presented this case in our conferences, there was universal agreement that such a traumatic event merits, even demands, team debriefing and processing. But in the real life aftermath of this traumatic event, the take‐home message for the medical student was that the hospital didn't wait for such discussions. We know this is not unique to our institution. In a study of 32 medical students who were asked to reflect on their most memorable patient death,1 debriefing sessions were rare and many students felt inadequately supported. While experienced clinicians may be accustomed to seeing patients die, students are new to the culture of the hospital, and have not had the chance to develop the defense mechanisms necessary to cope with this sort of experience. Angoff2 writes, As medical educators, we ought to ask our students how they are coping with long hours, fatigue, illness, suffering, and death. We ought to model and commend compassion and react to the deep feelings of our students in the same way we would teach them to react to the deep feelings of their patients.
I Told a Man Today That He Had Brain Cancer
The resident, intern, and I were huddled together in our team room when the report came back on the computer. New 3.5 2.3 1.7 cm contrast‐enhancing lesion seen anterior to genu of corpus callosum. Concerning for metastatic focus vs. lymphoma. Advise follow‐up. It wasn't unexpected but we had nevertheless been hoping for better.
The three of us went into his room and I was waiting to see how my resident would deliver the bad news, but she didn't. She simply said that we were continuing to do imaging studies and that a neurology team would be in touch. There were probably several reasons why she didn't tell him: not enough time, not her responsibility, or maybe she was just uncomfortable with it. Whatever the case, we left the room with my patient still oblivious to the awful mass now tangled in his head.
If my resident was taking a pass on this conversation, I knew it fell to me he needed to hear it from his primary team. I came back after rounds alone, sat down next to his bed, and told him that his MRI results had come back, and that I had unfortunate news.
I told him that the images showed that his lung cancer had spread to his brain.
I paused to give him a chance to let it sink in. He turned away and looked up at the ceiling.
Where is it? How big is it?
What now?
Reflecting on this case, our audiences were disturbed that a student would attempt this difficult conversation alone, while recognizing that the student clearly felt a sense of responsibility and desire to help his patient by sharing important information. We talked about how students may erroneously pick up a message that the team member who has spent the most time with a patient is the most obvious choice to have difficult conversations. We also noted that, unfortunately, sometimes students are directly asked by their team to shoulder this responsibility on their own. In this painful account, there is no mention of preparation, supervision, or support for the student before or after the encounter. The student perceived (rightly or wrongly) that the team leaders lacked comfort or skill to deliver the bad news, and stepped in. It is possible that the attending lacked the skill and ability to model an interaction, but more likely the deficit was in awareness and attitude. It is unlikely the attending knew that the student had this conversation alone. One of the major reasons we present these vignettes is to make attendings and housestaff more aware of issues that occur under their radar so that they can take preventative action. However, once the resident or attending found out that the student had this conversation alone, the student should be pulled aside for a 1:1 discussion. At the end of the day, the student should know that it was inappropriate to attempt this conversation alone
Rosenbaum3 reviewed a number of strategies to teach the skill of delivering bad news, from lecture and small group discussions to role play and standardized patients. When asked, students cited role‐modeling as the best way to learn how to deliver bad news.4 Observation of a veteran clinician provides a firm foundation for learning; but that is not enough. Unfortunately, we know from the literature (and our student vignettes suggest) that students and residents are unprepared to carry out these conversations properly, either because of misguided attitudes, lack of experience, or inadequate training.57 We conceptualize engaging in difficult conversations as a procedure, demanding a skill set. Mere observation of an expert executing this procedure is only a beginning. With any other skill, from successful completion of a lumbar puncture to initiating cardiopulmonary resuscitation (CPR), a student would never conclude that knowing the patient the best sufficiently credentials the student to undertake these procedures. We maintain that a difficult conversationbe it breaking bad news, discussing end‐of‐life care preferences, code status discussions, or prognosisis a clinical intervention, like any other procedure in medicine. If performed with skill and caution, it can bring about a stronger therapeutic relationship and increased support for the patient; if performed clumsily, it can lead to unintended adverse outcomes, including misunderstanding, mistrust, anxiety, and anger.
A Decimal Point Got Misplaced
On palliative care, I had a 90 year‐old man with end stage lung CA that presented to the ED with increasing SOB. The resident decided that giving him some morphine would be a good solution but was worried that too much would push him over the edge. He was thin; his O2 sats weren't that good After some discussion it was decided that 2.5 mg should be the starting amount. Unfortunately, when the note was written a decimal point got misplaced and he got 25 mg as a first dose. He ended up very sedated for most of the day but his breathing was ok.
The mistake was not discussed with the patient or the patient's family. While it did not cause any lasting harm, I wondered if telling the patient/patient's family that an error had been made would have been more ethically sound.
When we presented this case in our conferences, there was little controversy about whether the error should have been disclosed. The discussion did provide reinforcement for doing a simple but difficult task. Our analysis is that the nondiscussion of this error reflects a deficit in attitude and possibly skill. The team was aware of the error, but the resident and attending did not take the opportunity to disclose an error. They should have. We do not know whether the attending or resident felt unprepared to discuss this or were simply unimpressed with the adverse event. We do get the sense that the student did not feel comfortable raising the issue with the team. As such, it was a missed opportunity to seek help from any number of hospital resources and find encouragement to take on difficult encounters.
Much has been written about apologies.810 Disclosing errors and apologizing is the ethical standard, and many of our institutions have made it policy. Yet in the moment, it is embarrassing, anxiety provoking, and our concern about litigation looms large. Learning to do the right thing begins, perhaps with lectures and standardized patients, but only when students see it modeled by our housestaff and faculty, does it take root for good.
Our housestaff are quite good at managing medical issues, but they may still need help in creating the appropriate environment for professional learning and growth. This is 1 of the most important contributions an attending can make. We have emphasized that faculty have an important role to play in the area of professional development, reinforcing the rudimentary information preclinical students are presented with in the classroom and processing experiences residents are exposed to on a regular basis. If the hospital doesn't wait, then it is the attending physician's job to create the space and time for trainees to think about what is happening and ask if it could have been done better.
A number of seasoned clinical teachers have written about ways to improve teaching on the wards.11 Below, we will add to that discussion by considering practical ways to enhance learning about professionalism and ethics (see Table 1). Note should be made that while we focus on specific behaviors and activities, underlying all is the importance of availability, presence, and intention. Like all good teaching, these activities require planning and effort.
| Attending Activity | Examples |
|---|---|
| Creating an Open Climate | |
| Breaking Communication Barriers | Setting aside time for introductions and team building exercises at the beginning of a rotation, with attending participating equally with residents and students |
| Emphasizing attending availability to discuss or review problems of any kind | |
| Setting Clear Expectations | Emphasizing the importance of patient‐clinician or family‐clinician communication from the outset |
| Devoting some attending rounds to Difficult Conversations (e.g., breaking bad news or code status discussions) | |
| Explicitly stating that no ethical question is a stupid question and providing positive feedback for raising such questions for the team | |
| Regular Check‐ins | Establishing team communication rounds: 10 minutes every day to review a good, bad, or awkward interaction from the past day (e.g., family meeting, DNR discussion) |
| Setting aside time on rounds or during attending teaching sessions to explore the team's or an individual's emotional responses to a patient's death or deterioration | |
| Writing exercises that focus on our reactions to challenging situations that are shared with the group | |
| Supervision and Modeling | |
| Planning | Clarifying an agenda and practicing key phrases for a family meeting with the resident prior to meeting the family |
| Anticipating which patients may require a code status discussion and discussing a game plan on rounds | |
| Modeling | Students observe the attending facilitate a family meeting |
| Residents observe the attending apologizing for an error, no matter how small | |
| Attending thinks about an interpersonal conflict out loud and models asking patient‐relations for help | |
| Debriefing | Reviewing a family meeting with and giving feedback to the resident who facilitated |
| Reviewing a challenging code status discussion as a team |
Creating an Open Climate
The medical team, of which the attending, residents, and students are all a part, should not only be a unit that provides excellent medical care to its patients, but should also create a culture of continuous learning and improvement. As such, it is important to create a safe atmosphere where teachers are invested in the growth of their learners and learners feel free to question the prevailing logic and practice, including issues of professionalism and ethics. As Malcolm Gladwell12 describes in Outliers, Korean Air jets were crashing because subordinates were afraid to question their superiors. Once that culture changed, Korean Air safety improved dramatically. Similarly, breaking down some of the hierarchical barriers should improve the culture of a medical team. We typically make an effort to get to know our students and residents on a more personal basis: where they are from, who is in their family, what was their major, what are their interests outside of medicine, and what has been surprising to them in their training so far. Whether we set aside time when we first meet or e‐mail our questions before the first day, we aim for this to be 1 of the first team activities. We also share our own stories, making clear that the attending is part of the team, and not just an evaluating supervisor.
Vignette 1 describes the student's trauma of witnessing a code and the inability to process the event with anyone afterward. Failed resuscitation attempts are the most dramatic examples, but even expected deaths, nonfatal adverse events, and conflict between patients and providers may be traumatic for new trainees inexperienced with the reality of medicine. Attendings should be aware of these potentially traumatic events and make time to check in with the team members about how they are dealing with their emotions. Taking time on attending rounds, for example, allows the attending to not only model reflective practice and self‐care, but also elevates team support to a place traditionally reserved for discussions about diagnosis and treatment.
Supervision and Modeling
Vignettes 2 and 3 center around challenging communication tasks that require special training, including instruction, modeling, feedback, and practice. Unfortunately, as some of our student accounts document, many teaching opportunities are missed. As attendings, our duties include being aware of these opportunities, and being prepared to model competent patientor familydoctor interactions. Emphasizing the importance of the doctor‐patient relationship is in fact one of the key skills of an effective attending role model.13
When opportunities arise for any potentially difficult conversation, we make every effort to identify the issue, prebrief with the team about how to conduct the discussion, and either offer to model the conversation or be present to observe and provide feedback and debriefing afterwards. For example, by asking about all DNR discussions had with our patients, we gain insight into the skill level of our housestaff. As important, the housestaff understand that we believe that these conversations are vital to review during formal rounds, with the same attention we give to chest pain and electrocardiograms (ECGs).
Two key skills that develop with experience are the ability to know the limits of one's knowledge and to know when to ask for help. We try to be open about naming those limits and thinking about the other members of the larger healthcare team that may provide insight, skill, and expertise. We are used to doing this with medical questions (eg, asking the gastroenterology consult team to locate a source of bleeding). Asking our risk management, patient‐relations, or ethics services to assist with a difficult communication task or conflict with a family is no different, and often something the housestaff may not readily do.
We are grateful to our students and their postcards for the snapshots of our local medical culture. While we are gratified to read of excellent role modeling, we are also disappointed to read of situations which have left our students confused, demoralized and cynical. But if these exercises are to reach their full potential, they should tell us about where we would like to go, in addition to where we have been. We believe that our conferences have stimulated our faculty and housestaff to reflect on the professionalism lessons they are teaching. Reading the student postings has definitely affected our approach to teaching professionalism. They reinforce what every parent and educator knows: when it comes to teaching professionalism, communication and ethics, what matters most is the behavior of the teacher. Our words mean little if our actions do not live out what we espouse.
Acknowledgements
We are grateful for Michael Chan and his classmates from the NUFSM class of 2010 for their thoughtful essays. David Neely, Director of Undergraduate Education, Department of Medicine, Eytan Szmuilowicz, Palliative Medicine. Kathy Neely, Chairman of NMH Ethics Committee. Co‐director of Patient, Physician and Society. This article was previously published in this journal in Vol 5, Issue 5:E10E13 (2010) as online‐only.
- .This is just too awful; I just can't believe I experienced that.Acad Med.2005;80(7):634–640.
- .A piece of my mind.JAMA.2001;286(9):1017–1018.
- .Teaching medical students and residents skills for delivering bad news: a review of strategies.Acad Med.2004;79(2):107–117.
- .Third‐year medical students' experiences with dying patients during the internal medicine clerkship: a qualitative study of the informal curriculum.Acad Med.2005;80(7):641–647.
- ,,.How do medical residents discuss resuscitation with patients? Official journal of the Society for Research and Education in Primary Care Internal Medicine.J Gen Intern Med.1995;10(8):436–442.
- ,,.See one, do one, teach one? House staff experience discussing do‐not‐resuscitate orders.Arch Intern Med.1996;156(12):1285–1289.
- ,,,.Residents' end‐of‐life decision making with adult hospitalized patients: a review of the literature.Acad Med.2005:80(7)622–633.
- .Physician error and disclosure.Clin Obstet Gynecol.2008;51(4):700–708.
- .Revealing medical errors to your patients.Chest.2009;133:1064–1065.
- .Apology in medical practice.JAMA.2006;296:1401–1404.
- .What if Osler were one of us? Inpatient teaching today.J Gen Intern Med.1997;12(Suppl 2):S41–S48.
- Malcolm Gladwell.Outliers.New York:Little, Brown, Co.,2008: p.177–223.
- ,,,,.Attributes of excellent attending‐physician role models.N Engl J Med.1998;339(27):1986–1993.
- .This is just too awful; I just can't believe I experienced that.Acad Med.2005;80(7):634–640.
- .A piece of my mind.JAMA.2001;286(9):1017–1018.
- .Teaching medical students and residents skills for delivering bad news: a review of strategies.Acad Med.2004;79(2):107–117.
- .Third‐year medical students' experiences with dying patients during the internal medicine clerkship: a qualitative study of the informal curriculum.Acad Med.2005;80(7):641–647.
- ,,.How do medical residents discuss resuscitation with patients? Official journal of the Society for Research and Education in Primary Care Internal Medicine.J Gen Intern Med.1995;10(8):436–442.
- ,,.See one, do one, teach one? House staff experience discussing do‐not‐resuscitate orders.Arch Intern Med.1996;156(12):1285–1289.
- ,,,.Residents' end‐of‐life decision making with adult hospitalized patients: a review of the literature.Acad Med.2005:80(7)622–633.
- .Physician error and disclosure.Clin Obstet Gynecol.2008;51(4):700–708.
- .Revealing medical errors to your patients.Chest.2009;133:1064–1065.
- .Apology in medical practice.JAMA.2006;296:1401–1404.
- .What if Osler were one of us? Inpatient teaching today.J Gen Intern Med.1997;12(Suppl 2):S41–S48.
- Malcolm Gladwell.Outliers.New York:Little, Brown, Co.,2008: p.177–223.
- ,,,,.Attributes of excellent attending‐physician role models.N Engl J Med.1998;339(27):1986–1993.
Management of Inpatient Hyperglycemia
Hyperglycemia that develops acutely due to illness is associated with poor patient outcomes in hospitalized inpatients, especially those critically ill in the intensive care unit (ICU).18 In fact, those without a prior diagnosis of diabetes and therefore newly found to have hyperglycemia have worse outcomes than those who have a prior diagnosis of diabetes.1, 2, 4, 68 Many mechanisms have been put forward to explain the adverse outcomes related to hyperglycemia, including the release of counter‐regulatory hormones, increased lipolysis with free fatty acid release, the release of inflammatory cytokines and growth factors, increased reactive oxygen species with oxidative stress and altered immunoglobulin, and neutrophil phagocytic function.911
The practical importance of this was brought home by Furnary et al.12, 13 who showed that glycemic control using 3 days of intensive intravenous (IV) insulin therapy of diabetic patients undergoing cardiac surgical procedures was able to reduce significantly the risk of deep sternal wound infections and mortality and to bring these adverse outcomes to the same levels as those of nondiabetic patients. However, the benefits of intensive insulin therapy are not limited to those with diabetes and extend to those with critical illness‐induced hyperglycemia. In a landmark, randomized, prospective study from Belgium, van den Berghe et al.14 showed that the use of an intensive IV insulin protocol designed to maintain serum blood glucose 80 mg/dL to 110 mg/dL significantly decreased morbidity and mortality following admission to the surgical ICU (SICU). Of note, only 13% of the individuals in the study had a previously known diagnosis of diabetes, showing that hyperglycemia was common following SICU admission and glycemic control was beneficial regardless of diabetes status.14
These impressive benefits1214 led to the call for improved glycemic control in the hospital with glucose targets similar to those used in the Belgian study.15 The development of protocols for such treatment proceeded rapidly.16, 17 A meta‐analysis that reviewed 14 trials through May 1, 2006 of patients in SICUs showed a 31% reduction in mortality with intensive therapy, albeit at the expense of a substantially increased risk of hypoglycemia.18 Our own studies19 using 1 day of continuous insulin infusion followed by subcutaneous basal/bolus insulin for all hyperglycemic patients following coronary artery bypass surgery showed results similar to those of Furnary et al.12, 13
Subsequently, 3 large, multicenter studies of patients in medical ICU (MICU) and SICUs, the VISEP, NICE‐SUGAR, and GLUCONTROL studies, failed to show the benefit of intensive insulin therapy on mortality and all had very high rates of hypoglycemia.2022 The VISEP20 study was stopped prematurely because of excessive hypoglycemia in the intensive treatment arm and the GLUCONTROL study was stopped prematurely because of multiple protocol violations.22 The NICE‐SUGAR study actually showed an increased mortality in the intensively treated group21 but the target range for their control group was 140 mg/dL to 180 mg/dL rather than 180 mg/dL to 215 mg/dL and this likely accounted for the better mortality in their control group compared to other studies. Van den Berghe et al.,23 in a design similar to their earlier one in the SICU, found that intensive insulin therapy in the MICU resulted in significant reductions in new onset renal injury, MICU and hospital length of stay, and an improved ability to wean off mechanical ventilation; however, no improvement in mortality was found except for those whose MICU stay was >3 days duration. In a post hoc analysis of their combined SICU and MICU studies, van den Berghe et al.23 found that a glucose target of 110 mg/dL to 150 mg/dL accounted for about 75% of the mortality benefit with a low risk of hypoglycemia.24 A recent meta‐analysis that included data on 13,567 patients from 26 trials, including the NICE‐SUGAR study, concluded that although overall there was no mortality benefit from intensive insulin therapy there was benefit in the SICU but not in the MICU or mixed ICU units.25
As a result of these later studies, new recommendations from the American Association of Clinical Endocrinologists and the American Diabetes Association state that for optimal risk/benefit, the overall goal of inpatient treatment for most patients should be 140 mg/dL to 180 mg/dL, although a range of 110 mg/dL to 140 mg/dL may be appropriate for some patients.26 Stressed in this Consensus Statement is the need for experienced practitioners and systems to provide optimal implementation of protocols so as to provide adequate glycemic control without an undue amount of hypoglycemia. We have found that active individual patient management by experienced nurse practitioners who can modify existing protocols as needed provides better glycemic control with less hypoglycemia than nursing personnel adhering to a protocol without taking into account the myriad of factors affecting patients daily.16
Although hypoglycemia is certainly to be avoided and has been associated with increased mortality,6, 27 Kosiborod et al.7 showed that mortality in hyperglycemic patients following an acute myocardial infarction was not related to insulin‐induced hypoglycemia but to hypoglycemia unassociated with insulin use. In the latter case, the hypoglycemia is generally attributable to shock, sepsis, malnutrition, liver failure, renal failure, or multiorgan failure.
One of the potential hurdles to achievement of glycemic control in the critically ill is the labor‐intensive changes in patient care policies necessary to attain these goals. Particular concern lies in the ability of inpatient care providers to develop and implement successful insulin protocols. Intravenous insulin administration is effective and appropriate in the ICU and some non‐ICU settings, but administration of insulin subcutaneously is less nursing intensive and a more familiar hyperglycemia treatment option. However, glycemic control with subcutaneous insulin is only achieved using basal/bolus regimens and not with simple sliding‐scale regimens that omit basal insulin and attempt to treat rather than prevent hyperglycemia.28
In this issue of the Journal of Hospital Medicine, 3 articles deal with some of the practical aspects of inpatient hyperglycemia management. In ICU patients on continuous IV insulin infusions, Newton et al.29 demonstrated improved glycemic control without an increase in hypoglycemia when using a computer‐guided insulin algorithm using a hand‐held device (Glucommander) compared to a paper algorithm. A previous publication in JHM showed that when continuous insulin infusions were used on the regular hospital floors outside of the ICU, Smiley et al.30 found that 67% of patients achieved the targeted goal of 150 mg/dL by day 2. Wesorick et al.31 found that simply educating floor nurses as well as physicians and using standardized insulin protocols resulted in improved glycemic control and less hypoglycemia on inpatient services outside of the ICU. In the third paper, Ramos et al. found that those with glycosylated hemoglobin (HbA1c) levels >6.0%, a prior history of diabetes, or chronic steroid use did better with basal insulin than with no basal insulin when converting from insulin infusions.32 In contrast to their using only 40% of the stable insulin infusion rate for their basal dose, we found that 80% worked better.33 We also learned the hard way that overlap of the infusion by 2 hours to 4 hours after giving the basal insulin subcutaneous dose is just not carried out by the treating team because of timing and practical considerations. We now just give a dose of rapid acting insulin equal to 10% of the basal insulin dose at the time of the injection of the basal dose; this allows for the immediate cessation of the infusion without loss of glycemic control (Table 1).
|
| Measure HbA1c on admission to aid in discharge planning |
| Start insulin infusions in postoperative and other unstable patients if blood glucose >180 mg/dL on 2 or more occasions |
| Begin IV continuous insulin infusion using validated protocols |
| Glucose target: 140‐180 mg/dL* |
| When converting from IV to subcutaneous insulin |
| Give 80% of stable IV dose as glargine insulin |
| Give 10% of glargine dose as rapid acting insulin |
| Then stop insulin infusion |
| If starting with subcutaneous insulin without prior insulin infusion |
| Give 50% as long‐acting insulin (glargine or detemir) |
| Give 50% as rapid‐acting insulin, divided into 3 for the 3 meals |
Intensive insulin treatment in the ICU clearly results in better outcomes when compared to letting glucose levels remain greater than 200 mg/dL. A glucose target range of 140 mg/dL to 180 mg/dL provides improved mortality and morbidity with a low risk of hypoglycemia and is suitable for most hospitals. A more aggressive target range of 110 mg/dL to 140 mg/dL provides further improvement but increases the risk of hypoglycemia and would only be appropriate for those institutions with considerable experience with such therapy and demonstrated low rates of hypoglycemia. Work is still needed on devising the ideal treatment algorithm, regimens for conversion from IV to subcutaneous insulin, and discharge planning. However, the most important part of patient care we have found is the insertion of an intelligent and experienced brain between the patient and the insulin protocol.
- ,,, et al.Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: A systematic overview.Stroke.2001;32;2426–2432.
- ,,, et al.Hyperglycemia: an independent marker of in‐hospital mortality in patients with undiagnosed diabetes.J Clin Endocrinol Metab.2002;87;978–982.
- .Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients.Mayo Clin Proc.2003;78:1471–1478.
- ,,, et al.Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes mellitus.Mayo Clin Proc.2005;80:1558–1567.
- ,,, et al.The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community acquired pneumonia.Diabetes Care.2005;28:810–815.
- ,,, et al.Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction. Implications for patients with and without recognized diabetes.Circulation.2005;111:3078–3086.
- ,,, et al.Glucometrics in patients hospitalized with acute myocardial infarction. Defining the optimal outcomes‐based measure of risk.Circulation.2008;117:1018–1027.
- ,,, et al.Hyperglycemia‐related mortality in critically ill patients varies with admission diagnosis.Crit Care Med.2009;37:3001–3009.
- .Effect of insulin therapy on nonglycemic variables during acute illness.Endocr Pract.2004;10(Suppl 2):63–70.
- ,, et al.Therapy insight: the effect of tight glycemic control in acute illness.Nature Clin Pract Endocrinol Metab.2007;3:270–278.
- ,,.Stress hyperglycemia.Lancet.2009;373:1798–1807.
- ,,, et al.Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures.Ann Thorac Surg.1999;67:352–362.
- ,,, et al.Insulin infusion reduces mortality in patients undergoing coronary artery bypass grafting.J Thorac Cardiovasc Surg.2003;125:1007–1021.
- ,,, et al.Intensive insulin therapy in critically ill patients.N Engl J Med.2001;345:1359–1367.
- ,,, et al.American College of Endocrinology Position Statement on inpatient diabetes and metabolic control.Endocr Pract.2004;10:77–82.
- ,,, et al.Inpatient management of hyperglycemia: The Northwestern Experience.Endocr Pract.2006:12;491–505.
- ,,.Insulin infusion protocols for critically ill patients: a highlight of differences and similarities.Endocr Pract.2007;13:137–146.
- ,,, et al.Effect of perioperative insulin infusion on surgical morbidity and mortality: systematic review and meta‐analysis of randomized trials.Mayo Clin Proc.2008;83:418–430.
- ,,, et al.Reduction in surgical mortality and morbidity in diabetic patients undergoing cardiac surgery with a combined intravenous and subcutaneous insulin glucose management.Diabetes Care.2007;30:823–828.
- ,,, et al.Intensive insulin therapy and pentastarch resuscitation in severe sepsis.N Engl J Med.2008;358:125–139.
- ,,Su SY for the NICE‐SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients.N Engl J Med.2009;360:1283–1297.
- ,,, et al.A prospective randomised multi‐centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol Study.Intensive Care Med.2009;35:1738–1748.
- ,,, et al.Intensive insulin therapy in the medical ICU.N Engl J Med.2006;354:449–461.
- ,,, et al.Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm.Diabetes.2006;55:3151–3159.
- ,,, et al.Intensive insulin therapy and mortality among critically ill patients: a meta‐analysis including NIC‐SUGAR study data.CMAJ.2009;180:821–827.
- ,,, et al.American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.Diabetes Care.2009;32:1119–1131.
- ,.Severe hypoglycemia in critically ill patients: risk factors and outcomes.Crit Care Med.2007;35:2262–2267.
- ,,, et al.Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial).Diabetes Care.2007;30:2181–2186.
- ,,, et al.A comparison study of continuous insulin infusion protocols in the Medical Intensive Care Unit: computer‐guided versus standard column‐based algorithms.J Hosp Med. 2010;5:432–437.
- ,,, et al.Safety and efficacy of continuous insulin infusion in noncritical care settings.J Hosp Med.2010;5(4):212–217.
- ,,, et al.Effects of an educational program and a standardized insulin order form on glycemic outcomes in non‐critically ill hospitalized patients.J Hosp Med. 2010;5:438–445.
- ,,, et al.Maintaining glycemic control when transitioning from infusion insulin: a protocol driven, multidisciplinary approach.J Hosp Med. 2010;5:446–451.
- ,,, et al.Conversion of intravenous insulin infusions to subcutaneously administered insulin glargine in patients with hyperglycemia.Endocr Pract.2006;12:641–650.
Hyperglycemia that develops acutely due to illness is associated with poor patient outcomes in hospitalized inpatients, especially those critically ill in the intensive care unit (ICU).18 In fact, those without a prior diagnosis of diabetes and therefore newly found to have hyperglycemia have worse outcomes than those who have a prior diagnosis of diabetes.1, 2, 4, 68 Many mechanisms have been put forward to explain the adverse outcomes related to hyperglycemia, including the release of counter‐regulatory hormones, increased lipolysis with free fatty acid release, the release of inflammatory cytokines and growth factors, increased reactive oxygen species with oxidative stress and altered immunoglobulin, and neutrophil phagocytic function.911
The practical importance of this was brought home by Furnary et al.12, 13 who showed that glycemic control using 3 days of intensive intravenous (IV) insulin therapy of diabetic patients undergoing cardiac surgical procedures was able to reduce significantly the risk of deep sternal wound infections and mortality and to bring these adverse outcomes to the same levels as those of nondiabetic patients. However, the benefits of intensive insulin therapy are not limited to those with diabetes and extend to those with critical illness‐induced hyperglycemia. In a landmark, randomized, prospective study from Belgium, van den Berghe et al.14 showed that the use of an intensive IV insulin protocol designed to maintain serum blood glucose 80 mg/dL to 110 mg/dL significantly decreased morbidity and mortality following admission to the surgical ICU (SICU). Of note, only 13% of the individuals in the study had a previously known diagnosis of diabetes, showing that hyperglycemia was common following SICU admission and glycemic control was beneficial regardless of diabetes status.14
These impressive benefits1214 led to the call for improved glycemic control in the hospital with glucose targets similar to those used in the Belgian study.15 The development of protocols for such treatment proceeded rapidly.16, 17 A meta‐analysis that reviewed 14 trials through May 1, 2006 of patients in SICUs showed a 31% reduction in mortality with intensive therapy, albeit at the expense of a substantially increased risk of hypoglycemia.18 Our own studies19 using 1 day of continuous insulin infusion followed by subcutaneous basal/bolus insulin for all hyperglycemic patients following coronary artery bypass surgery showed results similar to those of Furnary et al.12, 13
Subsequently, 3 large, multicenter studies of patients in medical ICU (MICU) and SICUs, the VISEP, NICE‐SUGAR, and GLUCONTROL studies, failed to show the benefit of intensive insulin therapy on mortality and all had very high rates of hypoglycemia.2022 The VISEP20 study was stopped prematurely because of excessive hypoglycemia in the intensive treatment arm and the GLUCONTROL study was stopped prematurely because of multiple protocol violations.22 The NICE‐SUGAR study actually showed an increased mortality in the intensively treated group21 but the target range for their control group was 140 mg/dL to 180 mg/dL rather than 180 mg/dL to 215 mg/dL and this likely accounted for the better mortality in their control group compared to other studies. Van den Berghe et al.,23 in a design similar to their earlier one in the SICU, found that intensive insulin therapy in the MICU resulted in significant reductions in new onset renal injury, MICU and hospital length of stay, and an improved ability to wean off mechanical ventilation; however, no improvement in mortality was found except for those whose MICU stay was >3 days duration. In a post hoc analysis of their combined SICU and MICU studies, van den Berghe et al.23 found that a glucose target of 110 mg/dL to 150 mg/dL accounted for about 75% of the mortality benefit with a low risk of hypoglycemia.24 A recent meta‐analysis that included data on 13,567 patients from 26 trials, including the NICE‐SUGAR study, concluded that although overall there was no mortality benefit from intensive insulin therapy there was benefit in the SICU but not in the MICU or mixed ICU units.25
As a result of these later studies, new recommendations from the American Association of Clinical Endocrinologists and the American Diabetes Association state that for optimal risk/benefit, the overall goal of inpatient treatment for most patients should be 140 mg/dL to 180 mg/dL, although a range of 110 mg/dL to 140 mg/dL may be appropriate for some patients.26 Stressed in this Consensus Statement is the need for experienced practitioners and systems to provide optimal implementation of protocols so as to provide adequate glycemic control without an undue amount of hypoglycemia. We have found that active individual patient management by experienced nurse practitioners who can modify existing protocols as needed provides better glycemic control with less hypoglycemia than nursing personnel adhering to a protocol without taking into account the myriad of factors affecting patients daily.16
Although hypoglycemia is certainly to be avoided and has been associated with increased mortality,6, 27 Kosiborod et al.7 showed that mortality in hyperglycemic patients following an acute myocardial infarction was not related to insulin‐induced hypoglycemia but to hypoglycemia unassociated with insulin use. In the latter case, the hypoglycemia is generally attributable to shock, sepsis, malnutrition, liver failure, renal failure, or multiorgan failure.
One of the potential hurdles to achievement of glycemic control in the critically ill is the labor‐intensive changes in patient care policies necessary to attain these goals. Particular concern lies in the ability of inpatient care providers to develop and implement successful insulin protocols. Intravenous insulin administration is effective and appropriate in the ICU and some non‐ICU settings, but administration of insulin subcutaneously is less nursing intensive and a more familiar hyperglycemia treatment option. However, glycemic control with subcutaneous insulin is only achieved using basal/bolus regimens and not with simple sliding‐scale regimens that omit basal insulin and attempt to treat rather than prevent hyperglycemia.28
In this issue of the Journal of Hospital Medicine, 3 articles deal with some of the practical aspects of inpatient hyperglycemia management. In ICU patients on continuous IV insulin infusions, Newton et al.29 demonstrated improved glycemic control without an increase in hypoglycemia when using a computer‐guided insulin algorithm using a hand‐held device (Glucommander) compared to a paper algorithm. A previous publication in JHM showed that when continuous insulin infusions were used on the regular hospital floors outside of the ICU, Smiley et al.30 found that 67% of patients achieved the targeted goal of 150 mg/dL by day 2. Wesorick et al.31 found that simply educating floor nurses as well as physicians and using standardized insulin protocols resulted in improved glycemic control and less hypoglycemia on inpatient services outside of the ICU. In the third paper, Ramos et al. found that those with glycosylated hemoglobin (HbA1c) levels >6.0%, a prior history of diabetes, or chronic steroid use did better with basal insulin than with no basal insulin when converting from insulin infusions.32 In contrast to their using only 40% of the stable insulin infusion rate for their basal dose, we found that 80% worked better.33 We also learned the hard way that overlap of the infusion by 2 hours to 4 hours after giving the basal insulin subcutaneous dose is just not carried out by the treating team because of timing and practical considerations. We now just give a dose of rapid acting insulin equal to 10% of the basal insulin dose at the time of the injection of the basal dose; this allows for the immediate cessation of the infusion without loss of glycemic control (Table 1).
|
| Measure HbA1c on admission to aid in discharge planning |
| Start insulin infusions in postoperative and other unstable patients if blood glucose >180 mg/dL on 2 or more occasions |
| Begin IV continuous insulin infusion using validated protocols |
| Glucose target: 140‐180 mg/dL* |
| When converting from IV to subcutaneous insulin |
| Give 80% of stable IV dose as glargine insulin |
| Give 10% of glargine dose as rapid acting insulin |
| Then stop insulin infusion |
| If starting with subcutaneous insulin without prior insulin infusion |
| Give 50% as long‐acting insulin (glargine or detemir) |
| Give 50% as rapid‐acting insulin, divided into 3 for the 3 meals |
Intensive insulin treatment in the ICU clearly results in better outcomes when compared to letting glucose levels remain greater than 200 mg/dL. A glucose target range of 140 mg/dL to 180 mg/dL provides improved mortality and morbidity with a low risk of hypoglycemia and is suitable for most hospitals. A more aggressive target range of 110 mg/dL to 140 mg/dL provides further improvement but increases the risk of hypoglycemia and would only be appropriate for those institutions with considerable experience with such therapy and demonstrated low rates of hypoglycemia. Work is still needed on devising the ideal treatment algorithm, regimens for conversion from IV to subcutaneous insulin, and discharge planning. However, the most important part of patient care we have found is the insertion of an intelligent and experienced brain between the patient and the insulin protocol.
Hyperglycemia that develops acutely due to illness is associated with poor patient outcomes in hospitalized inpatients, especially those critically ill in the intensive care unit (ICU).18 In fact, those without a prior diagnosis of diabetes and therefore newly found to have hyperglycemia have worse outcomes than those who have a prior diagnosis of diabetes.1, 2, 4, 68 Many mechanisms have been put forward to explain the adverse outcomes related to hyperglycemia, including the release of counter‐regulatory hormones, increased lipolysis with free fatty acid release, the release of inflammatory cytokines and growth factors, increased reactive oxygen species with oxidative stress and altered immunoglobulin, and neutrophil phagocytic function.911
The practical importance of this was brought home by Furnary et al.12, 13 who showed that glycemic control using 3 days of intensive intravenous (IV) insulin therapy of diabetic patients undergoing cardiac surgical procedures was able to reduce significantly the risk of deep sternal wound infections and mortality and to bring these adverse outcomes to the same levels as those of nondiabetic patients. However, the benefits of intensive insulin therapy are not limited to those with diabetes and extend to those with critical illness‐induced hyperglycemia. In a landmark, randomized, prospective study from Belgium, van den Berghe et al.14 showed that the use of an intensive IV insulin protocol designed to maintain serum blood glucose 80 mg/dL to 110 mg/dL significantly decreased morbidity and mortality following admission to the surgical ICU (SICU). Of note, only 13% of the individuals in the study had a previously known diagnosis of diabetes, showing that hyperglycemia was common following SICU admission and glycemic control was beneficial regardless of diabetes status.14
These impressive benefits1214 led to the call for improved glycemic control in the hospital with glucose targets similar to those used in the Belgian study.15 The development of protocols for such treatment proceeded rapidly.16, 17 A meta‐analysis that reviewed 14 trials through May 1, 2006 of patients in SICUs showed a 31% reduction in mortality with intensive therapy, albeit at the expense of a substantially increased risk of hypoglycemia.18 Our own studies19 using 1 day of continuous insulin infusion followed by subcutaneous basal/bolus insulin for all hyperglycemic patients following coronary artery bypass surgery showed results similar to those of Furnary et al.12, 13
Subsequently, 3 large, multicenter studies of patients in medical ICU (MICU) and SICUs, the VISEP, NICE‐SUGAR, and GLUCONTROL studies, failed to show the benefit of intensive insulin therapy on mortality and all had very high rates of hypoglycemia.2022 The VISEP20 study was stopped prematurely because of excessive hypoglycemia in the intensive treatment arm and the GLUCONTROL study was stopped prematurely because of multiple protocol violations.22 The NICE‐SUGAR study actually showed an increased mortality in the intensively treated group21 but the target range for their control group was 140 mg/dL to 180 mg/dL rather than 180 mg/dL to 215 mg/dL and this likely accounted for the better mortality in their control group compared to other studies. Van den Berghe et al.,23 in a design similar to their earlier one in the SICU, found that intensive insulin therapy in the MICU resulted in significant reductions in new onset renal injury, MICU and hospital length of stay, and an improved ability to wean off mechanical ventilation; however, no improvement in mortality was found except for those whose MICU stay was >3 days duration. In a post hoc analysis of their combined SICU and MICU studies, van den Berghe et al.23 found that a glucose target of 110 mg/dL to 150 mg/dL accounted for about 75% of the mortality benefit with a low risk of hypoglycemia.24 A recent meta‐analysis that included data on 13,567 patients from 26 trials, including the NICE‐SUGAR study, concluded that although overall there was no mortality benefit from intensive insulin therapy there was benefit in the SICU but not in the MICU or mixed ICU units.25
As a result of these later studies, new recommendations from the American Association of Clinical Endocrinologists and the American Diabetes Association state that for optimal risk/benefit, the overall goal of inpatient treatment for most patients should be 140 mg/dL to 180 mg/dL, although a range of 110 mg/dL to 140 mg/dL may be appropriate for some patients.26 Stressed in this Consensus Statement is the need for experienced practitioners and systems to provide optimal implementation of protocols so as to provide adequate glycemic control without an undue amount of hypoglycemia. We have found that active individual patient management by experienced nurse practitioners who can modify existing protocols as needed provides better glycemic control with less hypoglycemia than nursing personnel adhering to a protocol without taking into account the myriad of factors affecting patients daily.16
Although hypoglycemia is certainly to be avoided and has been associated with increased mortality,6, 27 Kosiborod et al.7 showed that mortality in hyperglycemic patients following an acute myocardial infarction was not related to insulin‐induced hypoglycemia but to hypoglycemia unassociated with insulin use. In the latter case, the hypoglycemia is generally attributable to shock, sepsis, malnutrition, liver failure, renal failure, or multiorgan failure.
One of the potential hurdles to achievement of glycemic control in the critically ill is the labor‐intensive changes in patient care policies necessary to attain these goals. Particular concern lies in the ability of inpatient care providers to develop and implement successful insulin protocols. Intravenous insulin administration is effective and appropriate in the ICU and some non‐ICU settings, but administration of insulin subcutaneously is less nursing intensive and a more familiar hyperglycemia treatment option. However, glycemic control with subcutaneous insulin is only achieved using basal/bolus regimens and not with simple sliding‐scale regimens that omit basal insulin and attempt to treat rather than prevent hyperglycemia.28
In this issue of the Journal of Hospital Medicine, 3 articles deal with some of the practical aspects of inpatient hyperglycemia management. In ICU patients on continuous IV insulin infusions, Newton et al.29 demonstrated improved glycemic control without an increase in hypoglycemia when using a computer‐guided insulin algorithm using a hand‐held device (Glucommander) compared to a paper algorithm. A previous publication in JHM showed that when continuous insulin infusions were used on the regular hospital floors outside of the ICU, Smiley et al.30 found that 67% of patients achieved the targeted goal of 150 mg/dL by day 2. Wesorick et al.31 found that simply educating floor nurses as well as physicians and using standardized insulin protocols resulted in improved glycemic control and less hypoglycemia on inpatient services outside of the ICU. In the third paper, Ramos et al. found that those with glycosylated hemoglobin (HbA1c) levels >6.0%, a prior history of diabetes, or chronic steroid use did better with basal insulin than with no basal insulin when converting from insulin infusions.32 In contrast to their using only 40% of the stable insulin infusion rate for their basal dose, we found that 80% worked better.33 We also learned the hard way that overlap of the infusion by 2 hours to 4 hours after giving the basal insulin subcutaneous dose is just not carried out by the treating team because of timing and practical considerations. We now just give a dose of rapid acting insulin equal to 10% of the basal insulin dose at the time of the injection of the basal dose; this allows for the immediate cessation of the infusion without loss of glycemic control (Table 1).
|
| Measure HbA1c on admission to aid in discharge planning |
| Start insulin infusions in postoperative and other unstable patients if blood glucose >180 mg/dL on 2 or more occasions |
| Begin IV continuous insulin infusion using validated protocols |
| Glucose target: 140‐180 mg/dL* |
| When converting from IV to subcutaneous insulin |
| Give 80% of stable IV dose as glargine insulin |
| Give 10% of glargine dose as rapid acting insulin |
| Then stop insulin infusion |
| If starting with subcutaneous insulin without prior insulin infusion |
| Give 50% as long‐acting insulin (glargine or detemir) |
| Give 50% as rapid‐acting insulin, divided into 3 for the 3 meals |
Intensive insulin treatment in the ICU clearly results in better outcomes when compared to letting glucose levels remain greater than 200 mg/dL. A glucose target range of 140 mg/dL to 180 mg/dL provides improved mortality and morbidity with a low risk of hypoglycemia and is suitable for most hospitals. A more aggressive target range of 110 mg/dL to 140 mg/dL provides further improvement but increases the risk of hypoglycemia and would only be appropriate for those institutions with considerable experience with such therapy and demonstrated low rates of hypoglycemia. Work is still needed on devising the ideal treatment algorithm, regimens for conversion from IV to subcutaneous insulin, and discharge planning. However, the most important part of patient care we have found is the insertion of an intelligent and experienced brain between the patient and the insulin protocol.
- ,,, et al.Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: A systematic overview.Stroke.2001;32;2426–2432.
- ,,, et al.Hyperglycemia: an independent marker of in‐hospital mortality in patients with undiagnosed diabetes.J Clin Endocrinol Metab.2002;87;978–982.
- .Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients.Mayo Clin Proc.2003;78:1471–1478.
- ,,, et al.Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes mellitus.Mayo Clin Proc.2005;80:1558–1567.
- ,,, et al.The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community acquired pneumonia.Diabetes Care.2005;28:810–815.
- ,,, et al.Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction. Implications for patients with and without recognized diabetes.Circulation.2005;111:3078–3086.
- ,,, et al.Glucometrics in patients hospitalized with acute myocardial infarction. Defining the optimal outcomes‐based measure of risk.Circulation.2008;117:1018–1027.
- ,,, et al.Hyperglycemia‐related mortality in critically ill patients varies with admission diagnosis.Crit Care Med.2009;37:3001–3009.
- .Effect of insulin therapy on nonglycemic variables during acute illness.Endocr Pract.2004;10(Suppl 2):63–70.
- ,, et al.Therapy insight: the effect of tight glycemic control in acute illness.Nature Clin Pract Endocrinol Metab.2007;3:270–278.
- ,,.Stress hyperglycemia.Lancet.2009;373:1798–1807.
- ,,, et al.Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures.Ann Thorac Surg.1999;67:352–362.
- ,,, et al.Insulin infusion reduces mortality in patients undergoing coronary artery bypass grafting.J Thorac Cardiovasc Surg.2003;125:1007–1021.
- ,,, et al.Intensive insulin therapy in critically ill patients.N Engl J Med.2001;345:1359–1367.
- ,,, et al.American College of Endocrinology Position Statement on inpatient diabetes and metabolic control.Endocr Pract.2004;10:77–82.
- ,,, et al.Inpatient management of hyperglycemia: The Northwestern Experience.Endocr Pract.2006:12;491–505.
- ,,.Insulin infusion protocols for critically ill patients: a highlight of differences and similarities.Endocr Pract.2007;13:137–146.
- ,,, et al.Effect of perioperative insulin infusion on surgical morbidity and mortality: systematic review and meta‐analysis of randomized trials.Mayo Clin Proc.2008;83:418–430.
- ,,, et al.Reduction in surgical mortality and morbidity in diabetic patients undergoing cardiac surgery with a combined intravenous and subcutaneous insulin glucose management.Diabetes Care.2007;30:823–828.
- ,,, et al.Intensive insulin therapy and pentastarch resuscitation in severe sepsis.N Engl J Med.2008;358:125–139.
- ,,Su SY for the NICE‐SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients.N Engl J Med.2009;360:1283–1297.
- ,,, et al.A prospective randomised multi‐centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol Study.Intensive Care Med.2009;35:1738–1748.
- ,,, et al.Intensive insulin therapy in the medical ICU.N Engl J Med.2006;354:449–461.
- ,,, et al.Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm.Diabetes.2006;55:3151–3159.
- ,,, et al.Intensive insulin therapy and mortality among critically ill patients: a meta‐analysis including NIC‐SUGAR study data.CMAJ.2009;180:821–827.
- ,,, et al.American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.Diabetes Care.2009;32:1119–1131.
- ,.Severe hypoglycemia in critically ill patients: risk factors and outcomes.Crit Care Med.2007;35:2262–2267.
- ,,, et al.Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial).Diabetes Care.2007;30:2181–2186.
- ,,, et al.A comparison study of continuous insulin infusion protocols in the Medical Intensive Care Unit: computer‐guided versus standard column‐based algorithms.J Hosp Med. 2010;5:432–437.
- ,,, et al.Safety and efficacy of continuous insulin infusion in noncritical care settings.J Hosp Med.2010;5(4):212–217.
- ,,, et al.Effects of an educational program and a standardized insulin order form on glycemic outcomes in non‐critically ill hospitalized patients.J Hosp Med. 2010;5:438–445.
- ,,, et al.Maintaining glycemic control when transitioning from infusion insulin: a protocol driven, multidisciplinary approach.J Hosp Med. 2010;5:446–451.
- ,,, et al.Conversion of intravenous insulin infusions to subcutaneously administered insulin glargine in patients with hyperglycemia.Endocr Pract.2006;12:641–650.
- ,,, et al.Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: A systematic overview.Stroke.2001;32;2426–2432.
- ,,, et al.Hyperglycemia: an independent marker of in‐hospital mortality in patients with undiagnosed diabetes.J Clin Endocrinol Metab.2002;87;978–982.
- .Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients.Mayo Clin Proc.2003;78:1471–1478.
- ,,, et al.Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes mellitus.Mayo Clin Proc.2005;80:1558–1567.
- ,,, et al.The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community acquired pneumonia.Diabetes Care.2005;28:810–815.
- ,,, et al.Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction. Implications for patients with and without recognized diabetes.Circulation.2005;111:3078–3086.
- ,,, et al.Glucometrics in patients hospitalized with acute myocardial infarction. Defining the optimal outcomes‐based measure of risk.Circulation.2008;117:1018–1027.
- ,,, et al.Hyperglycemia‐related mortality in critically ill patients varies with admission diagnosis.Crit Care Med.2009;37:3001–3009.
- .Effect of insulin therapy on nonglycemic variables during acute illness.Endocr Pract.2004;10(Suppl 2):63–70.
- ,, et al.Therapy insight: the effect of tight glycemic control in acute illness.Nature Clin Pract Endocrinol Metab.2007;3:270–278.
- ,,.Stress hyperglycemia.Lancet.2009;373:1798–1807.
- ,,, et al.Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures.Ann Thorac Surg.1999;67:352–362.
- ,,, et al.Insulin infusion reduces mortality in patients undergoing coronary artery bypass grafting.J Thorac Cardiovasc Surg.2003;125:1007–1021.
- ,,, et al.Intensive insulin therapy in critically ill patients.N Engl J Med.2001;345:1359–1367.
- ,,, et al.American College of Endocrinology Position Statement on inpatient diabetes and metabolic control.Endocr Pract.2004;10:77–82.
- ,,, et al.Inpatient management of hyperglycemia: The Northwestern Experience.Endocr Pract.2006:12;491–505.
- ,,.Insulin infusion protocols for critically ill patients: a highlight of differences and similarities.Endocr Pract.2007;13:137–146.
- ,,, et al.Effect of perioperative insulin infusion on surgical morbidity and mortality: systematic review and meta‐analysis of randomized trials.Mayo Clin Proc.2008;83:418–430.
- ,,, et al.Reduction in surgical mortality and morbidity in diabetic patients undergoing cardiac surgery with a combined intravenous and subcutaneous insulin glucose management.Diabetes Care.2007;30:823–828.
- ,,, et al.Intensive insulin therapy and pentastarch resuscitation in severe sepsis.N Engl J Med.2008;358:125–139.
- ,,Su SY for the NICE‐SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients.N Engl J Med.2009;360:1283–1297.
- ,,, et al.A prospective randomised multi‐centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol Study.Intensive Care Med.2009;35:1738–1748.
- ,,, et al.Intensive insulin therapy in the medical ICU.N Engl J Med.2006;354:449–461.
- ,,, et al.Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm.Diabetes.2006;55:3151–3159.
- ,,, et al.Intensive insulin therapy and mortality among critically ill patients: a meta‐analysis including NIC‐SUGAR study data.CMAJ.2009;180:821–827.
- ,,, et al.American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.Diabetes Care.2009;32:1119–1131.
- ,.Severe hypoglycemia in critically ill patients: risk factors and outcomes.Crit Care Med.2007;35:2262–2267.
- ,,, et al.Randomized study of basal‐bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial).Diabetes Care.2007;30:2181–2186.
- ,,, et al.A comparison study of continuous insulin infusion protocols in the Medical Intensive Care Unit: computer‐guided versus standard column‐based algorithms.J Hosp Med. 2010;5:432–437.
- ,,, et al.Safety and efficacy of continuous insulin infusion in noncritical care settings.J Hosp Med.2010;5(4):212–217.
- ,,, et al.Effects of an educational program and a standardized insulin order form on glycemic outcomes in non‐critically ill hospitalized patients.J Hosp Med. 2010;5:438–445.
- ,,, et al.Maintaining glycemic control when transitioning from infusion insulin: a protocol driven, multidisciplinary approach.J Hosp Med. 2010;5:446–451.
- ,,, et al.Conversion of intravenous insulin infusions to subcutaneously administered insulin glargine in patients with hyperglycemia.Endocr Pract.2006;12:641–650.
Continuing Medical Education Program in
If you wish to receive credit for this activity, which begins on the next page, please refer to the website:
Accreditation and Designation Statement
Blackwell Futura Media Services designates this educational activity for a 1 AMA PRA Category 1 Credit. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Blackwell Futura Media Services is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Educational Objectives
Continuous participation in the Journal of Hospital Medicine CME program will enable learners to be better able to:
-
Interpret clinical guidelines and their applications for higher quality and more efficient care for all hospitalized patients.
-
Describe the standard of care for common illnesses and conditions treated in the hospital; such as pneumonia, COPD exacerbation, acute coronary syndrome, HF exacerbation, glycemic control, venous thromboembolic disease, stroke, etc.
-
Discuss evidence‐based recommendations involving transitions of care, including the hospital discharge process.
-
Gain insights into the roles of hospitalists as medical educators, researchers, medical ethicists, palliative care providers, and hospital‐based geriatricians.
-
Incorporate best practices for hospitalist administration, including quality improvement, patient safety, practice management, leadership, and demonstrating hospitalist value.
-
Identify evidence‐based best practices and trends for both adult and pediatric hospital medicine.
Instructions on Receiving Credit
For information on applicability and acceptance of continuing medical education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity during the valid credit period that is noted on the title page.
Follow these steps to earn credit:
-
Log on to
www.blackwellpublishing.com/cme . -
Read the target audience, learning objectives, and author disclosures.
-
Read the article in print or online format.
-
Reflect on the article.
-
Access the CME Exam, and choose the best answer to each question.
-
Complete the required evaluation component of the activity.
If you wish to receive credit for this activity, which begins on the next page, please refer to the website:
Accreditation and Designation Statement
Blackwell Futura Media Services designates this educational activity for a 1 AMA PRA Category 1 Credit. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Blackwell Futura Media Services is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Educational Objectives
Continuous participation in the Journal of Hospital Medicine CME program will enable learners to be better able to:
-
Interpret clinical guidelines and their applications for higher quality and more efficient care for all hospitalized patients.
-
Describe the standard of care for common illnesses and conditions treated in the hospital; such as pneumonia, COPD exacerbation, acute coronary syndrome, HF exacerbation, glycemic control, venous thromboembolic disease, stroke, etc.
-
Discuss evidence‐based recommendations involving transitions of care, including the hospital discharge process.
-
Gain insights into the roles of hospitalists as medical educators, researchers, medical ethicists, palliative care providers, and hospital‐based geriatricians.
-
Incorporate best practices for hospitalist administration, including quality improvement, patient safety, practice management, leadership, and demonstrating hospitalist value.
-
Identify evidence‐based best practices and trends for both adult and pediatric hospital medicine.
Instructions on Receiving Credit
For information on applicability and acceptance of continuing medical education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity during the valid credit period that is noted on the title page.
Follow these steps to earn credit:
-
Log on to
www.blackwellpublishing.com/cme . -
Read the target audience, learning objectives, and author disclosures.
-
Read the article in print or online format.
-
Reflect on the article.
-
Access the CME Exam, and choose the best answer to each question.
-
Complete the required evaluation component of the activity.
If you wish to receive credit for this activity, which begins on the next page, please refer to the website:
Accreditation and Designation Statement
Blackwell Futura Media Services designates this educational activity for a 1 AMA PRA Category 1 Credit. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Blackwell Futura Media Services is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Educational Objectives
Continuous participation in the Journal of Hospital Medicine CME program will enable learners to be better able to:
-
Interpret clinical guidelines and their applications for higher quality and more efficient care for all hospitalized patients.
-
Describe the standard of care for common illnesses and conditions treated in the hospital; such as pneumonia, COPD exacerbation, acute coronary syndrome, HF exacerbation, glycemic control, venous thromboembolic disease, stroke, etc.
-
Discuss evidence‐based recommendations involving transitions of care, including the hospital discharge process.
-
Gain insights into the roles of hospitalists as medical educators, researchers, medical ethicists, palliative care providers, and hospital‐based geriatricians.
-
Incorporate best practices for hospitalist administration, including quality improvement, patient safety, practice management, leadership, and demonstrating hospitalist value.
-
Identify evidence‐based best practices and trends for both adult and pediatric hospital medicine.
Instructions on Receiving Credit
For information on applicability and acceptance of continuing medical education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity during the valid credit period that is noted on the title page.
Follow these steps to earn credit:
-
Log on to
www.blackwellpublishing.com/cme . -
Read the target audience, learning objectives, and author disclosures.
-
Read the article in print or online format.
-
Reflect on the article.
-
Access the CME Exam, and choose the best answer to each question.
-
Complete the required evaluation component of the activity.
Transitioning From Infusion Insulin
Hyperglycemia due to diabetes or stress is prevalent in the intensive care unit (ICU) and general ward setting. Umpierrez et al.1 reported hyperglycemia in 38% of hospitalized ward patients with 26% having a known history of diabetes. While patients with hyperglycemia admitted to the ICU are primarily treated with infusion insulin, those on the general wards usually receive a subcutaneous regimen of insulin. How best to transition patients from infusion insulin to a subcutaneous regimen remains elusive and under evaluated.
A recent observational pilot study of 24 surgical and 17 cardiac/medical intensive care patients at our university‐based hospital found that glycemic control significantly deteriorated when patients with diabetes transitioned from infusion insulin to subcutaneous insulin. A total of 21 critical care patients with a history of diabetes failed to receive basal insulin prior to discontinuation of the drip and developed uncontrolled hyperglycemia (mean glucose Day 1 of 216 mg/dL and Day 2 of 197 mg/dL). Patients without a history of diabetes did well post transition with a mean glucose of 142 mg/dL Day 1 and 133 mg/dL Day 2. A similar study by Czosnowski et al.2 demonstrated a significant increase in blood glucose from 123 26 mg/dL to 168 50 mg/dL upon discontinuation of infusion insulin.
This failed transition is disappointing, especially in view of the existence of a reliable subcutaneous (SC) insulin order set at our institution, but not surprising, as this is an inherently complex process. The severity of illness, the amount and mode of nutritional intake, geographic location, and provider team may all be in flux at the time of this transition. A few centers have demonstrated that a much improved transition is possible,36 however many of these solutions involve technology or incremental personnel that may not be available or the descriptions may lack sufficient detail to implement theses strategies with confidence elsewhere.
Therefore, we designed and piloted a protocol, coordinated by a multidisciplinary team, to transition patients from infusion insulin to SC insulin. The successful implementation of this protocol could serve as a blueprint to other institutions without the need for additional technology or personnel.
Methods
Patient Population/Setting
This was a prospective study of patients admitted to either the medical/cardiac intensive care unit (MICU/CCU) or surgical intensive care unit (SICU) at an academic medical facility and placed on infusion insulin for >24 hours. The Institutional Review Board (IRB) approved the study for prospective chart review and anonymous results reporting without individual consent.
Patients in the SICU were initiated on infusion insulin after 2 blood glucose readings were above 150 mg/dL, whereas initiation was left to the discretion of the attending physician in the MICU/CCU. A computerized system created in‐house recommends insulin infusion rates based on point‐of‐care (POC) glucose measurements with a target range of 91 mg/dL to 150 mg/dL.
Inclusion/Exclusion Criteria
All patients on continuous insulin infusion admitted to the SICU or the MICU/CCU between May 2008 and September 2008 were evaluated for the study (Figure 1). Patients were excluded from analysis if they were on the infusion for less than 24 hours, had a liver transplant, were discharged within 48 hours of transition, were made comfort care or transitioned to an insulin pump. All other patients were included in the final analysis.
Transition Protocol
Step 1: Does the Patient Need Basal SC Insulin?
Patients were recommended to receive basal SC insulin if they either: (1) were on medications for diabetes; (2) had an A1c 6%; or (3) received the equivalent of 60 mg of prednisone; AND had an infusion rate 1 unit/hour (Supporting Information Appendix 1). Patients on infusion insulin due to stress hyperglycemia, regardless of the infusion rate, were not placed on basal SC insulin. Patients on high dose steroids due to spinal injuries were excluded because their duration of steroid use was typically less than 48 hours and usually ended prior to the time of transition. The protocol recommends premeal correctional insulin for those not qualifying for basal insulin.
In order to establish patients in need of basal/nutritional insulin we opted to use A1c as well as past medical history to identify patients with diabetes. The American Diabetes Association (ADA) has recently accepted using an A1c 6.5% to make a new diagnosis of diabetes.7 In a 2‐week trial prior to initiating the protocol we used a cut off A1c of 6.5%. However, we found that patients with an A1c of 6% to 6.5% had poor glucose control post transition; therefore we chose 6% as our identifier. In addition, using a cut off A1c of 6% was reported by Rohlfing et al.8 and Greci et al.9 to be more than 97% sensitive at identifying a new diagnosis of diabetes.
To ensure an A1c was ordered and available at the time of transition, critical care pharmacists were given Pharmacy and Therapeutics Committee authorization to order an A1c at the start of the infusion. Pharmacists would also guide the primary team through the protocol's recommendations as well as alert the project team when a patient was expected to transition.
Step 2: Evaluate the Patient's Nutritional Intake to Calculate the Total Daily Dose (TDD) of Insulin
TDD is the total amount of insulin needed to cover both the nutritional and basal requirements of a patient over the course of 24 hours. TDD was calculated by averaging the hourly drip rate over the prior 6 hours and multiplying by 20 if taking in full nutrition or 40 if taking minimal nutrition while on the drip. A higher multiplier was used for those on minimal nutrition with the expectation that their insulin requirements would double once tolerating a full diet. Full nutrition was defined as eating >50% of meals, on goal tube feeds, or receiving total parenteral nutrition (TPN). Minimal nutrition was defined as taking nothing by mouth (or NPO), tolerating <50% of meals, or on a clear liquid diet.
Step 3: Divide the TDD Into the Appropriate Components of Insulin Treatment (Basal, Nutritional and Correction), Depending on the Nutritional Status
In Step 3, the TDD was evenly divided into basal and nutritional insulin. A total of 50% of the TDD was given as glargine (Lantus) 2 hours prior to stopping the infusion. The remaining 50% was divided into nutritional components as either Regular insulin every 6 hours for patients on tube feeds or lispro (Humalog) before meals if tolerating an oral diet. For patients on minimal nutrition, the 50% nutritional insulin dose was not initiated until the patient was tolerating full nutrition.
The protocol recommended basal insulin administration 2 hours prior to infusion discontinuation as recommended by the American Association of Clinical Endocrinologists (AACE) and ADA consensus statement on inpatient glycemic control as well as pharmacokinetics.10, 11 For these reasons, failure to receive basal insulin prior to transition was viewed as failure to follow the protocol.
Safety features of the protocol included a maximum TDD of 100 units unless the patient was on >100 units/day of insulin prior to admission. A pager was carried by rotating hospitalists or pharmacist study investigators at all hours during the protocol implementation phase to answer any questions regarding a patient's transition.
Data Collection/Monitoring
A multidisciplinary team consisting of hospitalists, ICU pharmacists, critical care physicians and nursing representatives was assembled during the study period. This team was responsible for protocol implementation, data collection, and surveillance of patient response to the protocol. Educational sessions with house staff and nurses in each unit were held prior to the beginning of the study as well as continued monthly educational efforts during the study. In addition, biweekly huddles to review ongoing patient transitions as well as more formal monthly reviews were held.
The primary objective was to improve glycemic control, defined as the mean daily glucose, during the first 48 hours post transition without a significant increase in the percentage of patients with hypoglycemia (41‐70 mg/dL) or severe hypoglycemia (40 mg/dL). Secondary endpoints included the percent of patients with severe hyperglycemia (300 mg/dL), length of stay (LOS) calculated from the day of transition, number of restarts back onto infusion insulin within 72 hours of transition, and day‐weighted glucose mean up to 12 days following transition for patients with diabetes.
Glucose values were collected and averaged over 6‐hour periods for 48 hours post transition. For patients with diabetes, POC glucose values were collected up to 12 days of hospitalization. Day‐weighted means were obtained by calculating the mean glucose for each hospital day, averaged across all hospital days.12
Analysis
Subjects were divided by the presence or absence of diabetes. Those with diabetes were recommended to receive basal SC insulin during the transition period. Within each group, subjects were further divided by adherence to the protocol. Failure to transition per protocol was defined as: not receiving at least 80% of the recommended basal insulin dose, receiving the initial dose of insulin after the drip was discontinued, or receiving basal insulin when none was recommended.
Descriptive statistics within subgroups comparing age, gender, LOS by analysis of variance for continuous data and by chi‐square for nominal data, were compared. Twenty‐four and 48‐hour post transition mean glucose values and the 12 day weighted‐mean glucose were compared using analysis of variance (Stata ver. 10). All data are expressed as mean standard deviation with a significance value established at P < 0.05.
Results
A total of 210 episodes of infusion insulin in ICU patients were evaluated for the study from May of 2008 to September 2008 (Figure 1). Ninety‐six of these episodes were excluded, most commonly due to time on infusion insulin <24 hours or transition to comfort care. The remaining 114 infusions were eligible to use the protocol. Because the protocol recommends insulin therapy based on a diagnosis of diabetes, patients were further divided into these subcategories. Of these 114 transitions, the protocol was followed 66 times (58%).
Patients With Diabetes
(Table 1: Patient Demographics; Table 2: Insulin Use and Glycemic Control; Figure 2: Transition Graph).
| Patients With Diabetes | P Value | Patients Without Diabetes | P Value | |||
|---|---|---|---|---|---|---|
| Protocol Followed, n = 29 Patients* | Protocol NOT Followed, n = 33 Patients | Protocol Followed, n = 30 Patients | Protocol NOT Followed, n = 9 Patients | |||
| ||||||
| Average age, years, mean SD | 57.7 12.1 | 57.8 12.3 | 0.681 | 56.5 18.1 | 62.4 15.5 | 0.532 |
| Male patients | 21 (72%) | 21 (63%) | 0.58 | 20 (66%) | 7 (77%) | 0.691 |
| BMI | 30.7 7.2 | 28.6 6.8 | 0.180 | 27 5.4 | 25.2 3 | 0.081 |
| History of diabetes* | 18 (64%) | 25 (86%) | 0.07 | 0 | 0 | |
| Mean Hgb A1c (%) | 6.61.2 | 7.3 1.8 | 0.136 | 5.6 0.3 | 5.4 0.4 | 0.095 |
| Full nutrition | 26 (79%) | 24 (61%) | 0.131 | 23 (70%) | 9 (100%) | |
| On hemodialysis | 5 (17%) | 9 (27%) | 0.380 | 3 (10%) | 0 | |
| On >60 mg prednisone or equivalent per day | 7 (24%) | 10 (30%) | 0.632 | 0 | 0 | |
| Patients With Diabetes | P Value | Patients Without Diabetes | P Value | |||
|---|---|---|---|---|---|---|
| Protocol Followed, n = 33 transitions | Protocol NOT followed, n = 39 transitions | Protocol Followed, n = 33 transitions | Protocol NOT Followed, n = 9 transitions | |||
| ||||||
| Average infusion rate, hours | 3.96 3.15 | 3.74 3.64 | 0.1597 | 2.34 1.5 | 4.78 1.6 | <0.001 |
| Average BG on infusion insulin (mg/dL) | 122.5 27.5 | 122.5 31.8 | 0.844 | 115.1 22.7 | 127.5 27.2 | 0.006 |
| Average basal dose (units) given | 34.5 14.4 | 14.4 15.3 | <0.001 | 0 | 32.7 | <0.001 |
| Hours before () or after (+) infusion stopped basal insulin given | 1.13 0.9 | 11.6 9.3 | <0.001 | n/a | 0.33 | * |
| Average BG 6 hours post transition (mg/dL) | 143.7 39.4 | 182 62.5 | 0.019 | 150.2 54.9 | 142.1 34.1 | 0.624 |
| Average BG 0 to 24 hours post transition (mg/dL) | 167.98 50.24 | 211.02 81.01 | <0.001 | 150.24 54.9 | 150.12 32.4 | 0.600 |
| Total insulin used from 0 to 24 hours (units) | 65 32.2 | 26.7 25.4 | <0.001 | 3.2 4.1 | 51.3 30.3 | <0.001 |
| Average BG 25 to 48 hours post transition (mg/dL) | 176.1 55.25 | 218.2 88.54 | <0.001 | 153 35.3 | 154.4 46.7 | 0.711 |
| Total insulin used from 25 to 48 hours (units) | 60.5 35.4 | 28.1 24.4 | <0.001 | 2.8 3.8 | 44.9 34 | <0.001 |
| # of patients with severe hypoglycemia (<40 mg/dL) | 1 (3%) | 1 (2.6%) | * | 0 | 1 | * |
| # of patients with hypoglycemia (4170 mg/dL) | 3 (9%) | 2 (5.1%) | * | 1 | 0 | * |
| % of BG values in goal range (80180 mg/dL) (# in range/total #) | 60.2% (153/254) | 38.2% (104/272) | 0.004 | 80.1% (173/216) | 75.4% (49/65) | 0.83 |
| # of patients with severe hyperglycemia (>300 mg/dL) | 5 (15.2%) | 19 (48.7%) | 0.002 | 1 (3%) | 1 (11.1%) | * |
| LOS from transition (days) | 14.6 11.3 | 14 11.4 | 0.836 | 25.3 24.4 | 13.6 7.5 | 0.168 |
A total of 62 individual patients accounted for 72 separate transitions in patients with diabetes based on past medical history or an A1c 6% (n = 14). Of these 72 transitions, 33 (46%) adhered to the protocol while the remaining 39 (54%) transitions varied from the protocol at the treatment team's discretion. Despite similar insulin infusion rates and mean glucose values pretransition, patients with diabetes following the protocol had better glycemic control at both 24 hours and 48 hours after transition than those patients transitioned without the protocol. Day 1 mean blood glucose was 168 mg/dL vs. 211 mg/dL (P = <0.001) and day 2 mean blood glucose was 176 mg/dL vs. 218 mg/dL (P = <0.001) in protocol vs. nonprotocol patients with diabetes respectively (Figure 2).
There was a severe hypoglycemic event (40 mg/dL) in 1 patient with diabetes following the protocol and 1 patient not following the protocol within 48 hours of transition. Both events were secondary to nutritional‐insulin mismatch with emesis after insulin in one case and tube feeds being held in the second case. These findings were consistent with our prior examination of hypoglycemia cases.13 Severe hyperglycemia (glucose 300mg/dL) occurred in 5 (15 %) patients following the protocol vs. 19 (49%) patients not following protocol (P = 0.002.) Patients with diabetes following the protocol received significantly more insulin in the first 24 hours (mean of 65 units vs. 27 units, P 0.001) and 24 to 48 hours after transition (mean of 61 units vs. 28 units, p0.001) than those not following protocol.
An alternate method used at our institution and others14, 15 to calculate TDD is based on the patient's weight and body habitus. When we compared the projected TDD based on weight with the TDD using the transition protocol, we found that the weight based method was much less aggressive. For patients following the protocol, the weight based method projected a mean TDD of 46.3 16.9 units whereas the protocol projected a mean TDD of 65 33.2 units (P = 0.001).
Patients with diabetes following protocol received basal insulin an average of 1.13 hours prior to discontinuing the insulin infusion versus 11.6 hours after for those not following protocol.
Three patients with diabetes following the protocol and 3 patients with diabetes not following the protocol were restarted on infusion insulin within 72 hours of transition.
LOS from final transition to discharge was similar between protocol vs. nonprotocol patients (14.6 vs. 14 days, P = 0.836).
Figure 3 demonstrates that when used correctly, the protocol provides an extended period of glycemic control up to 12 days post transition. Patients transitioned per protocol had a day‐weighted mean glucose of 155 mg/dL vs. 184 mg/dL (P = 0.043) in patients not following protocol. There was only 1 glucose value less than 40 mg/dL between days 2 to 12 in the protocol group.
Patients Without Diabetes
Of the 39 individual patients without diabetes there were 42 transition events, 33 transitions (78.6%) were per protocol and placed on correctional insulin only. The remaining 9 transitions failed to follow protocol in that basal insulin was prescribed, but these patients maintained comparable glycemic control without an increase in hypoglycemic events. Following transition, patients without diabetes on protocol maintained a mean glucose of 150 mg/dL in the first 24 hours and 153 mg/dL in 24 to 48 hours post transition. They required a mean daily correctional insulin dose of 3.2 units on Day 1 and 2.8 units on Day 2 despite having an average drip rate of 2.3 units/hour at the time of transition (Table 2). There were no severe hypoglycemic events and 80% of blood sugars were within the goal range of 80 mg/dL to 180 mg/dL. Only 1 patient had a single blood glucose of >300mg/dL. No patient was restarted on infusion insulin once transitioned.
Patients without diabetes had a longer LOS after transition off of infusion insulin when compared to their diabetic counterparts (22 vs. 14 days).
Discussion
This study demonstrates the utility of hospitalist‐pharmacist collaboration in the creation and implementation of a safe and effective transition protocol for patients on infusion insulin. The protocol identifies patients appropriate for transition to a basal/nutritional insulin regimen versus those who will do well with premeal correctional insulin alone. Daily mean glucose was improved post transition for diabetic patients following the protocol compared to those not following the protocol without an increase in hypoglycemic events.
We found an equal number of insulin infusion restarts within 72 hours of transition and a similar LOS in protocol vs. nonprotocol patients with diabetes. The LOS was increased for patients without diabetes. This may be due to worse outcomes noted in patients with stress hyperglycemia in other studies.1, 16
The use of the higher multiplier for patients on minimal nutrition led to confusion among many protocol users. The protocol has since been modified to start by averaging the infusion rate over the prior 6 hours and then multiplying by 20 for all patients. This essentially calculates 80% of projected insulin requirements for the next 24 hours based on the patient's current needs. This calculation is then given as 50% basal and 50% nutritional for those on full nutrition vs. 100% basal for those on minimal nutrition. This protocol change has no impact on the amount of insulin received by the patient, but is more intuitive to providers. Instead of calculating the TDD as the projected requirement when full nutrition is obtained, the TDD is now calculated based on current insulin needs, and then doubled when patients who are receiving minimal nutrition advance to full nutrition.
Our study is limited by the lack of a true randomized control group. In lieu of this, we used our patients who did not follow protocol as our control. While not truly randomized, this group is comparable based on their age, gender mix, infusion rate, mean A1c, and projected TDD. This group was also similar to our preprotocol group mentioned in the Introduction.
Additional study limitations include the small number of nondiabetic patients not following the protocol (n = 9). We noted higher infusion rates in nondiabetics not following protocol versus those following protocol, which may have driven the primary team to give basal insulin. It is possible that these 9 patients were not yet ready to transition from infusion insulin or had other stressors not measured in our study. Unfortunately their small population size limits more extensive analysis.
The protocol was followed only 50% of the time for a variety of reasons. Patients who transitioned at night or on weekends were monitored by covering pharmacists and physicians who may not have been familiar with the protocol. Many physicians and nurses remain fearful of hypoglycemia and the outcomes of our study were not yet available for education. Some reported difficulty fully understanding how to use the protocol and why a higher multiplier was used for patients who were on minimal nutrition.
Efforts to improve adherence to the protocol are ongoing with some success, aided by the data demonstrating the safety and efficacy of the transition protocol.
Conclusion
By collaborating with ICU pharmacists we were able to design and implement a protocol that successfully and safely transitioned patients from infusion insulin to subcutaneous insulin. Patients following the protocol had a higher percentage of glucose values within the goal glucose range of 80 mg/dL to 180 mg/dL. In the future, we hope to automate the calculation of TDD and directly recommend a basal/bolus regimen for the clinical provider.
- ,,,,,.Hyperglycemia: an independent marker of in‐hospital mortality in patients with undiagnosed diabetes.J Clin Endocrinol Metab.2002;87:978–982.
- ,,,,,.Evaluation of glycemic control following discontinuation of an intensive insulin protocol.J Hosp Med.2009;4:28–34.
- ,,, et al.Inpatient management of hyperglycemia: the Northwestern experience.Endocr Pract.2006;12:491–505.
- ,,,.Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy.Endocr Pract.2004;10Suppl 2:71–80.
- ,,, et al.Conversion of intravenous insulin infusions to subcutaneously administered insulin glargine in patients with hyperglycemia.Endocr Pract.2006;12:641–650.
- ,.Effects of outcome on in‐hospital transition from intravenous insulin infusion to subcutaneous therapy.Am J Cardiol.2006;98:557–564.
- International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes.Diabetes Care.2009;32:1327–1334.
- ,,, et al.Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population.Diabetes Care.2000;23:187–191.
- ,,, et al.Utility of HbA(1c) levels for diabetes case finding in hospitalized patients with hyperglycemia.Diabetes Care.2003;26:1064–1068.
- ,,, et al.American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.Endocr Pract.2009;15(4):353–369.
- ,,, et al.Pharmacokinetics and pharmacodynamics of subcutaneous injection of long‐acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.Diabetes.2000;49:2142–2148.
- ,,, et al.“Glucometrics”‐‐assessing the quality of inpatient glucose management.Diabetes Technol Ther.2006;8:560–569.
- ,,.Iatrogenic Inpatient Hypoglycemia: Risk Factors, Treatment, and Prevention: Analysis of Current Practice at an Academic Medical Center With Implications for Improvement Efforts.Diabetes Spectr.2008;21:241–247.
- ,,, et al.Management of diabetes and hyperglycemia in hospitals.Diabetes Care.2004;27:553–591.
- .Insulin management of diabetic patients on general medical and surgical floors.Endocr Pract.2006;12Suppl 3:86–90.
- ,,,.Inadequate blood glucose control is associated with in‐hospital mortality and morbidity in diabetic and nondiabetic patients undergoing cardiac surgery.Circulation.2008;118:113–123.
Hyperglycemia due to diabetes or stress is prevalent in the intensive care unit (ICU) and general ward setting. Umpierrez et al.1 reported hyperglycemia in 38% of hospitalized ward patients with 26% having a known history of diabetes. While patients with hyperglycemia admitted to the ICU are primarily treated with infusion insulin, those on the general wards usually receive a subcutaneous regimen of insulin. How best to transition patients from infusion insulin to a subcutaneous regimen remains elusive and under evaluated.
A recent observational pilot study of 24 surgical and 17 cardiac/medical intensive care patients at our university‐based hospital found that glycemic control significantly deteriorated when patients with diabetes transitioned from infusion insulin to subcutaneous insulin. A total of 21 critical care patients with a history of diabetes failed to receive basal insulin prior to discontinuation of the drip and developed uncontrolled hyperglycemia (mean glucose Day 1 of 216 mg/dL and Day 2 of 197 mg/dL). Patients without a history of diabetes did well post transition with a mean glucose of 142 mg/dL Day 1 and 133 mg/dL Day 2. A similar study by Czosnowski et al.2 demonstrated a significant increase in blood glucose from 123 26 mg/dL to 168 50 mg/dL upon discontinuation of infusion insulin.
This failed transition is disappointing, especially in view of the existence of a reliable subcutaneous (SC) insulin order set at our institution, but not surprising, as this is an inherently complex process. The severity of illness, the amount and mode of nutritional intake, geographic location, and provider team may all be in flux at the time of this transition. A few centers have demonstrated that a much improved transition is possible,36 however many of these solutions involve technology or incremental personnel that may not be available or the descriptions may lack sufficient detail to implement theses strategies with confidence elsewhere.
Therefore, we designed and piloted a protocol, coordinated by a multidisciplinary team, to transition patients from infusion insulin to SC insulin. The successful implementation of this protocol could serve as a blueprint to other institutions without the need for additional technology or personnel.
Methods
Patient Population/Setting
This was a prospective study of patients admitted to either the medical/cardiac intensive care unit (MICU/CCU) or surgical intensive care unit (SICU) at an academic medical facility and placed on infusion insulin for >24 hours. The Institutional Review Board (IRB) approved the study for prospective chart review and anonymous results reporting without individual consent.
Patients in the SICU were initiated on infusion insulin after 2 blood glucose readings were above 150 mg/dL, whereas initiation was left to the discretion of the attending physician in the MICU/CCU. A computerized system created in‐house recommends insulin infusion rates based on point‐of‐care (POC) glucose measurements with a target range of 91 mg/dL to 150 mg/dL.
Inclusion/Exclusion Criteria
All patients on continuous insulin infusion admitted to the SICU or the MICU/CCU between May 2008 and September 2008 were evaluated for the study (Figure 1). Patients were excluded from analysis if they were on the infusion for less than 24 hours, had a liver transplant, were discharged within 48 hours of transition, were made comfort care or transitioned to an insulin pump. All other patients were included in the final analysis.
Transition Protocol
Step 1: Does the Patient Need Basal SC Insulin?
Patients were recommended to receive basal SC insulin if they either: (1) were on medications for diabetes; (2) had an A1c 6%; or (3) received the equivalent of 60 mg of prednisone; AND had an infusion rate 1 unit/hour (Supporting Information Appendix 1). Patients on infusion insulin due to stress hyperglycemia, regardless of the infusion rate, were not placed on basal SC insulin. Patients on high dose steroids due to spinal injuries were excluded because their duration of steroid use was typically less than 48 hours and usually ended prior to the time of transition. The protocol recommends premeal correctional insulin for those not qualifying for basal insulin.
In order to establish patients in need of basal/nutritional insulin we opted to use A1c as well as past medical history to identify patients with diabetes. The American Diabetes Association (ADA) has recently accepted using an A1c 6.5% to make a new diagnosis of diabetes.7 In a 2‐week trial prior to initiating the protocol we used a cut off A1c of 6.5%. However, we found that patients with an A1c of 6% to 6.5% had poor glucose control post transition; therefore we chose 6% as our identifier. In addition, using a cut off A1c of 6% was reported by Rohlfing et al.8 and Greci et al.9 to be more than 97% sensitive at identifying a new diagnosis of diabetes.
To ensure an A1c was ordered and available at the time of transition, critical care pharmacists were given Pharmacy and Therapeutics Committee authorization to order an A1c at the start of the infusion. Pharmacists would also guide the primary team through the protocol's recommendations as well as alert the project team when a patient was expected to transition.
Step 2: Evaluate the Patient's Nutritional Intake to Calculate the Total Daily Dose (TDD) of Insulin
TDD is the total amount of insulin needed to cover both the nutritional and basal requirements of a patient over the course of 24 hours. TDD was calculated by averaging the hourly drip rate over the prior 6 hours and multiplying by 20 if taking in full nutrition or 40 if taking minimal nutrition while on the drip. A higher multiplier was used for those on minimal nutrition with the expectation that their insulin requirements would double once tolerating a full diet. Full nutrition was defined as eating >50% of meals, on goal tube feeds, or receiving total parenteral nutrition (TPN). Minimal nutrition was defined as taking nothing by mouth (or NPO), tolerating <50% of meals, or on a clear liquid diet.
Step 3: Divide the TDD Into the Appropriate Components of Insulin Treatment (Basal, Nutritional and Correction), Depending on the Nutritional Status
In Step 3, the TDD was evenly divided into basal and nutritional insulin. A total of 50% of the TDD was given as glargine (Lantus) 2 hours prior to stopping the infusion. The remaining 50% was divided into nutritional components as either Regular insulin every 6 hours for patients on tube feeds or lispro (Humalog) before meals if tolerating an oral diet. For patients on minimal nutrition, the 50% nutritional insulin dose was not initiated until the patient was tolerating full nutrition.
The protocol recommended basal insulin administration 2 hours prior to infusion discontinuation as recommended by the American Association of Clinical Endocrinologists (AACE) and ADA consensus statement on inpatient glycemic control as well as pharmacokinetics.10, 11 For these reasons, failure to receive basal insulin prior to transition was viewed as failure to follow the protocol.
Safety features of the protocol included a maximum TDD of 100 units unless the patient was on >100 units/day of insulin prior to admission. A pager was carried by rotating hospitalists or pharmacist study investigators at all hours during the protocol implementation phase to answer any questions regarding a patient's transition.
Data Collection/Monitoring
A multidisciplinary team consisting of hospitalists, ICU pharmacists, critical care physicians and nursing representatives was assembled during the study period. This team was responsible for protocol implementation, data collection, and surveillance of patient response to the protocol. Educational sessions with house staff and nurses in each unit were held prior to the beginning of the study as well as continued monthly educational efforts during the study. In addition, biweekly huddles to review ongoing patient transitions as well as more formal monthly reviews were held.
The primary objective was to improve glycemic control, defined as the mean daily glucose, during the first 48 hours post transition without a significant increase in the percentage of patients with hypoglycemia (41‐70 mg/dL) or severe hypoglycemia (40 mg/dL). Secondary endpoints included the percent of patients with severe hyperglycemia (300 mg/dL), length of stay (LOS) calculated from the day of transition, number of restarts back onto infusion insulin within 72 hours of transition, and day‐weighted glucose mean up to 12 days following transition for patients with diabetes.
Glucose values were collected and averaged over 6‐hour periods for 48 hours post transition. For patients with diabetes, POC glucose values were collected up to 12 days of hospitalization. Day‐weighted means were obtained by calculating the mean glucose for each hospital day, averaged across all hospital days.12
Analysis
Subjects were divided by the presence or absence of diabetes. Those with diabetes were recommended to receive basal SC insulin during the transition period. Within each group, subjects were further divided by adherence to the protocol. Failure to transition per protocol was defined as: not receiving at least 80% of the recommended basal insulin dose, receiving the initial dose of insulin after the drip was discontinued, or receiving basal insulin when none was recommended.
Descriptive statistics within subgroups comparing age, gender, LOS by analysis of variance for continuous data and by chi‐square for nominal data, were compared. Twenty‐four and 48‐hour post transition mean glucose values and the 12 day weighted‐mean glucose were compared using analysis of variance (Stata ver. 10). All data are expressed as mean standard deviation with a significance value established at P < 0.05.
Results
A total of 210 episodes of infusion insulin in ICU patients were evaluated for the study from May of 2008 to September 2008 (Figure 1). Ninety‐six of these episodes were excluded, most commonly due to time on infusion insulin <24 hours or transition to comfort care. The remaining 114 infusions were eligible to use the protocol. Because the protocol recommends insulin therapy based on a diagnosis of diabetes, patients were further divided into these subcategories. Of these 114 transitions, the protocol was followed 66 times (58%).
Patients With Diabetes
(Table 1: Patient Demographics; Table 2: Insulin Use and Glycemic Control; Figure 2: Transition Graph).
| Patients With Diabetes | P Value | Patients Without Diabetes | P Value | |||
|---|---|---|---|---|---|---|
| Protocol Followed, n = 29 Patients* | Protocol NOT Followed, n = 33 Patients | Protocol Followed, n = 30 Patients | Protocol NOT Followed, n = 9 Patients | |||
| ||||||
| Average age, years, mean SD | 57.7 12.1 | 57.8 12.3 | 0.681 | 56.5 18.1 | 62.4 15.5 | 0.532 |
| Male patients | 21 (72%) | 21 (63%) | 0.58 | 20 (66%) | 7 (77%) | 0.691 |
| BMI | 30.7 7.2 | 28.6 6.8 | 0.180 | 27 5.4 | 25.2 3 | 0.081 |
| History of diabetes* | 18 (64%) | 25 (86%) | 0.07 | 0 | 0 | |
| Mean Hgb A1c (%) | 6.61.2 | 7.3 1.8 | 0.136 | 5.6 0.3 | 5.4 0.4 | 0.095 |
| Full nutrition | 26 (79%) | 24 (61%) | 0.131 | 23 (70%) | 9 (100%) | |
| On hemodialysis | 5 (17%) | 9 (27%) | 0.380 | 3 (10%) | 0 | |
| On >60 mg prednisone or equivalent per day | 7 (24%) | 10 (30%) | 0.632 | 0 | 0 | |
| Patients With Diabetes | P Value | Patients Without Diabetes | P Value | |||
|---|---|---|---|---|---|---|
| Protocol Followed, n = 33 transitions | Protocol NOT followed, n = 39 transitions | Protocol Followed, n = 33 transitions | Protocol NOT Followed, n = 9 transitions | |||
| ||||||
| Average infusion rate, hours | 3.96 3.15 | 3.74 3.64 | 0.1597 | 2.34 1.5 | 4.78 1.6 | <0.001 |
| Average BG on infusion insulin (mg/dL) | 122.5 27.5 | 122.5 31.8 | 0.844 | 115.1 22.7 | 127.5 27.2 | 0.006 |
| Average basal dose (units) given | 34.5 14.4 | 14.4 15.3 | <0.001 | 0 | 32.7 | <0.001 |
| Hours before () or after (+) infusion stopped basal insulin given | 1.13 0.9 | 11.6 9.3 | <0.001 | n/a | 0.33 | * |
| Average BG 6 hours post transition (mg/dL) | 143.7 39.4 | 182 62.5 | 0.019 | 150.2 54.9 | 142.1 34.1 | 0.624 |
| Average BG 0 to 24 hours post transition (mg/dL) | 167.98 50.24 | 211.02 81.01 | <0.001 | 150.24 54.9 | 150.12 32.4 | 0.600 |
| Total insulin used from 0 to 24 hours (units) | 65 32.2 | 26.7 25.4 | <0.001 | 3.2 4.1 | 51.3 30.3 | <0.001 |
| Average BG 25 to 48 hours post transition (mg/dL) | 176.1 55.25 | 218.2 88.54 | <0.001 | 153 35.3 | 154.4 46.7 | 0.711 |
| Total insulin used from 25 to 48 hours (units) | 60.5 35.4 | 28.1 24.4 | <0.001 | 2.8 3.8 | 44.9 34 | <0.001 |
| # of patients with severe hypoglycemia (<40 mg/dL) | 1 (3%) | 1 (2.6%) | * | 0 | 1 | * |
| # of patients with hypoglycemia (4170 mg/dL) | 3 (9%) | 2 (5.1%) | * | 1 | 0 | * |
| % of BG values in goal range (80180 mg/dL) (# in range/total #) | 60.2% (153/254) | 38.2% (104/272) | 0.004 | 80.1% (173/216) | 75.4% (49/65) | 0.83 |
| # of patients with severe hyperglycemia (>300 mg/dL) | 5 (15.2%) | 19 (48.7%) | 0.002 | 1 (3%) | 1 (11.1%) | * |
| LOS from transition (days) | 14.6 11.3 | 14 11.4 | 0.836 | 25.3 24.4 | 13.6 7.5 | 0.168 |
A total of 62 individual patients accounted for 72 separate transitions in patients with diabetes based on past medical history or an A1c 6% (n = 14). Of these 72 transitions, 33 (46%) adhered to the protocol while the remaining 39 (54%) transitions varied from the protocol at the treatment team's discretion. Despite similar insulin infusion rates and mean glucose values pretransition, patients with diabetes following the protocol had better glycemic control at both 24 hours and 48 hours after transition than those patients transitioned without the protocol. Day 1 mean blood glucose was 168 mg/dL vs. 211 mg/dL (P = <0.001) and day 2 mean blood glucose was 176 mg/dL vs. 218 mg/dL (P = <0.001) in protocol vs. nonprotocol patients with diabetes respectively (Figure 2).
There was a severe hypoglycemic event (40 mg/dL) in 1 patient with diabetes following the protocol and 1 patient not following the protocol within 48 hours of transition. Both events were secondary to nutritional‐insulin mismatch with emesis after insulin in one case and tube feeds being held in the second case. These findings were consistent with our prior examination of hypoglycemia cases.13 Severe hyperglycemia (glucose 300mg/dL) occurred in 5 (15 %) patients following the protocol vs. 19 (49%) patients not following protocol (P = 0.002.) Patients with diabetes following the protocol received significantly more insulin in the first 24 hours (mean of 65 units vs. 27 units, P 0.001) and 24 to 48 hours after transition (mean of 61 units vs. 28 units, p0.001) than those not following protocol.
An alternate method used at our institution and others14, 15 to calculate TDD is based on the patient's weight and body habitus. When we compared the projected TDD based on weight with the TDD using the transition protocol, we found that the weight based method was much less aggressive. For patients following the protocol, the weight based method projected a mean TDD of 46.3 16.9 units whereas the protocol projected a mean TDD of 65 33.2 units (P = 0.001).
Patients with diabetes following protocol received basal insulin an average of 1.13 hours prior to discontinuing the insulin infusion versus 11.6 hours after for those not following protocol.
Three patients with diabetes following the protocol and 3 patients with diabetes not following the protocol were restarted on infusion insulin within 72 hours of transition.
LOS from final transition to discharge was similar between protocol vs. nonprotocol patients (14.6 vs. 14 days, P = 0.836).
Figure 3 demonstrates that when used correctly, the protocol provides an extended period of glycemic control up to 12 days post transition. Patients transitioned per protocol had a day‐weighted mean glucose of 155 mg/dL vs. 184 mg/dL (P = 0.043) in patients not following protocol. There was only 1 glucose value less than 40 mg/dL between days 2 to 12 in the protocol group.
Patients Without Diabetes
Of the 39 individual patients without diabetes there were 42 transition events, 33 transitions (78.6%) were per protocol and placed on correctional insulin only. The remaining 9 transitions failed to follow protocol in that basal insulin was prescribed, but these patients maintained comparable glycemic control without an increase in hypoglycemic events. Following transition, patients without diabetes on protocol maintained a mean glucose of 150 mg/dL in the first 24 hours and 153 mg/dL in 24 to 48 hours post transition. They required a mean daily correctional insulin dose of 3.2 units on Day 1 and 2.8 units on Day 2 despite having an average drip rate of 2.3 units/hour at the time of transition (Table 2). There were no severe hypoglycemic events and 80% of blood sugars were within the goal range of 80 mg/dL to 180 mg/dL. Only 1 patient had a single blood glucose of >300mg/dL. No patient was restarted on infusion insulin once transitioned.
Patients without diabetes had a longer LOS after transition off of infusion insulin when compared to their diabetic counterparts (22 vs. 14 days).
Discussion
This study demonstrates the utility of hospitalist‐pharmacist collaboration in the creation and implementation of a safe and effective transition protocol for patients on infusion insulin. The protocol identifies patients appropriate for transition to a basal/nutritional insulin regimen versus those who will do well with premeal correctional insulin alone. Daily mean glucose was improved post transition for diabetic patients following the protocol compared to those not following the protocol without an increase in hypoglycemic events.
We found an equal number of insulin infusion restarts within 72 hours of transition and a similar LOS in protocol vs. nonprotocol patients with diabetes. The LOS was increased for patients without diabetes. This may be due to worse outcomes noted in patients with stress hyperglycemia in other studies.1, 16
The use of the higher multiplier for patients on minimal nutrition led to confusion among many protocol users. The protocol has since been modified to start by averaging the infusion rate over the prior 6 hours and then multiplying by 20 for all patients. This essentially calculates 80% of projected insulin requirements for the next 24 hours based on the patient's current needs. This calculation is then given as 50% basal and 50% nutritional for those on full nutrition vs. 100% basal for those on minimal nutrition. This protocol change has no impact on the amount of insulin received by the patient, but is more intuitive to providers. Instead of calculating the TDD as the projected requirement when full nutrition is obtained, the TDD is now calculated based on current insulin needs, and then doubled when patients who are receiving minimal nutrition advance to full nutrition.
Our study is limited by the lack of a true randomized control group. In lieu of this, we used our patients who did not follow protocol as our control. While not truly randomized, this group is comparable based on their age, gender mix, infusion rate, mean A1c, and projected TDD. This group was also similar to our preprotocol group mentioned in the Introduction.
Additional study limitations include the small number of nondiabetic patients not following the protocol (n = 9). We noted higher infusion rates in nondiabetics not following protocol versus those following protocol, which may have driven the primary team to give basal insulin. It is possible that these 9 patients were not yet ready to transition from infusion insulin or had other stressors not measured in our study. Unfortunately their small population size limits more extensive analysis.
The protocol was followed only 50% of the time for a variety of reasons. Patients who transitioned at night or on weekends were monitored by covering pharmacists and physicians who may not have been familiar with the protocol. Many physicians and nurses remain fearful of hypoglycemia and the outcomes of our study were not yet available for education. Some reported difficulty fully understanding how to use the protocol and why a higher multiplier was used for patients who were on minimal nutrition.
Efforts to improve adherence to the protocol are ongoing with some success, aided by the data demonstrating the safety and efficacy of the transition protocol.
Conclusion
By collaborating with ICU pharmacists we were able to design and implement a protocol that successfully and safely transitioned patients from infusion insulin to subcutaneous insulin. Patients following the protocol had a higher percentage of glucose values within the goal glucose range of 80 mg/dL to 180 mg/dL. In the future, we hope to automate the calculation of TDD and directly recommend a basal/bolus regimen for the clinical provider.
Hyperglycemia due to diabetes or stress is prevalent in the intensive care unit (ICU) and general ward setting. Umpierrez et al.1 reported hyperglycemia in 38% of hospitalized ward patients with 26% having a known history of diabetes. While patients with hyperglycemia admitted to the ICU are primarily treated with infusion insulin, those on the general wards usually receive a subcutaneous regimen of insulin. How best to transition patients from infusion insulin to a subcutaneous regimen remains elusive and under evaluated.
A recent observational pilot study of 24 surgical and 17 cardiac/medical intensive care patients at our university‐based hospital found that glycemic control significantly deteriorated when patients with diabetes transitioned from infusion insulin to subcutaneous insulin. A total of 21 critical care patients with a history of diabetes failed to receive basal insulin prior to discontinuation of the drip and developed uncontrolled hyperglycemia (mean glucose Day 1 of 216 mg/dL and Day 2 of 197 mg/dL). Patients without a history of diabetes did well post transition with a mean glucose of 142 mg/dL Day 1 and 133 mg/dL Day 2. A similar study by Czosnowski et al.2 demonstrated a significant increase in blood glucose from 123 26 mg/dL to 168 50 mg/dL upon discontinuation of infusion insulin.
This failed transition is disappointing, especially in view of the existence of a reliable subcutaneous (SC) insulin order set at our institution, but not surprising, as this is an inherently complex process. The severity of illness, the amount and mode of nutritional intake, geographic location, and provider team may all be in flux at the time of this transition. A few centers have demonstrated that a much improved transition is possible,36 however many of these solutions involve technology or incremental personnel that may not be available or the descriptions may lack sufficient detail to implement theses strategies with confidence elsewhere.
Therefore, we designed and piloted a protocol, coordinated by a multidisciplinary team, to transition patients from infusion insulin to SC insulin. The successful implementation of this protocol could serve as a blueprint to other institutions without the need for additional technology or personnel.
Methods
Patient Population/Setting
This was a prospective study of patients admitted to either the medical/cardiac intensive care unit (MICU/CCU) or surgical intensive care unit (SICU) at an academic medical facility and placed on infusion insulin for >24 hours. The Institutional Review Board (IRB) approved the study for prospective chart review and anonymous results reporting without individual consent.
Patients in the SICU were initiated on infusion insulin after 2 blood glucose readings were above 150 mg/dL, whereas initiation was left to the discretion of the attending physician in the MICU/CCU. A computerized system created in‐house recommends insulin infusion rates based on point‐of‐care (POC) glucose measurements with a target range of 91 mg/dL to 150 mg/dL.
Inclusion/Exclusion Criteria
All patients on continuous insulin infusion admitted to the SICU or the MICU/CCU between May 2008 and September 2008 were evaluated for the study (Figure 1). Patients were excluded from analysis if they were on the infusion for less than 24 hours, had a liver transplant, were discharged within 48 hours of transition, were made comfort care or transitioned to an insulin pump. All other patients were included in the final analysis.
Transition Protocol
Step 1: Does the Patient Need Basal SC Insulin?
Patients were recommended to receive basal SC insulin if they either: (1) were on medications for diabetes; (2) had an A1c 6%; or (3) received the equivalent of 60 mg of prednisone; AND had an infusion rate 1 unit/hour (Supporting Information Appendix 1). Patients on infusion insulin due to stress hyperglycemia, regardless of the infusion rate, were not placed on basal SC insulin. Patients on high dose steroids due to spinal injuries were excluded because their duration of steroid use was typically less than 48 hours and usually ended prior to the time of transition. The protocol recommends premeal correctional insulin for those not qualifying for basal insulin.
In order to establish patients in need of basal/nutritional insulin we opted to use A1c as well as past medical history to identify patients with diabetes. The American Diabetes Association (ADA) has recently accepted using an A1c 6.5% to make a new diagnosis of diabetes.7 In a 2‐week trial prior to initiating the protocol we used a cut off A1c of 6.5%. However, we found that patients with an A1c of 6% to 6.5% had poor glucose control post transition; therefore we chose 6% as our identifier. In addition, using a cut off A1c of 6% was reported by Rohlfing et al.8 and Greci et al.9 to be more than 97% sensitive at identifying a new diagnosis of diabetes.
To ensure an A1c was ordered and available at the time of transition, critical care pharmacists were given Pharmacy and Therapeutics Committee authorization to order an A1c at the start of the infusion. Pharmacists would also guide the primary team through the protocol's recommendations as well as alert the project team when a patient was expected to transition.
Step 2: Evaluate the Patient's Nutritional Intake to Calculate the Total Daily Dose (TDD) of Insulin
TDD is the total amount of insulin needed to cover both the nutritional and basal requirements of a patient over the course of 24 hours. TDD was calculated by averaging the hourly drip rate over the prior 6 hours and multiplying by 20 if taking in full nutrition or 40 if taking minimal nutrition while on the drip. A higher multiplier was used for those on minimal nutrition with the expectation that their insulin requirements would double once tolerating a full diet. Full nutrition was defined as eating >50% of meals, on goal tube feeds, or receiving total parenteral nutrition (TPN). Minimal nutrition was defined as taking nothing by mouth (or NPO), tolerating <50% of meals, or on a clear liquid diet.
Step 3: Divide the TDD Into the Appropriate Components of Insulin Treatment (Basal, Nutritional and Correction), Depending on the Nutritional Status
In Step 3, the TDD was evenly divided into basal and nutritional insulin. A total of 50% of the TDD was given as glargine (Lantus) 2 hours prior to stopping the infusion. The remaining 50% was divided into nutritional components as either Regular insulin every 6 hours for patients on tube feeds or lispro (Humalog) before meals if tolerating an oral diet. For patients on minimal nutrition, the 50% nutritional insulin dose was not initiated until the patient was tolerating full nutrition.
The protocol recommended basal insulin administration 2 hours prior to infusion discontinuation as recommended by the American Association of Clinical Endocrinologists (AACE) and ADA consensus statement on inpatient glycemic control as well as pharmacokinetics.10, 11 For these reasons, failure to receive basal insulin prior to transition was viewed as failure to follow the protocol.
Safety features of the protocol included a maximum TDD of 100 units unless the patient was on >100 units/day of insulin prior to admission. A pager was carried by rotating hospitalists or pharmacist study investigators at all hours during the protocol implementation phase to answer any questions regarding a patient's transition.
Data Collection/Monitoring
A multidisciplinary team consisting of hospitalists, ICU pharmacists, critical care physicians and nursing representatives was assembled during the study period. This team was responsible for protocol implementation, data collection, and surveillance of patient response to the protocol. Educational sessions with house staff and nurses in each unit were held prior to the beginning of the study as well as continued monthly educational efforts during the study. In addition, biweekly huddles to review ongoing patient transitions as well as more formal monthly reviews were held.
The primary objective was to improve glycemic control, defined as the mean daily glucose, during the first 48 hours post transition without a significant increase in the percentage of patients with hypoglycemia (41‐70 mg/dL) or severe hypoglycemia (40 mg/dL). Secondary endpoints included the percent of patients with severe hyperglycemia (300 mg/dL), length of stay (LOS) calculated from the day of transition, number of restarts back onto infusion insulin within 72 hours of transition, and day‐weighted glucose mean up to 12 days following transition for patients with diabetes.
Glucose values were collected and averaged over 6‐hour periods for 48 hours post transition. For patients with diabetes, POC glucose values were collected up to 12 days of hospitalization. Day‐weighted means were obtained by calculating the mean glucose for each hospital day, averaged across all hospital days.12
Analysis
Subjects were divided by the presence or absence of diabetes. Those with diabetes were recommended to receive basal SC insulin during the transition period. Within each group, subjects were further divided by adherence to the protocol. Failure to transition per protocol was defined as: not receiving at least 80% of the recommended basal insulin dose, receiving the initial dose of insulin after the drip was discontinued, or receiving basal insulin when none was recommended.
Descriptive statistics within subgroups comparing age, gender, LOS by analysis of variance for continuous data and by chi‐square for nominal data, were compared. Twenty‐four and 48‐hour post transition mean glucose values and the 12 day weighted‐mean glucose were compared using analysis of variance (Stata ver. 10). All data are expressed as mean standard deviation with a significance value established at P < 0.05.
Results
A total of 210 episodes of infusion insulin in ICU patients were evaluated for the study from May of 2008 to September 2008 (Figure 1). Ninety‐six of these episodes were excluded, most commonly due to time on infusion insulin <24 hours or transition to comfort care. The remaining 114 infusions were eligible to use the protocol. Because the protocol recommends insulin therapy based on a diagnosis of diabetes, patients were further divided into these subcategories. Of these 114 transitions, the protocol was followed 66 times (58%).
Patients With Diabetes
(Table 1: Patient Demographics; Table 2: Insulin Use and Glycemic Control; Figure 2: Transition Graph).
| Patients With Diabetes | P Value | Patients Without Diabetes | P Value | |||
|---|---|---|---|---|---|---|
| Protocol Followed, n = 29 Patients* | Protocol NOT Followed, n = 33 Patients | Protocol Followed, n = 30 Patients | Protocol NOT Followed, n = 9 Patients | |||
| ||||||
| Average age, years, mean SD | 57.7 12.1 | 57.8 12.3 | 0.681 | 56.5 18.1 | 62.4 15.5 | 0.532 |
| Male patients | 21 (72%) | 21 (63%) | 0.58 | 20 (66%) | 7 (77%) | 0.691 |
| BMI | 30.7 7.2 | 28.6 6.8 | 0.180 | 27 5.4 | 25.2 3 | 0.081 |
| History of diabetes* | 18 (64%) | 25 (86%) | 0.07 | 0 | 0 | |
| Mean Hgb A1c (%) | 6.61.2 | 7.3 1.8 | 0.136 | 5.6 0.3 | 5.4 0.4 | 0.095 |
| Full nutrition | 26 (79%) | 24 (61%) | 0.131 | 23 (70%) | 9 (100%) | |
| On hemodialysis | 5 (17%) | 9 (27%) | 0.380 | 3 (10%) | 0 | |
| On >60 mg prednisone or equivalent per day | 7 (24%) | 10 (30%) | 0.632 | 0 | 0 | |
| Patients With Diabetes | P Value | Patients Without Diabetes | P Value | |||
|---|---|---|---|---|---|---|
| Protocol Followed, n = 33 transitions | Protocol NOT followed, n = 39 transitions | Protocol Followed, n = 33 transitions | Protocol NOT Followed, n = 9 transitions | |||
| ||||||
| Average infusion rate, hours | 3.96 3.15 | 3.74 3.64 | 0.1597 | 2.34 1.5 | 4.78 1.6 | <0.001 |
| Average BG on infusion insulin (mg/dL) | 122.5 27.5 | 122.5 31.8 | 0.844 | 115.1 22.7 | 127.5 27.2 | 0.006 |
| Average basal dose (units) given | 34.5 14.4 | 14.4 15.3 | <0.001 | 0 | 32.7 | <0.001 |
| Hours before () or after (+) infusion stopped basal insulin given | 1.13 0.9 | 11.6 9.3 | <0.001 | n/a | 0.33 | * |
| Average BG 6 hours post transition (mg/dL) | 143.7 39.4 | 182 62.5 | 0.019 | 150.2 54.9 | 142.1 34.1 | 0.624 |
| Average BG 0 to 24 hours post transition (mg/dL) | 167.98 50.24 | 211.02 81.01 | <0.001 | 150.24 54.9 | 150.12 32.4 | 0.600 |
| Total insulin used from 0 to 24 hours (units) | 65 32.2 | 26.7 25.4 | <0.001 | 3.2 4.1 | 51.3 30.3 | <0.001 |
| Average BG 25 to 48 hours post transition (mg/dL) | 176.1 55.25 | 218.2 88.54 | <0.001 | 153 35.3 | 154.4 46.7 | 0.711 |
| Total insulin used from 25 to 48 hours (units) | 60.5 35.4 | 28.1 24.4 | <0.001 | 2.8 3.8 | 44.9 34 | <0.001 |
| # of patients with severe hypoglycemia (<40 mg/dL) | 1 (3%) | 1 (2.6%) | * | 0 | 1 | * |
| # of patients with hypoglycemia (4170 mg/dL) | 3 (9%) | 2 (5.1%) | * | 1 | 0 | * |
| % of BG values in goal range (80180 mg/dL) (# in range/total #) | 60.2% (153/254) | 38.2% (104/272) | 0.004 | 80.1% (173/216) | 75.4% (49/65) | 0.83 |
| # of patients with severe hyperglycemia (>300 mg/dL) | 5 (15.2%) | 19 (48.7%) | 0.002 | 1 (3%) | 1 (11.1%) | * |
| LOS from transition (days) | 14.6 11.3 | 14 11.4 | 0.836 | 25.3 24.4 | 13.6 7.5 | 0.168 |
A total of 62 individual patients accounted for 72 separate transitions in patients with diabetes based on past medical history or an A1c 6% (n = 14). Of these 72 transitions, 33 (46%) adhered to the protocol while the remaining 39 (54%) transitions varied from the protocol at the treatment team's discretion. Despite similar insulin infusion rates and mean glucose values pretransition, patients with diabetes following the protocol had better glycemic control at both 24 hours and 48 hours after transition than those patients transitioned without the protocol. Day 1 mean blood glucose was 168 mg/dL vs. 211 mg/dL (P = <0.001) and day 2 mean blood glucose was 176 mg/dL vs. 218 mg/dL (P = <0.001) in protocol vs. nonprotocol patients with diabetes respectively (Figure 2).
There was a severe hypoglycemic event (40 mg/dL) in 1 patient with diabetes following the protocol and 1 patient not following the protocol within 48 hours of transition. Both events were secondary to nutritional‐insulin mismatch with emesis after insulin in one case and tube feeds being held in the second case. These findings were consistent with our prior examination of hypoglycemia cases.13 Severe hyperglycemia (glucose 300mg/dL) occurred in 5 (15 %) patients following the protocol vs. 19 (49%) patients not following protocol (P = 0.002.) Patients with diabetes following the protocol received significantly more insulin in the first 24 hours (mean of 65 units vs. 27 units, P 0.001) and 24 to 48 hours after transition (mean of 61 units vs. 28 units, p0.001) than those not following protocol.
An alternate method used at our institution and others14, 15 to calculate TDD is based on the patient's weight and body habitus. When we compared the projected TDD based on weight with the TDD using the transition protocol, we found that the weight based method was much less aggressive. For patients following the protocol, the weight based method projected a mean TDD of 46.3 16.9 units whereas the protocol projected a mean TDD of 65 33.2 units (P = 0.001).
Patients with diabetes following protocol received basal insulin an average of 1.13 hours prior to discontinuing the insulin infusion versus 11.6 hours after for those not following protocol.
Three patients with diabetes following the protocol and 3 patients with diabetes not following the protocol were restarted on infusion insulin within 72 hours of transition.
LOS from final transition to discharge was similar between protocol vs. nonprotocol patients (14.6 vs. 14 days, P = 0.836).
Figure 3 demonstrates that when used correctly, the protocol provides an extended period of glycemic control up to 12 days post transition. Patients transitioned per protocol had a day‐weighted mean glucose of 155 mg/dL vs. 184 mg/dL (P = 0.043) in patients not following protocol. There was only 1 glucose value less than 40 mg/dL between days 2 to 12 in the protocol group.
Patients Without Diabetes
Of the 39 individual patients without diabetes there were 42 transition events, 33 transitions (78.6%) were per protocol and placed on correctional insulin only. The remaining 9 transitions failed to follow protocol in that basal insulin was prescribed, but these patients maintained comparable glycemic control without an increase in hypoglycemic events. Following transition, patients without diabetes on protocol maintained a mean glucose of 150 mg/dL in the first 24 hours and 153 mg/dL in 24 to 48 hours post transition. They required a mean daily correctional insulin dose of 3.2 units on Day 1 and 2.8 units on Day 2 despite having an average drip rate of 2.3 units/hour at the time of transition (Table 2). There were no severe hypoglycemic events and 80% of blood sugars were within the goal range of 80 mg/dL to 180 mg/dL. Only 1 patient had a single blood glucose of >300mg/dL. No patient was restarted on infusion insulin once transitioned.
Patients without diabetes had a longer LOS after transition off of infusion insulin when compared to their diabetic counterparts (22 vs. 14 days).
Discussion
This study demonstrates the utility of hospitalist‐pharmacist collaboration in the creation and implementation of a safe and effective transition protocol for patients on infusion insulin. The protocol identifies patients appropriate for transition to a basal/nutritional insulin regimen versus those who will do well with premeal correctional insulin alone. Daily mean glucose was improved post transition for diabetic patients following the protocol compared to those not following the protocol without an increase in hypoglycemic events.
We found an equal number of insulin infusion restarts within 72 hours of transition and a similar LOS in protocol vs. nonprotocol patients with diabetes. The LOS was increased for patients without diabetes. This may be due to worse outcomes noted in patients with stress hyperglycemia in other studies.1, 16
The use of the higher multiplier for patients on minimal nutrition led to confusion among many protocol users. The protocol has since been modified to start by averaging the infusion rate over the prior 6 hours and then multiplying by 20 for all patients. This essentially calculates 80% of projected insulin requirements for the next 24 hours based on the patient's current needs. This calculation is then given as 50% basal and 50% nutritional for those on full nutrition vs. 100% basal for those on minimal nutrition. This protocol change has no impact on the amount of insulin received by the patient, but is more intuitive to providers. Instead of calculating the TDD as the projected requirement when full nutrition is obtained, the TDD is now calculated based on current insulin needs, and then doubled when patients who are receiving minimal nutrition advance to full nutrition.
Our study is limited by the lack of a true randomized control group. In lieu of this, we used our patients who did not follow protocol as our control. While not truly randomized, this group is comparable based on their age, gender mix, infusion rate, mean A1c, and projected TDD. This group was also similar to our preprotocol group mentioned in the Introduction.
Additional study limitations include the small number of nondiabetic patients not following the protocol (n = 9). We noted higher infusion rates in nondiabetics not following protocol versus those following protocol, which may have driven the primary team to give basal insulin. It is possible that these 9 patients were not yet ready to transition from infusion insulin or had other stressors not measured in our study. Unfortunately their small population size limits more extensive analysis.
The protocol was followed only 50% of the time for a variety of reasons. Patients who transitioned at night or on weekends were monitored by covering pharmacists and physicians who may not have been familiar with the protocol. Many physicians and nurses remain fearful of hypoglycemia and the outcomes of our study were not yet available for education. Some reported difficulty fully understanding how to use the protocol and why a higher multiplier was used for patients who were on minimal nutrition.
Efforts to improve adherence to the protocol are ongoing with some success, aided by the data demonstrating the safety and efficacy of the transition protocol.
Conclusion
By collaborating with ICU pharmacists we were able to design and implement a protocol that successfully and safely transitioned patients from infusion insulin to subcutaneous insulin. Patients following the protocol had a higher percentage of glucose values within the goal glucose range of 80 mg/dL to 180 mg/dL. In the future, we hope to automate the calculation of TDD and directly recommend a basal/bolus regimen for the clinical provider.
- ,,,,,.Hyperglycemia: an independent marker of in‐hospital mortality in patients with undiagnosed diabetes.J Clin Endocrinol Metab.2002;87:978–982.
- ,,,,,.Evaluation of glycemic control following discontinuation of an intensive insulin protocol.J Hosp Med.2009;4:28–34.
- ,,, et al.Inpatient management of hyperglycemia: the Northwestern experience.Endocr Pract.2006;12:491–505.
- ,,,.Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy.Endocr Pract.2004;10Suppl 2:71–80.
- ,,, et al.Conversion of intravenous insulin infusions to subcutaneously administered insulin glargine in patients with hyperglycemia.Endocr Pract.2006;12:641–650.
- ,.Effects of outcome on in‐hospital transition from intravenous insulin infusion to subcutaneous therapy.Am J Cardiol.2006;98:557–564.
- International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes.Diabetes Care.2009;32:1327–1334.
- ,,, et al.Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population.Diabetes Care.2000;23:187–191.
- ,,, et al.Utility of HbA(1c) levels for diabetes case finding in hospitalized patients with hyperglycemia.Diabetes Care.2003;26:1064–1068.
- ,,, et al.American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.Endocr Pract.2009;15(4):353–369.
- ,,, et al.Pharmacokinetics and pharmacodynamics of subcutaneous injection of long‐acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.Diabetes.2000;49:2142–2148.
- ,,, et al.“Glucometrics”‐‐assessing the quality of inpatient glucose management.Diabetes Technol Ther.2006;8:560–569.
- ,,.Iatrogenic Inpatient Hypoglycemia: Risk Factors, Treatment, and Prevention: Analysis of Current Practice at an Academic Medical Center With Implications for Improvement Efforts.Diabetes Spectr.2008;21:241–247.
- ,,, et al.Management of diabetes and hyperglycemia in hospitals.Diabetes Care.2004;27:553–591.
- .Insulin management of diabetic patients on general medical and surgical floors.Endocr Pract.2006;12Suppl 3:86–90.
- ,,,.Inadequate blood glucose control is associated with in‐hospital mortality and morbidity in diabetic and nondiabetic patients undergoing cardiac surgery.Circulation.2008;118:113–123.
- ,,,,,.Hyperglycemia: an independent marker of in‐hospital mortality in patients with undiagnosed diabetes.J Clin Endocrinol Metab.2002;87:978–982.
- ,,,,,.Evaluation of glycemic control following discontinuation of an intensive insulin protocol.J Hosp Med.2009;4:28–34.
- ,,, et al.Inpatient management of hyperglycemia: the Northwestern experience.Endocr Pract.2006;12:491–505.
- ,,,.Intravenous insulin infusion therapy: indications, methods, and transition to subcutaneous insulin therapy.Endocr Pract.2004;10Suppl 2:71–80.
- ,,, et al.Conversion of intravenous insulin infusions to subcutaneously administered insulin glargine in patients with hyperglycemia.Endocr Pract.2006;12:641–650.
- ,.Effects of outcome on in‐hospital transition from intravenous insulin infusion to subcutaneous therapy.Am J Cardiol.2006;98:557–564.
- International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes.Diabetes Care.2009;32:1327–1334.
- ,,, et al.Use of GHb (HbA1c) in screening for undiagnosed diabetes in the U.S. population.Diabetes Care.2000;23:187–191.
- ,,, et al.Utility of HbA(1c) levels for diabetes case finding in hospitalized patients with hyperglycemia.Diabetes Care.2003;26:1064–1068.
- ,,, et al.American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control.Endocr Pract.2009;15(4):353–369.
- ,,, et al.Pharmacokinetics and pharmacodynamics of subcutaneous injection of long‐acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.Diabetes.2000;49:2142–2148.
- ,,, et al.“Glucometrics”‐‐assessing the quality of inpatient glucose management.Diabetes Technol Ther.2006;8:560–569.
- ,,.Iatrogenic Inpatient Hypoglycemia: Risk Factors, Treatment, and Prevention: Analysis of Current Practice at an Academic Medical Center With Implications for Improvement Efforts.Diabetes Spectr.2008;21:241–247.
- ,,, et al.Management of diabetes and hyperglycemia in hospitals.Diabetes Care.2004;27:553–591.
- .Insulin management of diabetic patients on general medical and surgical floors.Endocr Pract.2006;12Suppl 3:86–90.
- ,,,.Inadequate blood glucose control is associated with in‐hospital mortality and morbidity in diabetic and nondiabetic patients undergoing cardiac surgery.Circulation.2008;118:113–123.
Copyright © 2010 Society of Hospital Medicine
Researchers reveal structure of CXCR4
Credit: Raymond Stevens
Scripps Research Institute
A team of researchers has uncovered the structure of a cell surface receptor, CXCR4, which guides blood and immune cell movement throughout the body.
CXCR4 is also found on the surface of the human immunodeficiency virus (HIV), and helps the virus to enter blood cells.
The receptor is part of a group of about 700 proteins known as G protein-coupled receptors (GPCRs).
The team, led by Raymond C. Stevens, PhD, of Scripps Research Institute in La Jolla, California, and senior author of the study, already found the structures of two other GPCRs: the adrenergic receptor and A2A adenosine receptor.
CXCR4 belongs to a different group of GPCRs, one that binds to protein molecules called chemokines, responsible for steering blood and immune cells where they are needed.
The team used GPCR biochemistry, receptor stabilization, and X-ray crystallography to capture the first visual of a chemokine receptor bound to a ligand.
Unlike the adrenergic receptor and the A2A adenosine receptor, CXCR4 likes to form dimers.
“The dimerization observation was very intriguing,” said Dr Stevens. “We solved 5 different crystal structures in multiple crystal forms, and each one had the same dimer interface. It has long been debated how GPCRs might dimerize, if they did at all. This is the first solid observation about a consistent structural GPCR dimer.”
The team believes preventing dimerization might provide a new way to block CXCR4, which results in the release of hematopoietic stem cells from bone marrow into the bloodstream.
Currently, plerixafor injection is the only drug on the market that blocks CXCR4. Therapy that assists in the release of hematopoietic stem cells to the bloodstream is very useful following stem cell transplant.
Drugs that block CXCR4 are also useful in treating HIV infection.
Their findings were published in the October 7 issue of Science.
Credit: Raymond Stevens
Scripps Research Institute
A team of researchers has uncovered the structure of a cell surface receptor, CXCR4, which guides blood and immune cell movement throughout the body.
CXCR4 is also found on the surface of the human immunodeficiency virus (HIV), and helps the virus to enter blood cells.
The receptor is part of a group of about 700 proteins known as G protein-coupled receptors (GPCRs).
The team, led by Raymond C. Stevens, PhD, of Scripps Research Institute in La Jolla, California, and senior author of the study, already found the structures of two other GPCRs: the adrenergic receptor and A2A adenosine receptor.
CXCR4 belongs to a different group of GPCRs, one that binds to protein molecules called chemokines, responsible for steering blood and immune cells where they are needed.
The team used GPCR biochemistry, receptor stabilization, and X-ray crystallography to capture the first visual of a chemokine receptor bound to a ligand.
Unlike the adrenergic receptor and the A2A adenosine receptor, CXCR4 likes to form dimers.
“The dimerization observation was very intriguing,” said Dr Stevens. “We solved 5 different crystal structures in multiple crystal forms, and each one had the same dimer interface. It has long been debated how GPCRs might dimerize, if they did at all. This is the first solid observation about a consistent structural GPCR dimer.”
The team believes preventing dimerization might provide a new way to block CXCR4, which results in the release of hematopoietic stem cells from bone marrow into the bloodstream.
Currently, plerixafor injection is the only drug on the market that blocks CXCR4. Therapy that assists in the release of hematopoietic stem cells to the bloodstream is very useful following stem cell transplant.
Drugs that block CXCR4 are also useful in treating HIV infection.
Their findings were published in the October 7 issue of Science.
Credit: Raymond Stevens
Scripps Research Institute
A team of researchers has uncovered the structure of a cell surface receptor, CXCR4, which guides blood and immune cell movement throughout the body.
CXCR4 is also found on the surface of the human immunodeficiency virus (HIV), and helps the virus to enter blood cells.
The receptor is part of a group of about 700 proteins known as G protein-coupled receptors (GPCRs).
The team, led by Raymond C. Stevens, PhD, of Scripps Research Institute in La Jolla, California, and senior author of the study, already found the structures of two other GPCRs: the adrenergic receptor and A2A adenosine receptor.
CXCR4 belongs to a different group of GPCRs, one that binds to protein molecules called chemokines, responsible for steering blood and immune cells where they are needed.
The team used GPCR biochemistry, receptor stabilization, and X-ray crystallography to capture the first visual of a chemokine receptor bound to a ligand.
Unlike the adrenergic receptor and the A2A adenosine receptor, CXCR4 likes to form dimers.
“The dimerization observation was very intriguing,” said Dr Stevens. “We solved 5 different crystal structures in multiple crystal forms, and each one had the same dimer interface. It has long been debated how GPCRs might dimerize, if they did at all. This is the first solid observation about a consistent structural GPCR dimer.”
The team believes preventing dimerization might provide a new way to block CXCR4, which results in the release of hematopoietic stem cells from bone marrow into the bloodstream.
Currently, plerixafor injection is the only drug on the market that blocks CXCR4. Therapy that assists in the release of hematopoietic stem cells to the bloodstream is very useful following stem cell transplant.
Drugs that block CXCR4 are also useful in treating HIV infection.
Their findings were published in the October 7 issue of Science.
Anti-thrombotics, Bleeding Connection No Cause for Alarm
A new Archives of Internal Medicine study that shows the use of multiple anti-thrombotics increases the risk of bleeding in atrial fibrillation (AF) patients compared with warfarin monotherapy shouldn't change hospitalists' prescribing patterns, according to one physician.
Kurt Pfeifer, MD, FACP, program director of the Internal Medicine Residency program at Medical College in Milwaukee, says the research is important, as it adds to the knowledge base on the potential dangers of combining aspirin, warfarin, and clopidogrel. But even in cases where bleeding risks can be tripled, Dr. Pfeifer suggests hospitalists keep an eye on the risk-reward curve.
"It comes back to: Ask yourself, Do [patients] have a reason to be on it?" says Dr. Pfeifer, an associate professor who stays current on bleeding-risk research. "If they do, you better have a real reason for not putting them on it."
The study concluded that all combinations of the three medications in AF patients are associated with increased risk of both fatal and nonfatal bleeding (Arch Intern Med. 2010;170(16):1433-1441). The cohort study noted that "dual warfarin and clopidogrel therapy and triple therapy carried a more than 3-fold higher risk than did warfarin monotherapy."
Dr. Pfeifer doesn't discount the information, but notes that he would likely only discourage the use in patients with a particularly high risk for bleeding. However, he thinks the study is also a good reminder that HM practitioners should communicate the risks and therapies to both patients and their PCPs.
"It's important to know what the risks are, but it doesn't take away from what the indicators are," he says. "In most of these situations, I think you can feel better that you’ve academically addressed it."
A new Archives of Internal Medicine study that shows the use of multiple anti-thrombotics increases the risk of bleeding in atrial fibrillation (AF) patients compared with warfarin monotherapy shouldn't change hospitalists' prescribing patterns, according to one physician.
Kurt Pfeifer, MD, FACP, program director of the Internal Medicine Residency program at Medical College in Milwaukee, says the research is important, as it adds to the knowledge base on the potential dangers of combining aspirin, warfarin, and clopidogrel. But even in cases where bleeding risks can be tripled, Dr. Pfeifer suggests hospitalists keep an eye on the risk-reward curve.
"It comes back to: Ask yourself, Do [patients] have a reason to be on it?" says Dr. Pfeifer, an associate professor who stays current on bleeding-risk research. "If they do, you better have a real reason for not putting them on it."
The study concluded that all combinations of the three medications in AF patients are associated with increased risk of both fatal and nonfatal bleeding (Arch Intern Med. 2010;170(16):1433-1441). The cohort study noted that "dual warfarin and clopidogrel therapy and triple therapy carried a more than 3-fold higher risk than did warfarin monotherapy."
Dr. Pfeifer doesn't discount the information, but notes that he would likely only discourage the use in patients with a particularly high risk for bleeding. However, he thinks the study is also a good reminder that HM practitioners should communicate the risks and therapies to both patients and their PCPs.
"It's important to know what the risks are, but it doesn't take away from what the indicators are," he says. "In most of these situations, I think you can feel better that you’ve academically addressed it."
A new Archives of Internal Medicine study that shows the use of multiple anti-thrombotics increases the risk of bleeding in atrial fibrillation (AF) patients compared with warfarin monotherapy shouldn't change hospitalists' prescribing patterns, according to one physician.
Kurt Pfeifer, MD, FACP, program director of the Internal Medicine Residency program at Medical College in Milwaukee, says the research is important, as it adds to the knowledge base on the potential dangers of combining aspirin, warfarin, and clopidogrel. But even in cases where bleeding risks can be tripled, Dr. Pfeifer suggests hospitalists keep an eye on the risk-reward curve.
"It comes back to: Ask yourself, Do [patients] have a reason to be on it?" says Dr. Pfeifer, an associate professor who stays current on bleeding-risk research. "If they do, you better have a real reason for not putting them on it."
The study concluded that all combinations of the three medications in AF patients are associated with increased risk of both fatal and nonfatal bleeding (Arch Intern Med. 2010;170(16):1433-1441). The cohort study noted that "dual warfarin and clopidogrel therapy and triple therapy carried a more than 3-fold higher risk than did warfarin monotherapy."
Dr. Pfeifer doesn't discount the information, but notes that he would likely only discourage the use in patients with a particularly high risk for bleeding. However, he thinks the study is also a good reminder that HM practitioners should communicate the risks and therapies to both patients and their PCPs.
"It's important to know what the risks are, but it doesn't take away from what the indicators are," he says. "In most of these situations, I think you can feel better that you’ve academically addressed it."
MGMA Names Hospitalist CEO Physician Executive of the Year
Hospitalist leader Adam Singer, MD, is to be formally named physician executive of the year on Oct. 26 by the Medical Group Management Association (MGMA), a national association of 21,500 administrators and leaders of physician group practices. Dr. Singer, who learned of the award last month, is the first hospitalist honoree.
The award recognizes physician executives who have exhibited outstanding leadership and achieved exceptional performance in healthcare delivery.
Dr. Singer, 50, who is founder, CEO, and chief medical officer of IPC: The Hospitalist Company, took the North Hollywood, Calif.-based company public in 2008. A founding member of SHM, Dr. Singer's award represents a milestone in the growing acceptance of HM as a medical business and of its business model, says Dan Fuller, president of IN Compass Health of Alpharetta, Ga.
“We’re seeing more attention to hospitalist compensation models, payment incentives, and recognition of the need to align these with both productivity and quality,” says Dr. Fuller, a member of SHM's Practice Management Committee. The award “is great for Adam, but really exciting for our movement.”
Steven Deitelzweig, MD, chair of hospital medicine for Ochsner Health System in New Orleans and chair of SHM’s Practice Management Committee, says the MGMA honor reflects growing recognition of the role hospitalists will play in the changing business of hospital care under Affordable Care Act reforms. “Hospitalists will be the ones senior hospital leaders come to for help in figuring out healthcare reform,” he says.
Dr. Singer says the award recognizes his success, as a physician, and as an entrepreneur, and is a "signpost for hospital medicine as a whole. They're recognizing HM not just as a medical specialty that has emerged in recent years, but our success as a business," he says. "HM is a business, at least as we practice it at IPC. We've shown that it can be profitable as a standalone medical service, without requiring subsidization."
Hospitalist leader Adam Singer, MD, is to be formally named physician executive of the year on Oct. 26 by the Medical Group Management Association (MGMA), a national association of 21,500 administrators and leaders of physician group practices. Dr. Singer, who learned of the award last month, is the first hospitalist honoree.
The award recognizes physician executives who have exhibited outstanding leadership and achieved exceptional performance in healthcare delivery.
Dr. Singer, 50, who is founder, CEO, and chief medical officer of IPC: The Hospitalist Company, took the North Hollywood, Calif.-based company public in 2008. A founding member of SHM, Dr. Singer's award represents a milestone in the growing acceptance of HM as a medical business and of its business model, says Dan Fuller, president of IN Compass Health of Alpharetta, Ga.
“We’re seeing more attention to hospitalist compensation models, payment incentives, and recognition of the need to align these with both productivity and quality,” says Dr. Fuller, a member of SHM's Practice Management Committee. The award “is great for Adam, but really exciting for our movement.”
Steven Deitelzweig, MD, chair of hospital medicine for Ochsner Health System in New Orleans and chair of SHM’s Practice Management Committee, says the MGMA honor reflects growing recognition of the role hospitalists will play in the changing business of hospital care under Affordable Care Act reforms. “Hospitalists will be the ones senior hospital leaders come to for help in figuring out healthcare reform,” he says.
Dr. Singer says the award recognizes his success, as a physician, and as an entrepreneur, and is a "signpost for hospital medicine as a whole. They're recognizing HM not just as a medical specialty that has emerged in recent years, but our success as a business," he says. "HM is a business, at least as we practice it at IPC. We've shown that it can be profitable as a standalone medical service, without requiring subsidization."
Hospitalist leader Adam Singer, MD, is to be formally named physician executive of the year on Oct. 26 by the Medical Group Management Association (MGMA), a national association of 21,500 administrators and leaders of physician group practices. Dr. Singer, who learned of the award last month, is the first hospitalist honoree.
The award recognizes physician executives who have exhibited outstanding leadership and achieved exceptional performance in healthcare delivery.
Dr. Singer, 50, who is founder, CEO, and chief medical officer of IPC: The Hospitalist Company, took the North Hollywood, Calif.-based company public in 2008. A founding member of SHM, Dr. Singer's award represents a milestone in the growing acceptance of HM as a medical business and of its business model, says Dan Fuller, president of IN Compass Health of Alpharetta, Ga.
“We’re seeing more attention to hospitalist compensation models, payment incentives, and recognition of the need to align these with both productivity and quality,” says Dr. Fuller, a member of SHM's Practice Management Committee. The award “is great for Adam, but really exciting for our movement.”
Steven Deitelzweig, MD, chair of hospital medicine for Ochsner Health System in New Orleans and chair of SHM’s Practice Management Committee, says the MGMA honor reflects growing recognition of the role hospitalists will play in the changing business of hospital care under Affordable Care Act reforms. “Hospitalists will be the ones senior hospital leaders come to for help in figuring out healthcare reform,” he says.
Dr. Singer says the award recognizes his success, as a physician, and as an entrepreneur, and is a "signpost for hospital medicine as a whole. They're recognizing HM not just as a medical specialty that has emerged in recent years, but our success as a business," he says. "HM is a business, at least as we practice it at IPC. We've shown that it can be profitable as a standalone medical service, without requiring subsidization."
ONLINE EXCLUSIVE: HM is a perfect fit for a palliative care service
John Harney, COO at University of Colorado Hospital, moved west in 2008 after working at New York University Hospitals Center. The East Coast hospital had used a grant to establish a palliative-care program and witnessed immediate results.
“We truly believed it resulted in reductions in length of stay, as well as humanistic benefits,” Harney says. “When I came out to Colorado, I was pleasantly surprised at the breadth and depth of the programs here.”
Harney says he believes HM is a logical place to advance palliative care to the next level, as most HM groups already possess an in-house presence and commitment to efficient throughput. Hospital administrators will be concerned with consistency, routines, and protocols, he says, as well as the palliative-care service’s commitment to quality improvement. Those same administrators appreciate the need for program and salary support, although he advises palliative-care advocates to do their homework and develop a viable business plan.
“Hospital administrators will quickly figure out the math,” Harney says. “If you’re coming to speak to us, you need to have your numbers in order. You also need some monitoring in place.”
The initial salvo should include confirmation that HM group leaders have done their homework: surveyed their HM staff and discussed the idea with oncologists and other specialists. “It’s also helpful to have real champions in nursing and social work,” Harney says. “It’s never easy to get financial support for a new program, but if you have those ducks lined up, it goes better.”
John Harney, COO at University of Colorado Hospital, moved west in 2008 after working at New York University Hospitals Center. The East Coast hospital had used a grant to establish a palliative-care program and witnessed immediate results.
“We truly believed it resulted in reductions in length of stay, as well as humanistic benefits,” Harney says. “When I came out to Colorado, I was pleasantly surprised at the breadth and depth of the programs here.”
Harney says he believes HM is a logical place to advance palliative care to the next level, as most HM groups already possess an in-house presence and commitment to efficient throughput. Hospital administrators will be concerned with consistency, routines, and protocols, he says, as well as the palliative-care service’s commitment to quality improvement. Those same administrators appreciate the need for program and salary support, although he advises palliative-care advocates to do their homework and develop a viable business plan.
“Hospital administrators will quickly figure out the math,” Harney says. “If you’re coming to speak to us, you need to have your numbers in order. You also need some monitoring in place.”
The initial salvo should include confirmation that HM group leaders have done their homework: surveyed their HM staff and discussed the idea with oncologists and other specialists. “It’s also helpful to have real champions in nursing and social work,” Harney says. “It’s never easy to get financial support for a new program, but if you have those ducks lined up, it goes better.”
John Harney, COO at University of Colorado Hospital, moved west in 2008 after working at New York University Hospitals Center. The East Coast hospital had used a grant to establish a palliative-care program and witnessed immediate results.
“We truly believed it resulted in reductions in length of stay, as well as humanistic benefits,” Harney says. “When I came out to Colorado, I was pleasantly surprised at the breadth and depth of the programs here.”
Harney says he believes HM is a logical place to advance palliative care to the next level, as most HM groups already possess an in-house presence and commitment to efficient throughput. Hospital administrators will be concerned with consistency, routines, and protocols, he says, as well as the palliative-care service’s commitment to quality improvement. Those same administrators appreciate the need for program and salary support, although he advises palliative-care advocates to do their homework and develop a viable business plan.
“Hospital administrators will quickly figure out the math,” Harney says. “If you’re coming to speak to us, you need to have your numbers in order. You also need some monitoring in place.”
The initial salvo should include confirmation that HM group leaders have done their homework: surveyed their HM staff and discussed the idea with oncologists and other specialists. “It’s also helpful to have real champions in nursing and social work,” Harney says. “It’s never easy to get financial support for a new program, but if you have those ducks lined up, it goes better.”
ONLINE EXCLUSIVE: Early-Career Hospitalists Spark Growth in On-Site Night Coverage
They have grown up in an era of reality television and hyperbolic politics. They prefer news alerts and fantasy football on their handhelds to daily newspapers and leather-bound novels. They text, they text, they text.
The generation known as millennials—those who were born in the years 1982 to 1995—is a breed unto itself. Millennials have grown up in the information age, are adept with new technologies, and have been trained under the umbrella of duty-hour guidelines that protect both the patient and the physician.
So when you hire a millennial for your hospitalist group, you’d better be clear about your expectations. “Millennials are looking for jobs that provide flexibility—time with family, time with friends, time to do other things,” says Troy Ahlstrom, MD, FHM, CFO of Traverse City-based Hospitalists of Northern Michigan and a member of SHM’s Practice Analysis committee. “There is nothing wrong with that, except that the baby boomers look at millennials and say, ‘Gosh, you slugs don’t want to work.’ ”
Dr. Ahlstrom says the influx of millennials into HM in recent years has had a significant impact on group administration—namely, an increase in use of 24/7 on-site coverage. The State of Hospital Medicine: 2010 Report Based on 2009 Data shows 68% of hospitalist groups provide on-site coverage at night. SHM’s 2007-2008 survey data showed only 53% of HM groups provided on-site coverage at night; the 2005-2006 figure was 51%. (Although the 2010 report includes a small percentage of truly academic hospitalist groups and, therefore, probably pushes the on-site coverage a little higher than in past years, Dr. Ahlstrom says he expects the trend toward on-site coverage at night to continue in the near future.)
“Baby boomers are perfectly fine with the idea of working more. They grew up working those horrifically long shifts, 36 hours straight,” Dr. Ahlstrom says. “The millennials would rather have clearly defined shifts, with nocturnists around to work the nights. Or maybe they get to be the nocturnist and work the nights. That’s the trend with younger physicians: They are more interested in seeing that split, where the days and nights are clearly set off.”
Then again, not all physicians, young or old, are against the idea of working long hours. And plenty of well-seasoned physicians are more than happy to have a nocturnist around, “but not if it’s going to cost them a lot of money or productivity,” Dr. Ahlstrom says.
They have grown up in an era of reality television and hyperbolic politics. They prefer news alerts and fantasy football on their handhelds to daily newspapers and leather-bound novels. They text, they text, they text.
The generation known as millennials—those who were born in the years 1982 to 1995—is a breed unto itself. Millennials have grown up in the information age, are adept with new technologies, and have been trained under the umbrella of duty-hour guidelines that protect both the patient and the physician.
So when you hire a millennial for your hospitalist group, you’d better be clear about your expectations. “Millennials are looking for jobs that provide flexibility—time with family, time with friends, time to do other things,” says Troy Ahlstrom, MD, FHM, CFO of Traverse City-based Hospitalists of Northern Michigan and a member of SHM’s Practice Analysis committee. “There is nothing wrong with that, except that the baby boomers look at millennials and say, ‘Gosh, you slugs don’t want to work.’ ”
Dr. Ahlstrom says the influx of millennials into HM in recent years has had a significant impact on group administration—namely, an increase in use of 24/7 on-site coverage. The State of Hospital Medicine: 2010 Report Based on 2009 Data shows 68% of hospitalist groups provide on-site coverage at night. SHM’s 2007-2008 survey data showed only 53% of HM groups provided on-site coverage at night; the 2005-2006 figure was 51%. (Although the 2010 report includes a small percentage of truly academic hospitalist groups and, therefore, probably pushes the on-site coverage a little higher than in past years, Dr. Ahlstrom says he expects the trend toward on-site coverage at night to continue in the near future.)
“Baby boomers are perfectly fine with the idea of working more. They grew up working those horrifically long shifts, 36 hours straight,” Dr. Ahlstrom says. “The millennials would rather have clearly defined shifts, with nocturnists around to work the nights. Or maybe they get to be the nocturnist and work the nights. That’s the trend with younger physicians: They are more interested in seeing that split, where the days and nights are clearly set off.”
Then again, not all physicians, young or old, are against the idea of working long hours. And plenty of well-seasoned physicians are more than happy to have a nocturnist around, “but not if it’s going to cost them a lot of money or productivity,” Dr. Ahlstrom says.
They have grown up in an era of reality television and hyperbolic politics. They prefer news alerts and fantasy football on their handhelds to daily newspapers and leather-bound novels. They text, they text, they text.
The generation known as millennials—those who were born in the years 1982 to 1995—is a breed unto itself. Millennials have grown up in the information age, are adept with new technologies, and have been trained under the umbrella of duty-hour guidelines that protect both the patient and the physician.
So when you hire a millennial for your hospitalist group, you’d better be clear about your expectations. “Millennials are looking for jobs that provide flexibility—time with family, time with friends, time to do other things,” says Troy Ahlstrom, MD, FHM, CFO of Traverse City-based Hospitalists of Northern Michigan and a member of SHM’s Practice Analysis committee. “There is nothing wrong with that, except that the baby boomers look at millennials and say, ‘Gosh, you slugs don’t want to work.’ ”
Dr. Ahlstrom says the influx of millennials into HM in recent years has had a significant impact on group administration—namely, an increase in use of 24/7 on-site coverage. The State of Hospital Medicine: 2010 Report Based on 2009 Data shows 68% of hospitalist groups provide on-site coverage at night. SHM’s 2007-2008 survey data showed only 53% of HM groups provided on-site coverage at night; the 2005-2006 figure was 51%. (Although the 2010 report includes a small percentage of truly academic hospitalist groups and, therefore, probably pushes the on-site coverage a little higher than in past years, Dr. Ahlstrom says he expects the trend toward on-site coverage at night to continue in the near future.)
“Baby boomers are perfectly fine with the idea of working more. They grew up working those horrifically long shifts, 36 hours straight,” Dr. Ahlstrom says. “The millennials would rather have clearly defined shifts, with nocturnists around to work the nights. Or maybe they get to be the nocturnist and work the nights. That’s the trend with younger physicians: They are more interested in seeing that split, where the days and nights are clearly set off.”
Then again, not all physicians, young or old, are against the idea of working long hours. And plenty of well-seasoned physicians are more than happy to have a nocturnist around, “but not if it’s going to cost them a lot of money or productivity,” Dr. Ahlstrom says.